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ABSTRACT
PSYCHOLOGICAL FACTORS AND GASTROINTESTINAL SYMPTOMS DURING
RUNNING
Alex Michael Ehlert
Old Dominion University, 2021
Director: Dr. Patrick B. Wilson

Gastrointestinal (GI) symptoms, such as nausea and gas, are common problems for
athletes in endurance sport. There is considerable evidence that psychological factors influence
GI function, but little research has evaluated this in the context of exercise-induced GI
symptoms. The overall purpose of this dissertation was to explore the role of psychological
factors in the incidence and management of GI symptoms during endurance running. Study 1
assessed associations between several psychological factors, GI symptoms, and nutrition intake
before and during runs. Study 2 evaluated the effects of daily breathing interventions on GI
symptoms, psychological factors, and heart rate variability (HRV) in runners.
Eighty-two runners were recruited for study 1. They tracked information about their
running, GI symptoms, and nutrition intake before and during runs for seven days, and
completed a survey containing psychological questionnaires. Correlational analyses were used to
quantify associations between 1) GI symptoms and psychological factors and 2) psychological
factors and nutrition intake. A measure of GI-specific anxiety had statistically significant
correlations with GI symptom burden during runs (Spearman’s rho = 0.32 – 0.38), which
remained significant (although somewhat attenuated) after adjusting for potential confounders.
However, GI symptom burden did not have statistically significant correlations with measures of
stress, trait anxiety, or body vigilance. There were also no significant negative associations
between psychological factors and nutrition intake.

Fifty-six runners with at least mild levels of anxiety and previous experiences with GI
symptoms during running were recruited for study 2 and completed baseline measurements to
quantify levels of several psychological factors, GI symptom burden, and resting HRV. They
were then randomly allocated to slow deep breathing with breath counting (SLOWBC), normal
breathing with breath counting (NORMALBC), or control groups. Participants in SLOWBC and
NORMALBC were asked to complete daily, 5-minute breathing sessions for four weeks.
Additional measurements were completed at the midpoint and during the final week of the
intervention. The results generally did not support a treatment effect from either breathing
intervention compared to the control group, except for a group x time interaction for anxiety in a
per-protocol analysis. Follow-up analyses suggested anxiety tended to decrease over time in the
breathing groups, and participants who found the breathing sessions more engaging tended to
have larger reductions in anxiety levels. Overall, it seems more intensive breathing- and/or
mindfulness-based interventions are required to substantially influence GI symptoms, stress, GIspecific anxiety, mindfulness, and HRV in runners with elevated levels of anxiety and GI
symptom burden.
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CHAPTER I
INTRODUCTION
A competitive runner puts substantial effort toward preparing their body and mind for races.
They improve their fitness through a demanding training program and carefully develop
nutritional strategies to keep their body fueled and healthy. While all this preparation is crucial
for optimal performance, it may also be rendered meaningless if the runner has an untimely
episode of severe gastrointestinal (GI) distress. This has been the case for many endurance
athletes. For example, nausea and vomiting have been reported as a primary reason for athletes
to drop out of ultra-endurance races (Hoffman & Fogard, 2011), and even among those who
avoid dropping out, up to 44% may suffer worsened performance due to GI symptoms
(Stuempfle & Hoffman, 2015). Indeed, marathon legend Bill Rodgers once said that “more
marathons are won or lost in the porta-toilets than at the dinner table” (de Oliveira et al., 2014).
The GI system plays a critical role in digesting, absorbing, and transporting nutrients and
fluids at rest, during exercise, and in the post-exercise recovery periods (Jeukendrup et al., 2011).
This is particularly important for endurance athletes, who must often consume large quantities of
exogenous carbohydrates and fluids during exercise to sustain peak performance (Jeukendrup et
al., 2011). A well-functioning GI system will allow an endurance athlete to push their body to its
optimum level, while a compromised GI system can result in exercise-induced GI disturbances
ranging from mild irritations (e.g., mild flatulence, belching) to severe medical complications
(GI hemorrhage or ischemic colits) (Grames & Berry- Cabán, 2012; Papaioannides et al., 1984).
As such, endurance athletes must navigate a delicate balance between providing enough
exogenous fuel and fluid during competition with the risks of overconsumption, inducing GI
symptoms. The ability to maintain this balance can be a primary factor in whether an endurance
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athlete places in a race, or even whether they complete the race at all (de Oliveira et al., 2014;
Stuempfle & Hoffman, 2015).
Endurance athletes experience GI symptoms at a relatively high prevalence. While rates
can be low in recreational athletes in mild environments (e.g., Pfeiffer et al., 2012), large
percentages of endurance athletes experience symptoms during training and competition (Peters
et al., 1999; ter Steege et al., 2008). Additionally, a study that asked runners to track GI
symptoms over a 30-day period found that male and female runners experienced moderatesevere symptoms during 13.8% and 21.7% of runs, respectively (Wilson, 2017). In basic terms,
most runners are unlikely to experience major GI problems on any single run, but the risk of
having at least one major issue over a several-week period is notably higher.
While all endurance athletes can experience symptoms at a relatively high prevalence,
they are particularly common and severe with ultra-endurance exercise. For example, ultraendurance events performed in hot environments can elicit symptoms in almost all participants
(93-96%; Jeukendrup et al., 2000; Stuempfle & Hoffman, 2015), though it’s important to keep in
mind that some of these cases are mild in severity. Additionally, more bothersome symptoms
such as nausea, vomiting, and GI bleeding are commonly reported (Baska et al., 1990; Hoffman
& Fogard, 2011; Jeukendrup et al., 2000; Stuempfle & Hoffman, 2015). For example, one study
found that over half (60.3%) of participants at the Western States 100-Mile Endurance Run
experienced nausea, and that 43.9% thought GI symptoms limited their performance (Stuempfle
& Hoffman, 2015). As mentioned previously, GI symptoms such as nausea and vomiting have
been cited as common reasons for dropping out of ultra-marathon races (Hoffman & Fogard,
2011; Stuempfle & Hoffman, 2015). Objective markers of GI dysfunction have been noted as
well. In one case, mild endotoxemia was observed in 68% of triathletes after a race (Jeukendrup
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et al., 2000), while another study reported that 85% of 100-mile run participants exhibited
evidence of GI bleeding based on hemoccult-positive stool samples (Baska et al., 1990).
Notably, runners with hemoccult-positive stool samples also reported higher incidence and
severity of symptoms such as nausea, bloating, and diarrhea (Baska et al., 1990). These findings
are of interest given the growing popularity of ultra-endurance events (Cejka et al., 2014; Knoth
et al., 2012).
Taken together, research suggests that GI dysfunction is a relatively common occurrence
in endurance sport, that it has the ability to impair performance (O’Brien & Rowlands, 2011;
Stuempfle & Hoffman, 2015), and can even be a serious medical concern (Papaioannides et al.,
1984). Even in recreational athletes or casual exercisers, a bout of GI symptoms may reduce the
enjoyment of training and potentially discourage further participation in endurance sport. As a
result, there is significant interest in identifying the pathophysiology of GI dysfunction during
exercise, the factors that may place an athlete at a higher risk for GI symptoms, and interventions
that prevent or reduce the severity of these symptoms (de Oliveira et al., 2014; van Wijck et al.,
2012).
The specific underlying etiology of exercise-induced GI dysfunction has not been fully
elucidated, and in reality, the contributing causes are likely to differ depending on the specific
symptom(s) being studied (e.g., nausea vs. bloating). In many situations, however, current
evidence suggests GI dysfunction and distress result from a complex interaction of several
factors including splanchnic hypoperfusion, altered gastric motility, impaired nutrient absorption,
and mechanical stress or damage (de Oliveira et al., 2014; van Wijck et al., 2012). At the onset
of exercise, blood flow is redistributed towards the active muscles and skin to meet the increased
metabolic demands and to aid in thermoregulation (Joyner & Casey, 2015). This can result in
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splanchnic hypoperfusion and gut ischemia (van Wijck et al., 2012). In addition to potentially
impacting GI motility via changes in oxygen and nutrient supply to intestinal smooth muscle, GI
ischemia can compromise the integrity of the intestinal epithelium and ultimately allow intestinal
bacterial translocation into the circulation (Costa et al., 2017b; van Wijck et al., 2012). This in
turn can cause endotoxemia as well as localized and systemic inflammation, which can further
exacerbate damage to the intestinal epithelial cells and affect gastric motility or other GI
functions (Grootjans et al., 2010; van Wijck et al., 2012). Additionally, the strong sympathetic
drive and release of catecholamines during intense exercise can alter activity at the enteric
nervous system of the gut, resulting in delayed gastric emptying, reduced esophageal peristaltic
activity and/or sphincter tone, and potentially malabsorption of nutrients (Costa et al., 2017b; de
Oliveira et al., 2014; van Wijck et al., 2012). Exercise and increased sympathetic drive can also
impact large intestine motility, but results to date are largely mixed, perhaps due to differences in
exercise intensity, modality of exercise, and measurement techniques (Cheskin et al., 1992; Rao
et al., 1999).
These functional changes may cause or exacerbate GI symptoms during exercise in
several ways. Altered upper GI motility could result in greater occurrence of reflux,
regurgitation, nausea, and fullness (de Oliveira et al., 2014), particularly with vigorous exercise
because of its delaying effect on gastric emptying (Horner et al., 2015). The implications of
altered lower GI motility are less clear, but it’s been speculated that small and large intestine
dysmotility could elicit symptoms through bacterial fermentation of carbohydrates and osmotic
shifts of fluids into the intestinal lumen (Costa et al., 2017b). Increases in migrating motor
complexes induced by exercise may be partly responsible for the occurrence of loose stools and
diarrhea during running (i.e., the “runner’s trots”) (Gil, Yazaki, & Evans, 1998). Likewise,
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mechanical impact and jostling during running may result in damage to the intestinal lining,
leading to lower GI symptoms (de Oliveira & Burini, 2009; de Oliveira et al., 2014; Rudzki et
al., 1995).
These exercise-induced changes in gut function can be further worsened by factors such
as the environment and nutritional intake. For example, exercising in hot and humid
environments and while hypohydrated can exacerbate splanchnic hypoperfusion by increasing
blood redistribution to the skin for thermoregulation (Kenefick et al., 2007). In a recent
controlled experiment, the incidences of upper and lower GI symptoms during 2 hours of
running in the heat (35°C) were 90% and 70%, respectively, versus only 40% and 30% when the
same intensity of running was carried out in temperate conditions (22°C) (Snipe et al., 2018). In
terms of dietary factors, consuming large amounts of fiber, fat, and solid protein can delay
gastric emptying, while ingesting highly concentrated carbohydrate beverages also slows gastric
emptying and could cause osmotically driven fluid shifts into the gut, increasing the risk of GI
symptoms (de Oliveira et al., 2014). Further, dietary supplements such as sodium bicarbonate
can elicit GI symptoms during exercise (Kahle et al., 2013). Beyond these factors, younger age,
less experience, female gender, and the use of non-steroidal anti-inflammatory drugs (NSAIDs;
e.g. Ibuprofen) have been associated with greater GI symptoms during exercise (de Oliveira et
al., 2014; Peters et al., 1999; Wilson, 2018), which highlights the complexity of both predicting
and preventing GI dysfunction in athletes.
One understudied area of research is that of psychological factors and their effects on GI
dysfunction in athletes. There are several notable examples of athletes that have attributed GI
symptoms to pre-event stress or anxiety. Soccer superstar Lionel Messi has had several
incidences of vomiting before and during big matches which Argentinian manager, Alejandro

6

Sabella, attributed to anxiety (Associated Press, 2014). Additionally, mixed martial artist Donald
“Cowboy” Cerrone reported in an interview that he vomits before every fight (Edgars, 2020).
Some sports movies include a scene where athletes or coaches are vomiting due to nerves before
monumental games. Given the common belief that pre-competition nerves and anxiety can elicit
GI symptoms before or during exercise or sporting events, the relative paucity of research on the
topic is somewhat surprising.
There does appear to be a strong biological basis for how acute and chronic psychological
stressors could influence GI function. The brain and the GI system have an intricate bidirectional network of communication through several neural, endocrine, and immunological
pathways, often referred to as the “brain-gut axis” (Mayer et al., 2015). There is considerable
overlap between the pathways of the brain-gut axis and the stress response systems
(Boeckxstaens et al., 2016; Vanner et al., 2016). Additionally, studies with animal models and
humans suggest that psychological stressors and chronic stress or anxiety can influence GI
function through delayed gastric emptying (Bhatia & Tandon, 2005; Enck & Holtmann, 1992;
Rolan et al., 1990), alterations in colon motility (Almy et al., 1949; Ford et al., 1995; Holtman &
Enck, 1991), compromised epithelial barrier integrity (Hyland et al., 2014; Söderholm et al.,
2002), and ultimately increased visceral sensitivity (Larauche et al., 2012).
Indeed, the inter-connectedness of the brain and gut neuroendocrine pathways is now
widely recognized as highly relevant in functional GI disorders such as irritable bowel syndrome
(IBS) (Halpert & Drossman, 2005; Labanski et al., 2020). For example, chronic stress, anxiety,
depressive symptoms, and early life trauma have all been identified as risk factors for IBS
(Bennett et al., 1998; Labanski et al., 2020; Lampe et al., 2003; Moloney et al., 2016; Racine et
al., 2012). Additionally, perceived stress is associated with symptom severity and exacerbation in

7

inflammatory bowel diseases (Langhorst et al., 2013; Levenstein et al., 2000). Several studies
have also reported correlations between GI symptoms and levels of stress or anxiety in the
general population (Haug et al., 2002; Stanghellini, 1999). Considering that endurance athletes
are exposed to a combination of stressors related to training, competition, and daily life, it is
reasonable to suggest that stress or anxiety may be a significant risk factor for GI symptoms
during endurance sport training or competition as well (Wilson, 2020b). To date, there are only a
handful of studies that have evaluated psychological factors of GI distress in endurance athletes.
Early studies found that GI symptoms were common before competition when athletes were
emotionally stressed (Worobetz & Gerrad, 1985), and that 24% of symptomatic triathletes
believed anxiety contributed (Sullivan, 1987). More recently, Wilson (2018) found that levels of
perceived anxiety and stress were correlated with incidence of meaningful upper and lower GI
symptoms (severity of >3 out of 10) during running over the course of 30 days (Spearman rho =
0.18 – 0.36). Additionally, Wilson et al. (2021) observed that endurance athletes with higher
levels of anxiety were more likely to experience certain types of GI symptoms during races,
particularly in those with higher anxiety levels on the morning of the race. Finally, Wilson
(2020a) found that measures of trait anxiety and sport competition anxiety were significantly
correlated with GI discomfort during exercise races (rho = 0.22 – 0.33).
While these initial findings suggest that stress and anxiety may be risk factors for the
development of GI symptoms during endurance exercise, much more research is needed.
Specifically, more data is needed on how stress and anxiety interact with other risk factors such
as nutritional intake (Wilson, 2020b). Endurance athletes are urged to consume exogenous
carbohydrates and fluids before and during prolonged exercise (Thomas et al., 2016), but these
recommendations are primarily based off laboratory-based studies rather than during competition
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when anxiety and stress may be elevated. As a consequence, it is currently unknown whether
competition anxiety will interact with nutritional intake to compound the risk of GI symptoms
(Wilson, 2020b). Alternatively, athletes who regularly experience symptoms during competition
may be forced to alter their nutritional strategies to avoid GI symptoms. Given the lack of data
on the interaction between psychological and nutritional risk factors for GI problems, future
studies should consider evaluating the interactions between psychological, perceptual, and
nutritional measures before and during exercise. One such approach could be to evaluate the
associations between athletes’ competition anxiety, nutritional intake, and measures of perceived
visceral or internal sensations (e.g., visceral sensitivity, body vigilance) to identify if these
factors interact to increase the risk of GI distress. Additionally, it would be valuable to evaluate
whether athletes with high levels of anxiety, visceral sensitivity, or body vigilance modify their
nutrition intake to reduce their risk of GI symptoms.
There is also a need to identify the nature of the relationship between psychological
factors and GI problems in athletes. Given that most data are currently observational, and that the
brain-gut axis involves bi-directional communication, it is possible that GI symptoms cause
increased levels of stress or anxiety rather than vice versa (Labinski et al., 2020; Wilson, 2020b).
Indeed, several studies have suggested that a bi-directional association between GI symptoms
and stress or anxiety exists in those with bowel disorders as well as the general population
(Gracie et al., 2018; Koloski et al., 2012). Experimental studies would offer significant
advantages over the current observational literature in determining how these variables are
causally related. One specific experimental approach could involve exposing athletes to acute
psychological stressors and assessing whether GI symptoms worsen during subsequent exercise.
Similarly, the role of stress and anxiety on GI distress in athletes could be clarified through
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studies that use stress- or anxiety-reducing interventions. Two of these potential interventions are
slow deep breathing (Russo et al., 2017) and mindful breath counting (Gorman & Green, 2016;
Shuai et al., 2020). Slow deep breathing has been found to increase heart rate variability (HRV;
Tharion et al., 2013) and attenuate GI symptoms in individuals with functional GI disorders
(Hjelland et al., 2007). Further, mindful breath counting has recently been demonstrated to
reduce negative attentional effects from media multi-tasking (Gorman & Green, 2016) as well as
recovery from alcohol-seeking due to stress in students (Shuai et al., 2020). Additionally,
mindfulness training has attenuated GI symptoms in IBS patients (Gaylord et al., 2011). Thus,
each of these strategies could be potentially effective and feasible interventions for endurance
athletes who have elevated levels of stress or anxiety and who are prone to GI symptoms.

Statement of the Problem
GI dysfunction is common in endurance sport, particularly during more extreme events such as
ultra-marathons or long-duration triathlons (Costa et al., 2017b; de Oliveira et al., 2014). While
severity varies, GI symptoms can impair performance, make training unpleasant, and in more
severe cases, have serious health consequences (Papaioannides et al., 1984; Stuempfle &
Hoffman, 2015). As such, there is considerable interest in identifying the underlying mechanisms
and factors that contribute to GI symptoms, as well as effective interventions to reduce their
incidence and severity. The effects of endurance exercise on the GI system are thought to stem
partly from the increased sympathetic drive and release of catecholamines into circulation,
eliciting a series of changes in circulatory, neuroendocrine, and immunological functions that can
affect gut function (Costa et al., 2017b; van Wijck et al., 2012). Additionally, mechanical factors
such as the repetitive impact and gut jostling in runners, and the effects of posture in cyclists can
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further exacerbate gut function and induce symptoms (de Oliveira et al., 2014; Rudzki et al.,
1995; Waterman & Kapur, 2012). Many correlates and predictors of exercise-induced GI
symptoms have been identified in observational studies as well. This includes exercise duration,
exercise intensity, exercise modality, age, gender, training status or experience, environmental
conditions, nutritional intake (e.g., fat, protein, fiber, highly concentrated carbohydrate
beverages), and NSAIDs (de Oliveira et al., 2014; Peters et al., 1999; ter Steege et al., 2008).
However, one area that is relatively understudied is the role of psychological factors on GI
function in endurance sport.
The brain and gut have a complex functional relationship (termed the “brain-gut axis”)
and communicate through several neuroendocrine and immunological pathways (Mayer et al.,
2015). Several of these pathways overlap with those of stress response systems, suggesting that
psychological stressors may result in alterations to gut function and vice versa (Boeckxstaens et
al., 2016; Vanner et al., 2016). Indeed, stress, anxiety, and psychiatric conditions are considered
risk factors for some functional GI disorders (e.g., IBS, inflammatory bowel disease) (Halpert &
Drossman, 2005; Labanski et al., 2020), as well as the general population (Haug et al., 2002;
Stanghellini, 1999). Additionally, experimental studies have suggested that acute psychological
stressors can cause changes to the GI system including delayed gastric emptying, altered colon
motility, and potentially impaired barrier function (Bhatia & Tandon, 2005; Holtman & Enck,
1991; Hyland et al., 2014). These effects could elicit symptoms independently or through
increases in visceral sensitivity, as this appears to be an important factor for functional GI
disorders (Labinski et al., 2020; Larauche et al., 2012). Given that athletes are exposed to a
combination of physical and psychological stressors (Rice et al., 2019), it is reasonable to
suggest that stress and anxiety (either acute or chronic) could be risk factors for GI symptoms
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during exercise (Wilson, 2020b). Initial studies have supported this hypothesis (Sullivan, 1987;
Wilson, 2018; Wilson, 2020a; Wilson et al., 2021), though there are still substantial gaps and
limitations that should be addressed moving forward.
Given that many risk factors contribute to GI distress during exercise, it is important to
identify how various factors interact. One relevant example could be related to how various
psychological (e.g. competition anxiety, body vigilance, etc.) and nutritional (e.g. carbohydrate,
fat, protein, fiber, etc.) factors interact and contribute to GI dysfunction. In addition to GI
symptoms, it would be useful to evaluate if athletes modify their nutritional strategies based on
their levels of anxiety or other factors such as visceral sensitivity and body vigilance.
Additionally, the nature of the association between psychological factors and GI function is not
entirely clear. For example, studies in GI disorders and the general population have suggested a
bi-directional relationship between psychological factors and GI symptoms (Gracie et al., 2018;
Koloski et al., 2012). Experimental studies that induce stress before exercise may help determine
the nature of the association. This may be further evaluated with stress- or anxiety-reducing
interventions such as mindful breath counting or slow deep breathing (Gorman & Green, 2016;
Russo et al., 2017; Shuai et al., 2020). Such studies would also help to identify simple and
effective interventions that athletes could use to reduce their risk of GI symptoms.

Statement of Purpose
The purpose of this dissertation is to evaluate the role of psychological factors on the incidence,
severity, and management of GI symptoms in trained runners. This will be accomplished through
two studies; one survey-based observational study, and one experimental intervention study. The
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observational study will involve prospective tracking of training runs, GI symptoms, and
nutritional intake before and during runs for one week. Runners will then be asked to complete
several psychological questionnaires to evaluate the associations between GI symptoms,
nutritional intake, and psychological constructs such as perceived stress, anxiety, GI-specific
anxiety, and body vigilance. The experimental study evaluated the effects of daily four-week
breathing interventions on HRV, psychological measures (perceived stress, anxiety, GI-specific
anxiety, body vigilance, mindfulness), and GI symptoms in runners who had at least mild anxiety
and were prone to GI issues. To do so, runners were randomly assigned to one of three groups: 1)
slow deep breathing with breath counting (SLOWBC), 2) normal breathing with breath counting
(NORMALBC), or 3) a control group. Together, these studies advance our understanding of how
psychological factors influence GI distress in trained runners.

Specific Aims
Specific Aim #1: To evaluate whether measures of anxiety, GI-specific anxiety, and body
vigilance correlate with GI symptoms during exercise in trained runners.
Hypothesis: GI-specific anxiety, body vigilance, and anxiety have all been suggested to correlate
with GI symptoms in IBS and other GI disorders; however, there is limited information available
in endurance athletes. It was hypothesized that measures of stress, trait anxiety, GI-specific
anxiety, and body vigilance would have positive correlations with GI symptoms during running.
Specific Aim #2: To assess whether levels of perceived stress, anxiety, GI-specific anxiety, and
body vigilance are associated with nutrition intake before and during runs.
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Hypothesis: Minimal evidence is available in athletic populations, but it has been suggested that
individuals who are anxious and who are sensitive to visceral or bodily sensations may modify
their nutrition to avoid GI distress. As such, it was hypothesized that athletes who scored high in
anxiety, GI-specific anxiety, and body vigilance would consume lower quantities of nutrients and
fluids before and during exercise.
Specific Aim #3: To determine whether GI symptoms experienced during runs mediates the
relationship between psychological data (anxiety, GI-specific anxiety, body vigilance) and
nutrient intake before and during runs.
Hypothesis: Anecdotally, runners report reducing their food and fluid intake when they are
experiencing high anxiety and/or hypersensitivity to stressors in their environment. In theory,
this would result in lowered nutrition intake (i.e., specific aim 2) in proximity to exercise.
However, it’s unclear if having GI symptoms during running is on the causal pathway of this
proposed relationship. In other words, if anxiety, GI-specific anxiety, or body vigilance correlate
with reduced peri-exercise nutrition intake, is it in part due to a higher rate of GI problems? It
was hypothesized that GI symptoms would partly mediate the relationships between
psychological measures (anxiety, GI-specific anxiety, body vigilance) and nutrient intakes before
and during exercise.
Specific Aim #4: To determine the effects of four-week breathing interventions (SLOWBC,
NORMALBC) on measures of HRV, perceived stress and anxiety, mindfulness, GI-specific
anxiety, body vigilance, and GI symptoms in runners who have elevated levels of anxiety and
who are prone to GI problems.
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Hypothesis: Some research has suggested that slow deep breathing and mindful breath counting
interventions can be effective for increasing HRV, reducing stress, promoting mindfulness,
reducing visceral sensitivity, and improving symptom severity in functional GI disorders.
Therefore, it was hypothesized that both four weeks of SLOWBC and NORMALBC would
increase HRV and mindfulness, reduce measures of stress, anxiety, and body vigilance, and
ultimately attenuate GI symptoms in runners who reported elevations in both anxiety and GI
problems. However, given that the depth and frequency of breaths can influence
cardiopulmonary responses (Russo et al., 2017), it was hypothesized that SLOWBC would have
greater effects than NORMALBC on the outcomes.

Study Variables
For Aim #1, the independent variables were measures of perceived stress, trait anxiety, body
vigilance, and GI-specific anxiety based on scores from four psychological questionnaires: 1) the
perceived stress scale-14 (PSS-14; Cohen et al., 1983), the State-Trait Inventory for Cognitive
and Somatic Anxiety-Trait (STICSA-Trait; Ree et al., 2008), the Body Vigilance Scale (BVS;
Schmidt et al., 1997), and the Visceral Sensitivity Index (VSI; Labus et al., 2004). The
dependent variables were the percentages of runs that they experienced a meaningful GI
symptom (defined as subjective severity >3 out of 10) for upper and lower GI symptoms.
For Aim #2, the independent variables were perceived stress, trait anxiety, GI-specific anxiety,
and body vigilance from the psychological questionnaires. The dependent variable were mean
intake of total kilocalories, carbohydrates, fat, protein, fiber, caffeine, and fluid before and
during runs during one week of training.
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For Aim #3, significant associations from Aim #2 were planned to be further analyzed to
determine if associations between psychological variables and nutrition intake before or during
runs were mediated by GI symptoms. The percentage of runs that runners experienced a
meaningful GI symptom was to be inputted as a mediator variable. The lack of significant
negative associations resulted in these analyses being dropped from study 1.
For Aim #4, the independent variable was their treatment condition (SLOWBC vs. NORMALBC
vs. control). The dependent variables were measures of HRV, psychological measures from
questionnaires (perceived stress, anxiety, body vigilance, GI-specific anxiety, mindfulness), and
percentage of runs that they experienced a meaningful GI symptom defined as severity >3 out of
10) for upper and lower GI symptoms over a one-week span. An average GI burden during runs
score was also calculated by summing all GI ratings from each run together and averaging the
sum scores across all runs.

Limitations
1. Both studies relied on self-report and subjective measures for many outcomes. While this is
not the most valid method, it was necessary given the subjective nature of most outcomes (e.g.,
perceived stress or anxiety, GI-specific anxiety, body vigilance, GI symptoms) and the remote
data collection.
2. Due to the remote data collection method for this dissertation, participants completed
questionnaires and breathing interventions independently. To minimize problems that arose from
this methodology, precise instructions were provided, and regular communication was used to
prompt participants when needed. Further, participants were asked to log their breathing
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intervention sessions in a provided journal, and weekly correspondence was used to check
adherence, and to answer questions.

Delimitations
Participants were trained runners who run at least 15-20 miles per week of total volume. The
questionnaires and other measures used are valid and have been used extensively in related
literature. Additionally, the nature of questionnaires allows for remote data collection that will
advance the field of GI distress in endurance athletes, even during a global pandemic that
restricts the ability to conduct human subjects’ research.
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Chapter II
LITERATURE REVIEW

Introduction
The GI system consists of a series of organs spanning from the oral cavity to the rectum. In
addition to several other key functions (e.g., host defense, environmental sensing), it has the vital
role of digesting, absorbing, and assimilating nutrients and fluids at rest and during exercise. In
endurance athletes, the high metabolic and thermoregulatory demands of training and
competition often warrant the consumption of exogenous carbohydrates and fluids to sustain
high workloads for long durations of time (Jeukendrup et al., 2011). A well-functioning GI
system is a key component of success, while a compromised system can result in issues ranging
from mild inconveniences to severe health consequences (Costa et al., 2017b; de Oliveira et al.,
2014). As such, competitive endurance athletes must maintain a delicate balance between
supplying the body with enough nutrients and fluids to perform optimally, while minimizing the
risk of GI dysfunction (de Oliveira et al., 2014). This is particularly true in ultra-endurance
events, where nausea and vomiting are relatively common, and are considered primary reasons
for worsened performance and dropping out of races (Jeukendrup et al., 2000; Stuempfle &
Hoffman, 2015).
A growing number of individuals are participating in endurance sporting events,
including extreme variations such as ultra-marathons (Cejka et al., 2014; Knoth et al., 2012).
Participating in such activities can have a multitude of health benefits, due to the many beneficial
effects of physical activity on health and the GI system specifically (Warburton et al., 2006;
Wolin et al., 2009). However, GI symptoms may lessen the enjoyment obtained from
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participation in endurance sport, and in some cases result in medical consequences (Grames &
Berry- Cabán, 2012; Papaioannides et al., 1984). As a result, there has been a long-standing
interest in identifying the effects of exercise on GI function, the factors that affect prevalence and
severity of GI symptoms during exercise, and potential interventions to prevent or alleviate
symptoms that are common in endurance sport.
To date, most of the research has focused on the pathophysiology of GI dysfunction and
the factors that correlate with symptom incidence and severity (Costa et al., 2017b; de Oliveira et
al., 2014). Surprisingly, the role of psychological factors such as stress and anxiety has been
relatively unexplored, despite a strong psychobiological plausibility (Wilson, 2020b). Stress and
anxiety are considered important factors in functional GI disorders such as IBS (Labanski et al.,
2020) and have been correlated with GI symptoms in the general population (Haug et al., 2002).
Recent studies have suggested that stress and anxiety are associated with GI symptoms during
endurance exercise or competition as well (Wilson, 2018; Wilson, 2020a; Wilson et al., 2021).
Yet there is still much to be learned about the role of psychological factors on GI discomfort in
endurance sport, and whether interventions can be implemented to prevent or alleviate anxietyinduced GI symptoms.
The purpose of this dissertation is to evaluate the role of psychological factors on GI
discomfort in runners, which is an understudied area of research. Specifically, two studies (one
observational, one experimental) will be used to 1) evaluate the associations between GI
symptoms, psychological factors (stress, anxiety, body vigilance, GI-specific anxiety), and
nutritional intake before and during running, and 2) assess the effects of SLOWBC and
NORMALBC interventions on GI symptoms, as well as measures of HRV, stress, anxiety, GIspecific anxiety, body vigilance, and mindfulness.
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This literature review provides a thorough overview of the research on GI discomfort in
sport and how it may, in theory, be affected by stress and anxiety. The first section summarizes
the effects of exercise on the GI system and its functional capacity. This is followed by a
description of the pathophysiology and mechanisms that contribute to GI symptoms during
exercise. Factors associated with symptoms are then briefly described, in addition to the current
recommendations for endurance athletes who wish to avoid or alleviate GI symptoms during
training and competition. The remainder of the literature review focuses on psychological factors
and how they influence GI function and symptoms. This includes an overview of the research on
the interaction between the central nervous system and GI system, as well as how acute and
chronic psychological stressors can affect GI function in both individuals with functional GI
disorders, such as IBS, and the general population. A discussion of the available research on the
associations between psychological factors and GI symptoms in active or sporting populations is
also covered, with specific attention given to the gaps and limitations that should be addressed in
future studies.

Effects of Exercise on the GI System
Endurance exercise can cause numerous effects on the GI system and its function. The precise
pathophysiology and underlying mechanisms of exercise-induced GI dysfunction require further
elucidation, and the mechanisms likely differ between specific GI symptoms (e.g., nausea vs.
bloating). However, in many cases GI disturbances during exercise are believed to stem from a
complex interaction of circulatory, neuroendocrine, and mechanical mechanisms (Costa et al.,
2017b; de Oliveira et al., 2014; ter Steege & Kolkman, 2012), as well as potentially exacerbating
factors such as nutritional choices, environmental conditions (heat, altitude, etc.), and the use of
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GI-provoking medications (Wilson, 2019). Costa et al. (2017b) recently suggested that two
major pathways are responsible for triggering many of the common GI symptoms experienced
during exercise: 1) a circulatory-GI pathway stemming from redistribution of blood during
exercise, and 2) a neuroendocrine-GI pathway where increased sympathetic drive can alter GI
function. These pathways, as well as several mechanical factors, and their effects on GI function
are discussed below.

Circulatory-GI Pathway
The gut is perfused by an arterial network consisting of three main routes: the celiac trunk,
superior mesenteric artery, and inferior mesenteric artery (Mensink et al., 2001). Each of these
main arteries branch into dense vascular plexuses (serosal, submucosal, and mucosal), with the
mucosal plexus directing blood into the capillary beds that perfuse the intestinal mucosa. After
gas and nutrient exchange with the gut tissues, the blood drains into the superior and inferior
mesenteric veins, which merge to form the portal vein. An interesting aspect of the small
intestine is the relatively large distance between the arterial blood supply and the epithelial villi
(Blikslager, 2008). As such, there is a countercurrent mechanism place that facilitates oxygen
diffusion to the epithelium via a steep oxygen gradient (Blikslager et al., 2007; Blikslager, 2008).
At the onset of exercise, the sympathetic branch of the autonomic nervous system becomes
highly active (Borresen & Lambert, 2008; Joyner & Casey, 2015). Efferent sympathetic fibers
are stimulated and catecholamines are released, resulting in a plethora of physiologic effects (e.g.
increased heart rate and cardiac output) to accommodate for the increased metabolic demands of
the skeletal muscles and heart. The increased cardiac output is accompanied by blood
redistribution towards the active musculature to further facilitate nutrient and oxygen
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transportation to metabolically active tissues. Some blood is also directed towards the skin to aid
in thermoregulation, particularly as body temperature increases or in cases of hypohydration
(Kenefick et al., 2007). Ultimately, this results in decreased blood supply to the gut (ter Steege &
Kolkman, 2012).
The most pronounced decline in splanchnic blood flow occurs within the first 10 minutes
of exercise, which can increase to as much as an 80% decline after an hour of vigorous activity
(Rehrer et al., 2001; van Wijck et al., 2011). The magnitude of the hypoperfusion appears to also
increase in parallel with exercise intensity (ter Steege & Kolkman, 2012). Several additional
factors moderate the magnitude of exercise-induced splanchnic hypoperfusion, including age,
training experience, and hydration status. One study matched older and younger athletes by their
maximal oxygen consumption (VO2max) and found that older athletes had a less pronounced
decline in splanchnic perfusion during exercise (Kenney & Ho, 1995). This could, in part, help
explain the lower prevalence of GI symptoms in older individuals reported in some studies
(Keeffe et al., 1984; Peters et al., 1999; ter Steege et al., 2008), but it could also be related to
confounding factors such as total muscle mass or average training intensity. An early study also
found that splanchnic hypoperfusion was related to an individual’s relative workload, which
could indicate that training status moderates the blood distribution to the gut during exercise
(Clausen, 1977), though this needs to be confirmed in additional studies. Finally, greater body
temperature and dehydration result in greater amounts of blood distributed to the skin for
thermoregulation (Kenefick et al., 2007). Regardless of what causes it, splanchnic hypoperfusion
during and after exercise can result in gut ischemia (van Wijck et al., 2012a).
The enterocytes of the intestinal epithelium exist in a constant state of mild hypoxia,
relying on the countercurrent exchange mechanism for adequate diffusion of oxygen from the
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arterial blood to the adjacent villi (Blikslager et al. 2007; Blikslager, 2008). This makes them
particularly susceptible to ischemic events. Gut ischemia can increase hypoxia at the tip of the
villus, ultimately causing epithelial sloughing and damage (Blikslager et al., 2007; van Wijck et
al., 2012a). Gut ischemia appears to affect a variety of intestinal cells, particularly those that
form, support, and regulate the epithelial barrier (Costa et al., 2017b; van Wijck et al., 2012a).
Damage to intestinal cells can stimulate gene expression of NF-κB within the epithelium, which
then signals the release of pro-inflammatory cytokines (e.g. interleukin-1β, tumor necrosis
factor-α, interferon-γ) (Irving et al., 2014; Kaparakis-Liaskos & Ferrero, 2015). This
inflammatory cascade can exacerbate damage and dysfunction to the epithelial barrier (Capaldo
& Nusrat, 2009).
A compromised intestinal barrier, which results from physical damage to the enterocytes
as well as the proteins that support and regulate barrier tight-junctions, can lead to increased GI
permeability (Costa et al., 2017b; Dokladny et al., 2016). When the integrity of the intestinal
barrier is compromised, there is substantial translocation of intestinal bacteria into circulation
(van Wijck et al., 2012a). This further stimulates NF-κB expression within the vasculature,
facilitating the progression of local and even systemic inflammatory responses (Irving et al.,
2014; Kaparakis-Liaskos & Ferrero, 2015; Kulp & Kuehn, 2010). The localized and systemic
inflammatory responses can exacerbate damage to the intestinal epithelial barrier, creating a
cycle of dysfunction that may ultimately result in endotoxemia, systemic inflammation, and
possibly GI symptom provocation (Capaldo & Nusrat, 2009; Costa et al., 2017b; Zuhl et al.,
2014), though there is uncertainty as to whether endotoxemia plays an actual causative role in
provoking GI symptoms.
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Beyond damage to the epithelial barrier, gut ischemia can also affect specialized cells
such as Paneth cells that respond to bacterial threats and secrete antimicrobial proteins to prevent
and combat bacterial translocation (Ayabe et al., 2000; Vaishnava et al., 2008). Furthermore, the
reduced oxygen and nutrient supply to the intestinal smooth muscle could inhibit GI motility
(Costa et al., 2017b). Thus, there are clear pathways through which gut ischemia could elicit
several detrimental effects on GI function.
While more research is needed, there is evidence that endurance exercise can cause
intestinal damage, increase GI permeability, and in some cases, induce endotoxemia (Costa et al.,
2017b; de Oliveira et al., 2014). There is no single measure that is considered the gold standard
for measuring GI barrier damage and intestinal permeability. Common approaches include
measuring blood levels of intestinal fatty acid binding protein (I-FABP) and lipopolysaccharides
as well as carrying out sugar probe tests, which evaluate the levels of non-metabolizable sugars
in the blood or urine after ingestion. Since I-FABP is primarily an intracellular protein found in
intestinal mucosal cells, increasing levels of it in the blood is often used as a marker of intestinal
epithelial cell damage. Indeed, prolonged exercise commonly increases the secretion of I-FABP
into the blood (Costa et al., 2016; Lis et al., 2015; van Wijck et al., 2011). Although elevations of
I-FABP are thought to reflect GI barrier damage, they do not measure GI permeability per se.
Instead, the appearance of lipopolysaccharides (i.e., endotoxins) and poorly absorbed sugars
(e.g., lactulose) in the blood are better indicators of dysfunction in gut barrier function. Studies
using these direct measures have demonstrated that prolonged exercise at high intensities (~70%
VO2max or more) can increase small intestine permeability, which may be exacerbated by high
body temperatures and dehydration (Buchman et al., 1999; Lambert et al., 2008; Pals et al.,
1997; Yeh et al., 2013). It is less clear whether exercise causes similar effects in gastric or large
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intestine permeability, as there are currently limited studies with mixed results (Lambert et al.,
2008; Pals et al., 1997; van Wijck et al., 2011). Extreme endurance exercise can increase GI
permeability to the point of endotoxemia, characterized by a > 5 pg/mL increase in plasma or
serum lipopolysaccharide and an accompanying decrease in endotoxin antibody concentration
(Bosenberg et al., 1988; Camus et al., 1997; Camus et al., 1998; Jeukendrup et al., 2000;
Stuempfle et al., 2016). However, this is not a universal finding, even in ultra-endurance races,
as studies from one ultra-marathon event (Western States 100-mile Endurance Run) did not find
evidence of endotoxemia, despite there being a systemic inflammatory response (Nieman et al.,
2006; Stuempfle et al., 2016).
It seems likely that exercise duration and intensity, as well as the environmental
conditions, all affect the incidence and severity of changes to GI function. The largest
observations of intestinal damage and GI permeability have been in studies where participants
perform vigorous endurance exercise for long durations (e.g. Lis et al., 2015; van Wijck et al.,
2011) and particularly in hot ambient temperatures (>30° C) (Lambert et al., 2008; Morrison et
al., 2014). Similarly, endotoxemia has primarily been observed after more extreme endurance
events, such as ultra-marathons or long-duration triathlons (Gill et al., 2015a; Gill et al., 2015b;
Jeukendrup et al., 2000; Stuempfle et al., 2016). Alternatively, current research suggests that
endotoxemia is unlikely to occur during more moderate-duration exercise (<2 hours), unless it
involves very high-intensity bouts, is performed with substantial heat stress or dehydration
(Costa et al., 2017b), or an individual consumes non-steroidal anti-inflammatory drugs (van
Wijck et al., 2012b).
Considering that exercise-induced endotoxemia can persist for 1-7 days after cessation of
exercise (Gill et al., 2015a; Gill et al., 2015b; Jeukendrup et al., 2000; Stuempfle et al., 2016),
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there is a need for more research on its effects during multi-stage endurance events (e.g. Tour de
France). It is possible that consecutive days of prolonged endurance exercise could lead to
cumulative effects on GI permeability and endotoxemia, and thus increase the risk and severity
of GI symptoms or other complications like exertional heat illnesses (Lambert, 2008).
Additionally, while gut ischemia may affect specialized intestinal cells (e.g., Paneth cells), this
has not been evaluated in the context of exercise-induced ischemia. Further research is needed to
fully elucidate the effects of different exercise protocols on intestinal damage, gut permeability,
endotoxemia, and inflammatory responses. There also needs to be further attempts to link
changes in gut function (e.g. increased GI permeability, intestinal damage, endotoxemia) with GI
symptoms experienced during exercise. Currently, some studies in which endotoxemia or
systemic inflammation was observed reported concurrent elevations in the incidence/severity of
GI symptoms (e.g. nausea, regurgitation), but there has been some inconsistency in the literature
(Brock-Utne et al., 1988; Gill et al., 2015a; Gill et al., 2015b; Jeukendrup et al., 2000; Moore et
al., 1995; Stuempfle et al., 2015).
While more data would help clarify the role of circulatory factors on GI function and
symptoms, determination of a direct causal relationship will be challenging. Exercise induces an
array of physiological and neuroendocrine changes that occur simultaneously and that may
contribute to altered GI function and symptoms. Further, it is difficult to experimentally
manipulate isolated factors, such as splanchnic hypoperfusion, in a manner that is ethical and
sufficient to determine causality. So while current evidence suggests a contributing role of
splanchnic hypoperfusion in the development of GI symptoms, the methodological and ethical
limitations involved make it challenging to identify causality in humans. There will continue to
be reliance on observational and animal model studies for the foreseeable future.
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Neuroendocrine-GI Pathway
The enteric nervous system is an intricate neural network that regulates GI function
independently from central nervous system input (Furness, 2012). While the enteric nervous
system can act independently, it also receives and responds to input from the autonomic nervous
system and other neuroendocrine modulators. For example, parasympathetic activity tends to
promote GI motility and secretion of acids and hormones (e.g. gastrin), while sympathetic
activity primarily inhibits GI functions (Browning & Travagli, 2011). As such, the strong
sympathetic drive at the onset of exercise can alter GI function in several ways, including
inhibition of gastric motility and impaired nutrient absorption (Costa et al., 2017b). This concept
is supported by animal models, where reduced sympathetic activity after spinal injuries was
associated with enhancement of gastric emptying and GI motility (Camilleri et al., 1986; Costa et
al., 2017b; Song et al., 2014).
Considering the complex interaction of neural, endocrine, and circulatory factors that
regulate GI motility and absorption (Browning & Travagli, 2011), more research in this area is
clearly needed. However, Costa et al. (2017b) proposed a preliminary pathway through which
the neuroendocrine responses to exercise may influence GI motility and absorptive capacity.
Specifically, the increased sympathetic drive and release of stress hormones at the onset of
exercise could alter enteric nervous system activity. This may in turn inhibit GI motility or
transit, leading to delayed gastric emptying, reduced nutrient transporter capacity, and ultimately
nutrient malabsorption. This retention of unabsorbed nutrients in the intestinal lumen could
further impair gastric motility through neuroendocrine-mediated feedback mechanisms such as
the “ileal brake,” which acts to control the rate of nutrient movement through the GI tract to
maximize absorption (Layer et al., 1990; Shin et al., 2013). Finally, there is likely a degree of
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interaction between circulatory and neuroendocrine pathways, as gut ischemia could impair
nutrient absorption by damaging epithelial tissue, while reduced oxygen and nutrient transport
can alter GI motility (Costa et al., 2017b).
There are several potential pathways through which altered GI motility and absorption
could provoke various GI symptoms during exercise. In the small and large intestines,
unabsorbed carbohydrate leads to gas production from bacterial fermentation, osmotic shifts of
fluids into the intestinal lumen, and luminal distension (Putkonen et al., 2013; Yao et al., 2016).
In the stomach and esophagus, decreased motility could contribute to regurgitation/reflux,
fullness, and nausea (de Oliveira et al., 2014). Additionally, exercise could directly induce
nausea through activation of the vomiting center in the medulla oblongata via increased
catecholamine concentration as part of the sympathetic response to exercise (Becker, 2010;
Joyner & Casey, 2015; Wilson, 2019). Taken together, there is a compelling rationale for how
exercise could provoke GI symptoms through alterations in the complex network of
neuroendocrine pathways that regulate gut function (Browning & Travagli, 2011; Costa et al.,
2017b).
Indeed, research has demonstrated that vigorous exercise (e.g. intermittent exercise or
steady-state at >70% max power or VO2max) impairs gastric motility, delays gastric emptying,
and alters orocaecal transit time (Costa et al., 2017b; de Oliveira et al., 2014). Alternatively,
moderate intensities (60-70% VO2max or peak power) have had negligible effects in several
studies (Leiper et al., 2001; van Nieuwenhoven, 1999; van Nieuwenhoven et al., 2004), while
light exercise may stimulate motility (Costa et al., 2017b; Leiper et al., 2001). Most of the
alterations in motility have been demonstrated within the stomach and small intestine, and the
literature focusing on the colon is largely mixed, likely due to methodological differences in
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terms of the exercise protocols and measurement techniques used (Cheskin et al., 1992; Rao et
al., 1998).
While the research is currently mixed and inconclusive, nutrient absorption may also be
affected during intense exercise. For example, using measurements of urinary excretion of nonmetabolizable glucose analogues (e.g. D-xylose, 3-O-Methyl-D glucose), Lang et al. (2006)
found that one hour of running at 70% VO2max reduced passive and active carbohydrate
absorption compared to resting conditions and lower exercise intensities (30% and 50%
VO2max). Another study found that resistance exercise increased I-FABP concentrations and
reduced protein absorption during the post-exercise recovery period (van Wijck et al., 2013).
While this finding needs to be replicated with endurance protocols and absorption of other
nutrients or fluids, it supports the idea that intense exercise may influence nutrient absorption.
However, it is still not entirely clear to what extent intense exercise alters nutrient or fluid
absorption and how this relates to exercise-induced GI symptoms (de Oliveira et al., 2014).

Mechanical Factors
While the circulatory and neuroendocrine effects of exercise are considered primary mechanisms
through which GI discomfort is provoked, several other factors may contribute to GI functional
changes and exacerbate symptoms. One such factor is the mechanical stress of exercise on the GI
system. The repetitive impact of prolonged running has been hypothesized to cause greater
damage to the lining of the intestines compared to other exercise modalities (Rudzki et al., 1995).
Indeed, the combination of the mechanical impact and gut ischemia are thought to cause GI
bleeding that has been observed in some studies with endurance athletes (Costa et al., 2017b; de
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Oliveira & Burini, 2009; Moses, 1990). In one study, acceleration output from an actometer
positioned at the abdomen was approximately double in magnitude when six subjects ran in
comparison to when they cycled at similar relative intensities (Rehrer & Meijer, 1991). Although
running is often associated with higher rates of GI symptoms than other exercise modalities, this
isn’t always true and to some extent depends on the symptom being assessed. For example, the
hunched over posture during cycling may contribute to high rates of upper GI symptoms via
increased abdominal pressure (Costa et al., 2017b). As another example, an experimental study
found that weightlifting elicited more reflux-related symptoms than did running and cycling in
experienced athletes (Collings et al., 2003).

Summary of the Effects of Exercise on the GI System
Exercise can affect the GI system in numerous ways, which has been described under a few
distinct but interacting pathways (Costa et al., 2017b; de Oliveira et al., 2014). The first is a
circulatory-GI pathway, where the redistribution of blood flow to the active muscles and skin can
result in splanchnic hypoperfusion and gut ischemia. The ischemia can cause injury to the cells
that form, support, and regulate the epithelial barrier, which in turn increases small intestine
permeability. The compromised barrier integrity allows for intestinal bacteria translocation into
circulation, triggering localized inflammatory responses and the accumulation of endotoxins.
Inflammation and endotoxemia can further exacerbate the integrity of the epithelial barrier,
creating a vicious cycle that can result in endotoxemia and systemic inflammation. Additionally,
the reduced oxygen and nutrient transport to intestinal smooth muscle could inhibit motility.
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Costa et al. (2017b) also described a neuroendocrine-GI pathway, where strong
sympathetic drive and release of stress hormones affects enteric nervous system activity. This in
turn inhibits GI motility and nutrient transit in the GI tract. Delayed gastric emptying and transit
may provoke a variety of GI symptoms but could also further affect GI function through reduced
nutrient transporter activity, and consequently, carbohydrate absorption. This nutrient
malabsorption may also be influenced by epithelial injury and inhibited motility that occurs as
part of the circulatory-GI pathway, which may then cycle back to further inhibit GI motility
through negative feedback mechanisms (e.g. the “ileal brake”). In addition to the physiological
effects of exercise, mechanical impact and gut jostling during running could potentially damage
the intestinal lining and worsen certain GI symptoms.
It is important to note that these proposed mechanisms are an attempt to conceptualize
pathways that are complex, multi-faceted, and that require further elucidation. Realistically, the
effects of exercise on GI function involves a complicated interaction between numerous
neuroendocrine, circulatory, mechanical, and immunological factors, as well as choices an
athlete makes regarding fueling, hydration, and other factors. Additionally, the underlying
mechanisms likely differ by individual symptoms. For example, modified upper GI motility
could contribute to symptoms such as reflux, regurgitation, nausea, and fullness (de Oliveira et
al., 2014), while intestinal dysmotility has been suggested to contribute to symptoms such as
abdominal cramping, gas, and flatulence through bacterial fermentation of nutrients and osmotic
shifts of fluids into the lumen (Costa et al., 2017b). Additionally, nausea and vomiting are
elicited through activation of the vomiting center within the medulla oblongata, which has many
triggers including increased concentrations of circulating catecholamines (Becker, 2010; Joyner
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& Casey, 2015; Wilson, 2019). Finally, exercise can induce migrating motor complexes within
the GI system that may contribute to loose stools and diarrhea during running (Gil et al., 1998).
Future research should continue to determine the precise effects of various exercise
protocols on the GI system, and how these effects contribute to the prevalence and severity of GI
symptoms in endurance athletes. Additionally, research should discuss these mechanisms in
relation to specific GI symptoms, as they likely have different underlying causes and differential
functional effects in terms of GI discomfort (de Oliveira et al., 2014; Jeukendrup et al., 2000).

Prevalence of GI Symptoms in Sport and Exercise
GI symptoms are relatively common in endurance sports (e.g., running, cycling, triathlons),
though the prevalence estimates vary substantially between studies depending on the study
methodology, athlete population, characteristics of the race or exercise protocol, and other
factors such as nutritional intake and environmental conditions (Costa et al., 2017b; de Oliveira
et al., 2014). Rates also depend on how GI symptoms are defined, and whether researchers
evaluate individual symptoms or categorize them by location. For example, symptoms are often
categorized as upper or lower GI symptoms (de Oliveira et al., 2014; ter Steege & Kolkman,
2012). Symptoms such as reflux, regurgitation, heartburn, belching, stomach fullness, vomiting,
and nausea are typically categorized as upper GI symptoms, while flatulence, diarrhea, rectal
bleeding, abdominal cramps, and urge to defecate are considered lower GI symptoms (Brouns &
Beckers, 1993; Moses, 1990; Peters et al., 1999; Simons & Kennedy, 2004; Wilson, 2017).
Indeed, the heterogenous approaches in the literature make it difficult to directly compare or
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aggregate results across studies. However, it does appear that GI symptoms are a relatively
common occurrence, particularly as the duration and intensity of exercise increase.
For example, Pfeiffer et al. (2012) evaluated the prevalence of serious GI symptoms
(defined as severity > 4 out of 10) between different endurance athletes during races, including
professional cyclists, amateur cyclists, city marathon participants, and triathletes that completed
either full-length or half-length Ironman events. They found relatively low incidences of serious
GI symptoms in the marathon participants (4%) and both cycling groups (professionals: 7%;
amateurs: 4%). However, 14% of the half-Ironman participants, and 31-32% of full-length
Ironman participants experienced a severe symptom. Similarly, one study of 707 marathoners
found that reports of nausea were much more common during hard training runs than easy ones
(12% vs 1.8%; Keeffe et al., 1984). Additionally, prevalences can vary significantly across
studies, even in comparable events. For example, only 7% of 227 runners who completed a
recreational marathon reported a GI symptom in one study (ter Steege et al., 2008). However,
another study found relatively high rates of lower GI symptoms in male (69%) and female (74%)
distance runners that completed a marathon (Peters et al., 1999).
One consistent finding is that GI symptoms are common, and at times quite severe, in
athletes who complete ultra-endurance running races. For example, during 161-km ultramarathon events, studies have reported that as few as 60% (Stuempfle et al., 2013) and as many
as 96% of participants experience GI symptoms (Stuempfle & Hoffman, 2015). Costa et al.
(2016) reported that 73% of athletes who completed a 24-hour continuous run, and 85% that
completed a multi-stage ultra-marathon, experienced at least one meaningful GI symptom
(defined as >50 out of 100 on a visual analog scale). Jeukendrup et al. (2000) observed that 93%
of athletes who completed a particularly challenging Ironman-length triathlon (hot temperatures,
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3600 m of altitude change during the cycle, and running on unpaved roads) experienced some
form of GI symptoms. Severe symptoms were also relatively common. For example, 21% of
participants experienced nausea that was at least 5 out of 10. Similarly, a study at the Western
States 100-mile Endurance Run found that 96% of participants experienced a symptom of some
form, and 60.3% experienced nausea, particularly during the hottest portion of the event
(Stuempfle & Hoffman, 2015). Notably, nearly half (43.9%) of race finishers believed GI
symptoms impacted their performance, while 35.6% of non-finishers stated GI symptoms as a
reason for dropping out of the race. Similarly, participants in two different 161-km ultramarathons reported nausea or vomiting to be the most common reason that non-finishers dropped
out of the race (23.0%), while 36.8% of finishers thought those symptoms impaired their
performance (Hoffman & Fogard, 2011).
Most studies have reported GI symptoms during an individual race or training session.
However recent studies have also prospectively quantified symptoms over time (Wilson, 2017;
Wilson, 2018). Wilson (2017) found that over the course of 30 days, male and female runners
experienced at least one GI symptom during 84% and 78.3% of training runs, respectively.
While less common, moderate-to-severe GI symptoms (>5 on a 0-10 scale) were still fairly
prevalent (13.8% and 21.7% of runs for men and women, respectively). Wilson (2018) set the
threshold for a significant GI symptom at a severity of at least a 3 out of 10, which was
experienced, on average, during 45.6% of runs over a 30-day period across 150 runners. Thus,
while meaningful symptoms may not occur during every bout of exercise, a sizable number of
athletes will experience at least one meaningful symptom over the course of several weeks of
training.
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Another consideration is the incidence of GI symptoms after exercise, yet there is
currently limited data available. One study found that 11% of recreational runners experienced
symptoms after a race, with nausea (5%), shivering (5%), and diarrhea (5%) being the most
common (ter Steege et al., 2008). Peters et al. (1999) reported that anywhere from 29-58% of
athletes experienced upper GI symptoms and 39-60% experienced lower GI symptoms two hours
after exercise, depending on gender and the type of athlete (e.g. distance runners, cyclists,
triathletes).

Methodological Considerations
The heterogenous approaches taken across studies has made direct comparison of GI symptom
incidence and severity a challenge. While some heterogeneity is to be expected depending on the
athlete population or specific event of interest, there are methodological considerations that
would improve the ability to interpret and compare findings moving forward. Symptoms are
often either compiled together or categorized as upper and lower GI symptoms. Additionally,
there are inconsistencies in what constitutes a severe or non-severe symptom. This makes
interpretation and comparison across studies difficult. For example, symptoms such as flatulence
or fullness may only be a mild inconvenience, while more severe cases of those same symptoms
could be detrimental to athlete comfort or performance (de Oliveira et al., 2014). Similarly,
certain symptoms like nausea, vomiting, and abdominal cramps are more likely to be an issue
whenever they occur. It is important that authors carefully consider how they will classify GI
symptoms and their severity in future studies (de Oliveira et al., 2014; Jeukendrup et al., 2000).
Many studies have asked participants to retrospectively recall symptoms during runs that
occurred months ago (Pfeiffer et al., 2012; ten Haaf et al., 2014; Rehrer et al., 1992). This may
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be problematic considering that subjective recall of painful or uncomfortable experiences can
change over time (Ariely, 1998; Kahneman et al., 1993; Redelmeier & Kahneman, 1996).
Additionally, responses to retrospective questionnaires can be influenced by factors such as the
wording, ordering, and format of questions, including how variables are operationally defined
(Schwartz & Oyserman, 2001). There should be attempts to collect data within a short timeframe
after runs or races, and to use validated questionnaires with standardized terminology and
definitions to allow for improved interpretation and comparison between studies in the future.
As mentioned previously, most studies have collected data from single time-points such
as during laboratory visits or from individual training sessions and events (de Oliveira et al.,
2014). GI symptoms likely vary day-to-day and the severity of a symptom could fluctuate over
time. There is also the possibility that damage to the GI system could accumulate over the course
of consecutive days of training or competition, such as during an intense training block or during
a multi-stage endurance event. If that is the case, single time-point data collections may not
accurately reflect GI symptomology during times when risk is the highest (Wilson, 2017). For
example, Wilson (2017; 2018) recently evidenced that runners experienced at least one
moderate-severe GI symptom (>3 out of 10) on 13.8-45.6% of runs over the course of 30 days.
Additionally, endotoxemia induced by prolonged exercise has been shown to persist for 1-7 days
after exercise cessation (Gill et al., 2015a; Gill et al., 2015b; Jeukendrup et al., 2000; Stuempfle
et al., 2016). Given these findings, it is important that the cumulative effect of multiple exercise
bouts and the progression of GI symptoms over time be assessed in future studies.
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Correlates and Predictors of GI Symptoms
The effects of exercise on the GI system can vary substantially between studies and within
individuals. For example, exercise-induced splanchnic hypoperfusion can range from small
changes in blood redistribution to substantial gut ischemia, while GI symptoms can range from
mild irritations to serious health complications (Costa et al., 2017b; van Wijck et al., 2012a). As
such, research has attempted to identify factors that correlate or predict the prevalence and
severity of GI symptoms during endurance exercise. While a thorough discussion of the many
factors and their association with GI symptoms is outside the scope of this dissertation, a short
summary of previous findings is provided in this section. Readers interested in a more thorough
discussion are directed to recent reviews on the topic (e.g. Costa et al., 2017b; de Oliveira et al.,
2014; ter Steege & Kolkman, 2012). Several specific factors related to the individual athlete (e.g.
genetics, age, gender), exercise modality (running vs. cycling), nutritional factors, and several
others are addressed. Each individual factor does not completely explain the heterogeneity in GI
symptomology, but an unfavorable combination of factors could increase risk of GI discomfort
(ter Steege & Kolkman, 2012; van Wijck et al., 2012a).
A factor that consistently correlates with higher incidence of GI symptoms is a previous
history of GI discomfort at rest (Peters et al., 1999; Wilson, 2016) and during exercise (Pfeiffer
et al., 2009; Pfeiffer et al., 2012; ter Steege et al., 2008). As a result, authors have suggested that
some athletes are either genetically or anatomically predisposed to issues (de Oliveira et al.,
2014; Pfeiffer et al., 2009). Indeed, one study found that that the degree of intestinal damage
during gut ischemia is moderated by the Mannose-binding lectin 2 (MBL2) gene (Matthijsen et
al., 2009). Specifically, individuals with the MBL2 null allele appear to experience less epithelial
damage in response to gut ischemia and reperfusion, which could theoretically protect them from
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GI symptoms during exercise, though this has not yet been directly evaluated. Women also tend
to be more prone to GI symptoms than men, though it may depend on exercise modality and the
specific symptom (Costa et al., 2017b; Keefe et al., 1984; Koistinen et al., 1991; Peters et al.,
1999; ter Steege et al., 2008). Additionally, younger athletes tend to be more prone to GI
symptoms than their older counterparts (Keeffe et al., 1984; Peters et al., 1999; ter Steege et al.,
2008; Wilson, 2018), though others have found no effect of age (Gil et al., 1998; Halvorsen et
al., 1990; Koistenen et al., 1991). Along similar lines, more experienced athletes sometimes
report less severe GI symptoms (Riddoch & Trinick, 1988; Wilson, 2018), though this
association is confounded by age.
As mentioned above, older athletes often report fewer GI problems during exercise, but
the underlying mechanisms to explain this are not entirely clear. For example, older adults could
be less prone to GI disturbances due to being less sensitive to vascular changes induced by
catecholamine release (Lakatta et al., 1987). Indeed, one study found that older athletes had less
pronounced splanchnic hypoperfusion than younger athletes matched for VO2max, though this
effect could be a product of differences in muscle mass (Kenney & Ho, 1995). Alternatively,
younger athletes could be more likely to push themselves to greater intensities for longer
durations, even at the expense of GI symptoms. As referenced previously, it might be partly due
to differences in training experience, in that older athletes tend to be more experienced and thus
better able to regulate exercise intensity and nutritional intake in a way that minimizes GI
symptoms.
With respect to exercise modality, runners tend to experience greater prevalence and
severity of symptoms compared to cyclists (Pfeiffer et al., 2012; ter Steege & Kolkman, 2012;
van Niuwenhoven et al., 2004), though in some studies cyclists were at a higher risk of upper GI
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symptoms such as reflux or regurgitation (Peters et al., 1999; ter Steege et al., 2008). These
differences are likely due to the mechanical factors addressed earlier, as the repetitive jostling,
high impact, and induction of migrating motor complexes during running could contribute to
greater damage to the intestinal lining and the development of some symptoms (Gil et al., 1998;
Rudzki et al., 1995). Theoretically, cyclists may experience upper GI symptoms due to their
posture on the bike (Waterman & Kapur, 2012).
The environmental conditions and hydration status of the athlete are also highly relevant
to the risk of GI symptoms. The incidence of symptoms and the severity of damage to the GI
system is generally greater in hot ambient temperatures (>30° C), when athletes have elevated
body temperatures (>39° C), and when they are hypohydrated (Costa et al., 2016; Costa et al.,
2017b). This is likely due to increased blood redistribution to the skin to aid in thermoregulation,
resulting in greater splanchnic hypoperfusion (Kenefick et al., 2007; van Wijck et al., 2012a).
Additionally, hypohydration could result in elevated secretion of arginine vasopressin during
exercise (Hew-Butler, 2010; Montain et al., 1997), a hormone that has been demonstrated to
elicit nausea when directly administered to humans (Caras et al., 1997; Kim et al., 1997). While
only relevant to some endurance athletes or during specific events, altitude exposure could also
result in altitude sickness, with nausea being a primary symptom (Barry & Pollard, 2003).
Endurance sport requires substantial energetic demands to maximize performance and
push the body to its physical limits (Jeukendrup et al., 2011). While large intakes of nutrients and
fluids may be necessary to sustain high-intensity exercise for prolonged periods, there is also a
delicate balance whereas too much consumption may exacerbate GI symptoms and potentially
impair performance (de Oliveira et al., 2014). Previous research has found significant
correlations between GI symptoms and many nutritional factors. This has included highly
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concentrated carbohydrate beverages (Rehrer et al., 1992; van Nieuwenhoven et al., 2005), fiber
(Peters et al., 1999; Rehrer et al., 1992), pre-exercise protein, fat, carbohydrate and energy
intakes (Peters et al., 1999; Rehrer et al., 1992; Wilson, 2016), and overconsumption of fluid
(Rollo et al., 2012). While there are some differences between factors, many of these
components are thought to contribute to symptoms through delayed gastric emptying, activation
of stretch and mechanoreceptors within the GI tract, and/or osmotic shifts of fluids into the
intestines (Gentilcore et al., 2006; Karhunen et al., 2008; Khan et al., 1993; Ma et al., 2009).
Given that hypohydration is also a risk factor for symptoms (de Oliveira et al., 2014; Neufer et
al., 1989), consuming the proper quantity of fluids can be a challenge for athletes that have high
sweat rates and/or compete and train in hot and humid environments. Athletes should experiment
with their fluid consumption strategies in similar conditions as they will be competing and
should consider assessing their sweat rates when exercising in similar conditions to estimate
fluid needs. While not feasible for all athletes, they should also attempt to acclimate to the
environment in which they will be training and competing to reduce the thermoregulatory
demands on the body (Périard et al., 2015).
Additionally, aggressive carbohydrate intakes during exercise (e.g. >50-60 g/hour) can
increase the risk of symptoms due to saturation of intestinal nutrient transporters, causing the
carbohydrates to sit unabsorbed in the gut lumen (Jeukendrup et al., 2010; Wilson, 2015). If
athletes are going to consume such large quantities of carbohydrate during exercise, they may
limit their risk of symptoms by consuming combinations of glucose and fructose since they are
absorbed with different intestinal transporters (O’Brien & Rowlands, 2011; Wilson, 2015;
Wilson & Ingraham, 2015). Consuming a combination of carbohydrate types will avoid full

40

saturation of each transporter (which occurs at ~40-50 g/hour; Jeukendrup et al., 2010) and
minimize malabsorption of carbohydrate.
Athletes using aggressive in-race nutritional strategies may also benefit from “training
the gut” to tolerate higher quantities of carbohydrate (Costa et al., 2017a; Jeukendrup, 2017).
While data in humans is still limited, there are several studies that have suggested supplementing
the diet with higher-than-normal carbohydrate doses can increase gastric emptying during
subsequent carbohydrate test feeds (Cunningham et al., 1991; Horowitz et al., 1996; Yau et al.,
2014). This is thought to occur through nutrient-specific adaptations (Cunningham et al., 1991;
Horowitz et al., 1996) and/or attenuated feedback inhibition in response to distension of the
lumen (Horowitz et al., 1996). Indeed, animal studies have suggested that digestive enzymes and
carbohydrate transporters are responsive to carbohydrate intake and presence in the GI tract
(Deren et al., 1967; Dyer et al., 2009; Ferraris et al., 1992), though more research is needed to
determine the extent to which these changes occur in humans. Regardless, it is generally
recommended that athletes practice with the specific nutritional strategy that they will be using in
competition (de Oliveira et al., 2014).
In addition to carbohydrate quantity or type, there is emerging research on the effects of
fermentable oligo- di- and monosaccharides and polyols (i.e. FODMAPs) in athletes (Lis, 2019).
FODMAPs are short-chain carbohydrates that are not efficiently digested in some individuals,
particularly when GI function is impaired such as during vigorous exercise (Lis, 2019).
Undigested and absorbed FODMAPs present a similar issue as full saturation of carbohydrate
transporters, as the excess will be left sitting in the gut lumen, leading to gas production via
fermentation, distention of the lumen, and induction of osmotic fluid shifts into the intestines
(Putkonen et al., 2013; Yao et al., 2016). Initial studies have suggested a benefit of a low-
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FODMAP diet in some athletes, either chronically, or as a temporary approach prior to
competition (Gaskell et al., 2019; Lis et al., 2018; Lis, 2019). The efficacy of this approach likely
depends on the individual athlete and whether they experience symptoms from FODMAP-rich
food sources.
Several dietary supplements that are commonly used by endurance athletes elicit GI
symptoms in some cases, including caffeine and acid-buffering solutions (e.g. sodium
bicarbonate and sodium citrate). Caffeine is one of the most studied and commonly used
ergogenic aids and has been demonstrated to improve endurance exercise performance at the
meta-analytic level (e.g. Shen et al., 2019; Southward et al., 2018). However, it can also have
side effects, including nausea, when the dose is relatively high (e.g. 500 mg; Kaplan et al., 1997).
This is likely due to elevated catecholamine concentrations, which could exacerbate changes in
GI function that occur during exercise (Robertson et al., 1978) or by activating the vomit center
within the medulla oblongata (Becker, 2010). Similar findings have been reported with
caffeinated pre-workout formulations as well (Vogel et al., 2015). Sodium bicarbonate is another
well-studied and effective dietary supplement which acts as an acid-buffer during high-intensity
exercise (McNaughton et al., 2008). However, it can also induce moderate-to-severe GI
symptoms, which in some cases causes participants to stop exercise (Freis et al., 2017; Kahle et
al., 2013). While sodium citrate is thought to be a less risky alternative to sodium bicarbonate,
high rates of nausea have been reported in some studies (e.g. Urwin et al., 2016).
A final factor to consider is the use of non-steroidal anti-inflammatory drugs (NSAIDs).
Athletes commonly use NSAIDs to reduce or prevent pain or discomfort (Gorski et al., 2011).
However, NSAID use has been reported to increase risk of upper GI symptoms and other
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complications such as GI bleeding and intestinal damage (Bjarnason & Takeuchi, 2009; Gabriel
et al., 1991; Robertson et al., 1987; van Wijck et al., 2012b).

Summary of Factors and Recommendations for Athletes
The research up until this point has identified many factors that are associated with exerciseinduced GI symptoms. Exercise that is higher in intensity and longer in duration tends to result in
the highest incidence and severity of GI symptoms, particularly when performed in a hot and
humid environment. Runners typically experience more symptoms than cyclists, though cyclists
sometimes experience high rates of upper GI symptoms specifically. Women tend to be more
prone to symptoms compared to men, though this depends on the symptom. Additionally,
younger athletes report symptoms more often than their older counterparts. It is not currently
clear whether this is due to physiological differences (e.g. differences in blood flow regulation),
because younger athletes may push the intensity to the point of increased susceptibility to gut
dysfunction, if older athletes are more experienced and better able to manage their workload to
minimize risk, or some combination of these explanations. Indeed, fitter and more experienced
athletes have generally been shown to be less prone to GI problems.
Several nutritional components have been implicated as risk factors as well. This includes
ingesting large amounts of carbohydrate (>50-60 g/hour), highly concentrated carbohydrate
drinks, FODMAPs, fiber, fats, protein, and fluid (>1000 mL/h). Several popular dietary
supplements including caffeine and sodium bicarbonate may also elicit symptoms in certain
cases or when taken in high doses. Finally, NSAIDs and other analgesics can trigger gut
dysfunction and provoke GI symptoms during exercise.
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Based on these findings, a variety of recommendations have been developed for athletes.
From a nutrition perspective, athletes should avoid consuming large quantities of fats, proteins,
and fibers in the hour or two leading up to the start of heavy exercise. If they will be consuming
large quantities of carbohydrates (>50-60 g/h) during exercise, then they should consume a
combination of glucose and fructose to avoid fully saturating intestinal transporters. Athletes
should attempt to replace fluid losses from sweat while avoiding excessive fluid consumption.
This balance may require experimenting to determine their individual sweat rates, becoming
acclimated to the environment they will train or compete in, and practicing their hydration
strategies under similar conditions when feasible. Athletes may also wish to “train their gut” by
occasionally supplementing the diet with higher than normal quantities of fluids or nutrients, as
this may increase intestinal transporter capacity or improve tolerance of the higher intakes within
the GI tract. They should avoid high-dose NSAID ingestion, particularly immediately before,
during, and after intense or prolonged exercise. Ultimately, due to the many factors involved and
the individual differences in GI discomfort and responses, each athlete should experiment with
pre-race and race-day strategies to determine what is effective and what may place them at a
higher risk.
Given the wide array of symptoms that athletes experience and the many factors that can
contribute to such symptoms, it’s perhaps unsurprising that GI discomfort remains a common
problem among athletes despite hundreds of studies on the topic to date. Moreover, observational
studies consistently find that any singe variable typically only correlates modestly with the
severity of GI symptoms during endurance competition (e.g., Pfeiffer et al., 2012; Wilson, 2016;
Wilson, 2018), which re-enforces the notion that the origins of these problems are complex,
multi-faceted, and, to some extent, unresolved.
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Psychological Factors: A Missing Piece of the Puzzle
While a substantial amount of research has focused on the pathophysiology of exercise-induced
GI discomfort and the factors that contribute to it, surprisingly little has considered psychological
factors such as stress or anxiety. Within sport, psychological factors have been recognized as
being important not only for performance (Brown & Fletcher, 2017) but also in relation to the
risks of illness (Gleeson, 2016) and injury (Ardern et al., 2016; Yadava & Awasthi, 2016). There
is also a strong psychobiological basis for how psychological factors can influence GI symptoms
in athletes (Wilson, 2020b), while research in both clinical and general populations have
suggested that stress and anxiety contribute to the severity of GI symptoms (Haug et al., 2002;
Labanski et al., 2020).
The following sections introduce the concept of the brain-gut axis, which is a functional
relationship between the central nervous system and the GI system (Mayer et al., 2015). From
there, the effects of acute and chronic psychological stressors on GI function are discussed,
followed by an overview of proposed mechanisms for how stress and anxiety may influence
exercise-induced GI discomfort. These sections are followed by a review of the available
literature on psychological factors and GI symptoms in active or athletic populations, with
particular focus on some of the many potential future research directions.

Stress and Anxiety Overview
Many different descriptions of stress have been conceptualized over the years. Walter Cannon
developed a “fight or flight” response concept based on his early contributions to uncovering the
physiology of catecholamine secretion and the stress response systems (McCarty, 2016).
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Specifically, he discussed the functional relationship between the sympathetic nervous system
and the adrenal medulla, with epinephrine serving as the primary messenger to facilitate a
response to emotion or some form of stimuli. Around the same time, Hans Selye developed the
“General Adaptation Syndrome” concept, which is considered a primary launching point for
increased study and understanding of stress and its effects on human health and physiology
(Jackson et al., 2014; Selye, 1936). Selye’s General Adaptation Syndrome describes a triphasic
response to generalized stressors. This includes an alarm phase, whereas resources are mobilized
for a response, a resistance phase where the organism attempts to cope with the stressor, and then
finally a stage of exhaustion if the stressor continues and resources are depleted. While our
understanding of stress has evolved substantially since these early descriptions, the work by
Cannon and Selye are still considered foundational to how the human body can cope and adapt to
various stressors.
Stress is typically defined as either specific or non-specific responses to stimuli that
threaten a person’s homeostasis and challenge their coping abilities, while anxiety is referred to
as feelings of distress, worry, or manifestations of tension that occur due to the anticipation of
future danger or events (American Psychiatric Association, 2013; Chrousos, 2000). Stress and
anxiety tend to accompany each other (e.g. Fan et al., 2015; Kurebayashi et al., 2012), but it is
important to delineate between the two, which has often not been the case in research on
psychological factors and GI function. In a review of the literature, Wilson (2020) recently used
the term acute psychological stress to describe transient changes in gut function in response to a
stressor, while anxiety was used when measures were anxiety specific. To remain consistent with
recent articles in this area, these delineations are used in the remainder of the dissertation.
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The Brain-Gut Axis
The enteric system of the gut can act intrinsically, but it also receives and responds to input from
the central and autonomic nervous systems (Browning & Travagli, 2011). Indeed, the GI system
and brain have an intricate bi-directional connection known as the “brain-gut axis” (Mayer et al.,
2015; Molina-Torres et al., 2019). Communication occurs through several neural, endocrine, and
immunological pathways (Bercik & Collins, 2014; Mayer et al., 2015). Specifically, the vagus
nerve of the autonomic nervous system communicates with the enteric nervous system to help
regulate various effector cells within the GI system, including the smooth muscle and secretory
cells that regulate functions such as GI motility (Browning & Travagli, 2011). Similarly,
sympathetic stimulation can affect the GI system through the release and circulation of
catecholamines. Bi-directional communication is allowed through a dense network of visceral
afferent nerves that respond to stimuli and relay signals to the central nervous system. Another
important connection between the brain and gut is the HPA axis and its neuroendocrine
mediators, such as cortisol (Boeckxstaens et al., 2016).
The pathways that connect the brain-gut axis overlap with those of central and peripheral
stress systems (Boeckxstaens et al., 2016; Vanner et al., 2016). Stress or anxiety could
potentially modulate gut function through several pathways, including increased sympathetic
activity and/or dampened vagus nerve stimulation, HPA-axis stimulation, and release of
glucocorticoids such as cortisol. One hormone that is especially important in mediating the GI
changes with stress is corticotropin-releasing hormone (CRH), which influences GI function
through both central and peripheral actions (Boeckxstaens et al., 2016; Taché & Bonanz, 2007).
The following sections focus on the research that has evaluated the effects of psychological
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stressors on gut function, as well as the association between chronic stress or anxiety and GI
symptoms.

Acute Psychological Stressors and GI Function
The role of psychological factors on GI function was reported as early as 1833, when William
Beaumont observed an association between gastric secretions, gastric mucosal color, and
emotional states such as fear, anger or “…whatever depresses or disturbs the nervous system” in
a patient with a permanent fistula in the stomach (Beaumont & Osler, 1996). The role of the
vagus nerve on gastric secretion was also implicated as early as 1902, when Pavlov reported that
cephalic phase (e.g. central nervous system-mediated) gastric secretion was mediated by vagal
activity (Pavlov, 1902). Throughout the 20th century, animal models were evaluated to determine
the effects of various psychological stressors, such as cold-restraint, acoustic stress, neonatal
maternal separation, and water avoidance, on GI function (Barone et al., 1990; Coutinho et al.,
2002; Enck et al., 1989; Gue et al., 1987). While some models’ applicability to humans was
questioned, the findings from early animal studies were instrumental in identifying the effects of
psychological factors on the human GI system, and for sparking the interest in other relevant
topics such as the effects of stress on visceral pain and sensitivity (Elsenbruch & Enck, 2017).
Similar studies have since been conducted with human participants using non-invasive
psychologic stressors such as the Trier Social Stress Test (Kirschbaum et al., 1993), auditory
stressors (Dickhaus et al., 2003), listening to sad music (Coen et al., 2009), performing
demanding neurocognitive tasks (Posserud et al., 2004), or viewing emotional images or movies
(Fournier et al., 2018; Phillips et al., 2003). Taken together, the available research supplies

48

evidence that acute psychological stress can affect several aspects of GI function, including GI
motility (gastric and colonic) and GI permeability.

GI Motility
Cannon’s early work on “fight or flight” responses included several studies on the association
between psychological factors and gastric activity (Cannon, 1916; Cannon & de la Paz, 1911).
He manipulated the temperament of cats by either restraining them, or placing a barking dog
nearby, and evaluated the effects on gastric motility and smooth muscle activity. In one study,
gastric motility was reduced in cats that became agitated from being restrained, while those that
remained calm had negligible change (Cannon, 1916). Another study found that the presence of a
barking dog resulted in relaxation of the intestinal smooth muscle, indicative of altered gastric
motility (Cannon & de la Paz, 1911).
Since that time, numerous studies have also found that various acute psychological
stressors can inhibit gastric motility in both animal models (Enck & Holtmann, 1992; Taché,
1989) and humans (Roland et al., 1990; Simpson & Stakes, 1987). Inhibition of gastric motility
due to psychological stress is relevant to endurance athletes, considering that delayed gastric
emptying has been suggested as a cause of GI symptoms both during exercise (Costa et al.,
2017b; de Oliveira et al., 2014) and at rest (Khayyam et al., 2010; Sarnelli et al., 2003). Acute
psychological stress has also been found to inhibit small intestine motility in some studies with
both rodents (Wang & Wu, 2005) and humans (Kellow et al., 1992). Though others have found
that the small intestine is less responsive to psychological stressors than other parts of the GI
tract (Stam et al., 1995).
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Similarly, colonic motility appears to be responsive to psychological stressors. Early
studies demonstrated that discussing emotional topics stimulated large intestine motility (Almy
et al., 1949), which was replicated in studies that used various other psychological stressors
(Bhatia & Tandon, 2005; Ford et al., 1995; Holtmann & Enck, 1991; Rao et al., 1998; Welgan et
al., 1988). For example, Rao et al. (1998) found that a dichotomous listening task resulted in
increased propagating contractions and colonic motility in 12 healthy subjects. Similar results
have been demonstrated in response to mental arithmetic, fear stressors, and mirror tracing tasks
in IBS patients (Fukudo & Suzuki, 1987; Welgan et al., 1988). More indirect evidence of
alterations comes from animal studies, where exposure to a new environment caused increased
defecation frequency in rats (Candland et al., 1967; Hall, 1934) and similar responses in other
animals (e.g. Rushen et al., 2001). There are conflicting findings regarding the effects of altered
colon motility on GI symptoms. For example, it was originally assumed that hypermotility
resulted in diarrhea or loose stools, while hypomotility elicited constipation; however, this has
not always been the case (Chey et al., 2001; Parks et al., 1973; Wilson, 2020b). The differences
may be due to differences in methodology including where measurements are taken and the
specific type of motor activity that was evaluated (Wilson, 2020b).

Epithelial Damage, GI Permeability, and Inflammation
Some non-exercise studies in rats and humans have demonstrated that psychological stressors
can damage intestinal epithelial cells, increase GI permeability, and elicit intestinal inflammation
(Farhadi et al., 2005; Meddings & Swain, 2000; Saunders et al., 2002; Söderholm et al., 2002;
Vanuytsel et al., 2014; Yoshikawa et al., 2017). These effects have been attributed to several
potential mechanisms, but a common explanation is that the secretion of CRH and the
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subsequent activation of mucosa mast cells triggers an inflammatory cascade and increased
uptake of antigens into the mucosa wall (Overman et al., 2012; Taché & Perdue, 2004; Wallon &
Söderholm, 2009). Interestingly, Vanuysel et al. (2014) found that psychological stress increased
intestinal permeability in response to public speaking but not anticipation of an electrical shock.
They also found that the effects on permeability were only evident in participants who had
significant increases in cortisol concentrations. As a result, they suggested that the effects of
stress on GI permeability were due to coordinated activation of the autonomic nervous system
and HPA axis.
Taken together, acute psychological stress appears to alter several aspects of GI function
including gastric motility and intestinal permeability. There is also some evidence of altered
motility within the small and large intestine, though the results are still somewhat mixed. While
there is limited data on how these effects apply to an exercise setting, they do provide a
psychobiological mechanism through which acute psychological stress could either elicit or
exacerbate GI symptoms during exercise.

Chronic Psychological Stressors and the GI System
Current evidence clearly suggests that acute physiological stress can affect the GI system.
However, the role of chronic stress or anxiety is equally as important to identify. While acute
stress has relatively transient effects that are meant to prepare the body to respond to a potential
threat, chronic stress can result in maladaptive changes to an individual’s psychophysiology,
with potentially impactful health ramifications (Elsenbruch & Enck, 2017; Schneiderman et al.,
2005). This applies to GI health and function as well, as the brain-gut axis is now widely

51

recognized as an important factor in GI disorders such as IBS and inflammatory bowel diseases
(Bonaz & Bernstein, 2013; Halpert & Drossman, 2005; Labanski et al., 2020). Chronic stress,
early life trauma, and anxiety have all been identified as risk factors for IBS (Bennett et al.,
1998; Labanski et al., 2020; Lampe et al., 2003; Moloney et al., 2016; Racine et al., 2012), while
perceived stress is associated with the severity and progression of symptoms in inflammatory
bowel diseases (Langhorst et al., 2013). Indeed, functional GI disorders often have a high
comorbidity with affective disorders (Tanaka et al., 2011; Van Oudenhove et al., 2016), and
depression has been suggested to elicit or promote the onset of IBS (Moloney et al., 2016). This
appears to extend beyond GI disorders, as several studies have demonstrated that stress and
anxiety are associated with GI symptoms in the general population or otherwise healthy people
(Haug et al., 2002; Stanghellini, 1999; Suarez et al., 2002).
While there is observational evidence linking chronic stress and anxiety with GI
symptoms or disorders, the specific nature of the association has not yet been completely
elucidated. Given that the brain-gut axis has bi-directional communication through various
pathways, there is the possibility of reverse causation (e.g. GI dysfunction causes chronic stress
and anxiety), or a bi-directional association (Labanski et al., 2020). In fact, GI-specific anxiety
(anxiety stemming from GI sensations) has been proposed to be an important factor in IBS
symptom severity (Jerndal et al., 2010). Notably, the improved IBS outcomes that result from
psychological treatments may be mediated by reductions in GI-specific anxiety or GI-specific
cognitions (Windgassen et al., 2017). There is also evidence of a bi-directional association
between GI symptoms and stress or anxiety in both GI disorder patients and the general
population (Gracie et al., 2018; Koloski et al., 2012).
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Several mechanisms have been proposed to explain how chronic stress or anxiety may
influence GI symptoms. First, it is possible that chronic stress and anxiety affect GI function in a
similar way as acute psychological stress, namely by altering GI motility, increasing GI
permeability and damage, and promoting intestinal inflammation (Labanski et al., 2020; MolinaTorres et al., 2019). However, several studies have demonstrated that the effects of acute stress
on GI function diminish within a few days of exposure (Ochi et al., 2008; Zheng et al., 2009).
Unfortunately, there is little-to-no data available in humans, making it difficult to ascertain
whether repeated acute stressors and their effects accumulate. It is also challenging to generalize
findings of impaired GI function in patients with IBS or inflammatory bowel diseases to other
populations, as it is unclear whether the cause of GI dysfunction was due to stress or another
pathophysiological factor. There is, however, strong evidence that chronic stress and anxiety can
alter sensitization to GI pain or sensations, resulting in increased GI symptom incidence or
severity (Greenwood-Van Meerveld & Johnson, 2018). Ultimately, this may result in visceral
hypersensitivity, and as such, increased GI symptomology.
Visceral sensitivity refers to the perception of sensations or stimuli within the gut and
visceral organs, such as distension or pressure (Delvaux, 2002). Hypersensitivity to these
sensations and stimuli is considered a common feature of functional GI disorders such as IBS
(Keszthelyi et al., 2012). This can be characterized by hyperalgesia (enhanced pain response to a
stimuli) and allodynia (pain from a stimulus that is not usually perceived as painful) in some IBS
patients (Greenwood-Van Meerveld & Johnson, 2018). Notably, visceral sensitivity appears to
be responsive to life stress to some degree. For example, animal studies have demonstrated that
early life adversity or stress (Chaloner & Greenwood-Van Meerveld, 2013; Hyland et al., 2015;
Pohl et al., 2017) and neonatal maternal separation (Coutinho et al., 2002) can alter visceral
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sensitivity or perception of visceral sensations. The precise pathways through which visceral
hypersensitivity develops is still up for debate, but it is at least partly a result of sensitization of
visceral afferent nerves and altered activity in brain regions that process visceral sensations and
pain (Laurache et al., 2012).

Physiological Mechanisms: How Psychological Stressors May Influence GI Function
There is a functional relationship between the brain and gut, and both acute and chronic stress
and anxiety can influence various aspects of gut function, including altered GI motility,
increased GI permeability, and development of visceral hypersensitivity (Labanski et al., 2020).
While the precise mechanisms have not yet been completely elucidated, there is evidence that
CRH plays a primary role. CRH contributes to the stress response alongside its associated
peptides, urocortin 1, urocortin 2, and urocortin 3 (Takahashi, 2001; Tsigos & Chrousos, 2002).
CRH typically has a pulsatile secretion pattern with predictable rises during early morning
(Takahasi, 2001), but there is a large surge in secretion during times of stress which is thought to
elicit a variety of effects on the GI system (Taché & Bonanz, 2007; Takahasi, 2001).
Additionally, stress may influence GI function through alterations in the sympathomedullary
axis, increasing sympathetic activity and release of catecholamines into circulation (Ulrich-Lai &
Herman, 2009). These two pathways are briefly described below, including how they contribute
to GI discomfort.
The HPA axis and sympathomedullary axis are the two primary pathways through which
the body responds to stress (Moloney et al., 2016). The HPA axis is stimulated by acute
psychological stress, which initiates a cascade of responses (Smith & Vale, 2006). The first step
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is the release of CRH from the hypothalamus, which travels to the anterior pituitary gland and
binds to its receptor (CRH1), triggering the secretion of adrenocorticotropic hormone (ACTH)
into the blood stream. ACTH then binds to the adrenal cortex, causing production and release of
cortisol and other glucocorticoids. Cortisol acts on many tissues, but relevant to psychological
stress, it stimulates the release of CRH from the amygdala which further facilitates the stress
response (Schulkin et al., 1998). The large increase in CRH concentration during acute stress
causes numerous metabolic and neurophysiological effects, including altered GI functions such
as decreased gastric motility and acid secretion and increased colonic motility and transit (Taché
& Bonanz, 2007; Taché et al., 2001). The exact mechanisms through which CRH alters GI
function are not entirely clear but could include induction of mucosal mast cells and subsequent
epithelial damage and inflammation (Baldwin, 2006), and by altering autonomic nervous system
outflow to the GI system by actions at the paraventricular nucleus of the hypothalamus and the
dorsal vagal complex nuclei (Taché & Bonanz, 2007). These effects appear to operate
independently of the HPA axis cascade, as removal of the pituitary and adrenal glands in rats did
not affect CRH’s gastric effects (Lenz et al., 1988; Taché & Bonanz, 2007).
The fast-acting sympathomedullary axis is responsible for the “fight or flight” response to
acute stressors (Ulrich-Lai & Herman, 2009). It is initiated by activation of preganglionic
sympathetic neurons within the intermediolateral cell column of the thoracolumbar spinal cord.
Stimulation of the adrenal medulla through pre- and paravertebral ganglia results in the release of
catecholamines into circulation and many physiological responses associated with sympathetic
drive (e.g. increased heart rate, vasoconstriction of splanchnic vasculature, etc.) (Joyner &
Casey, 2015; ter Steege & Kolkman, 2012). Acute or chronic stress and anxiety could exacerbate
splanchnic hypoperfusion and gut ischemia during exercise by elevating sympathetic activity
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and/or dampening vagal activity. Indeed, some studies have suggested that acute psychological
stress or emotional states can reduce GI blood flow (Kuipers et al., 2008; Wolf, 1981), though
results have also been somewhat inconsistent (Gelman & Mushlin, 2004; Hayashi et al., 2009).
The mixed results could be due to the use of mild stressors in most experimental human studies.
Severe stressors (e.g. parachuting) can increase norepinephrine concentrations to levels twice
that of mental arithmetic or other mild-moderate stressors (Jern et al., 1991; Morgan et al., 2001).
Thus, while there is a strong biological plausibility for how increased sympathetic activity could
alter splanchnic blood, more research is needed. Finally, like CRH, increased catecholamine
release has been suggested to contribute to intestinal epithelial damage and inflammation through
mast cell induction (Baldwin, 2006).
While these mechanisms provide a clear rationale for how acute stress or anxiety could
influence GI function, it is also important to discuss the effects of chronic exposures to stressors.
Allostasis is a term used to conceptualize the typical stress response, whereas the body reacts by
activating the sympathetic nervous system and HPA axis, followed by a period of recovery (Cool
& Zappetti, 2019). Specifically, a healthy stress response involves a strong, transient activation
of the stress systems and release of neuroendocrine mediators such as catecholamines and
cortisol, which then return towards baseline after a period of recovery. Alternatively, allostatic
load refers to “wear and tear” that occurs when an individual experiences repeated stressors or
chronic exposure to stress with inefficient allostasis and recovery (Cool & Zappetti, 2019;
McEwen, 2007). McEwen (2007) described several manners through which allostatic load can
develop and eventually cause dysfunction to various body systems. An individual may be
exposed to “repeated hits” of acute stressors, where they have inadequate time to optimally
recover and adapt in-between. Additionally, some individuals are not only exposed to repeated
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stressors but also have an impaired ability to adapt so that each hit causes more dysfunction and
less ability to respond and cope. Similarly, some individuals develop a dysfunctional stress
response system where the body is unable to produce a robust physiological response to a
stressor. Finally, prolonged exposure to a stressor without opportunities for adequate recovery
can also contribute to allostatic load. In summary, allostatic load and the resulting dysfunction is
primarily due to either 1) inadequate recovery and/or adaptation to stressors, or 2) an inadequate
stress response (Cool & Zappetti, 2019; McEwen, 2007).
The precise pathways through which chronic stressors and allostatic load contribute to GI
disorders and symptoms is not entirely clear, but functional GI disorders tend to have a high comorbidity with chronic stress, anxiety, and affective disorders (Labanski et al., 2020).
Additionally, chronic stress or anxiety is associated with altered GI function and sensitization to
visceral stimuli (Greenwood-Van Meerveld & Johnson, 2018; Larauche et al., 2012; Moloney et
al., 2016). A series of rodent studies suggested that CRH signaling was heavily involved in
altered GI function in response to chronic stress exposure. For example, exposing rodents to
water avoidance stress for 7-10 days can increase visceral sensitivity (Bradesi et al., 2005; Hong
et al., 2009; Myers et al., 2012). Further, such water avoidance stressors increase CRH
expression within the central nucleus of the hypothalamus, and knock down of CRH from this
location inhibits stress-induced visceral sensitivity (Johnson et al., 2015). Taken together, these
findings suggest that CRH is heavily involved in the development of visceral sensitivity from
chronic stress exposure.
Some authors have suggested that cortisol release may also contribute to the effects of
psychological stress on alterations to GI function, likely by triggering further release of CRH
from the amygdala during periods of stress, amplifying the stress response (Ulrich-Lai &
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Herman, 2009). For instance, chronic exposure to various stressors has increased plasma
corticosterone (the animal equivalent of cortisol) in animal models (Bradesi et al., 2005; Myers
et al., 2012). While the stress was acute in nature, one study in humans found that acute public
speaking resulted in increased GI permeability through a mast-cell dependent mechanism;
however, this effect was only significant in those with elevated concentrations of cortisol
(Vanuytsel et al., 2014). Finally, there is some evidence of altered amygdala activity in IBS
patients (Tillisch et al., 2011). Thus, cortisol could facilitate the effects of CRH by stimulating
the amygdala and subsequently increasing CRH concentrations. CRH can then affect GI function
through numerous central and peripheral effects, but particularly by altering autonomic outflow
to the GI tract (Taché & Bonanz, 2007).
Indeed, modulation of vagal tone has been suggested to be a factor in chronic effects of
stress or anxiety on GI function (Labanski et al., 2020). For example, Farmer et al. (2013)
provided evidence for “pain clusters” that may explain some of the inter-individual differences in
visceral and somatic pain responses. Specifically, one cluster was characterized by higher trait
anxiety and neuroticism, baseline sympathetic nervous system activity, and HPA axis tone.
These participants also exhibited lower pain thresholds and less habituation to visceral and
somatic pain. Several additional studies have revealed that modulating vagal tone can reduce
pain sensitivity and increase gastroduodenal motility in response to both somatic and visceral
pain (Botha et al., 2015; Frøkjaer et al., 2016). This is further supported by studies finding that
deep breathing, which dampens sympathetic activity (Jerath et al., 2006), can positively
influence GI symptoms during motion-sickness and in those with functional dyspepsia (Hjelland
et al., 2007; Jokerst et al., 1999). Finally, recent evidence has suggested that chronic stress could
modify the gut microbiota, which is heavily involved in brain-gut axis activities (Grochowska et
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al., 2018; Martin et al., 2018). However, much more research is needed to clarify the effect of
stress on the gut microbiome and how this influences GI function and symptoms.
In summary, the effects of stress and anxiety on the GI system are complex and reliant on
various neural, endocrine, and immunological pathways (Labanski et al., 2020). However, there
are a few primary mechanisms through which psychological factors likely influence GI function
and symptoms. Acute elevations in stress or anxiety can increase GI permeability and
inflammation through activation of the HPA axis and sympathomedullary axis, which in turn
stimulate the release of CRH and catecholamines. This can cause an array of effects, including
activation of mast cells, which contributes to epithelial damage and changes to GI motility,
potentially through input to the enteric nervous system (Browning & Travagli, 2011). The
increased sympathetic activity and catecholamine concentrations could also exacerbate
splanchnic hypoperfusion and ischemia by altering blood flow away from the splanchnic
vasculature, (Joyner & Casey, 2015; ter Steege & Kolkman, 2012), though this requires further
study.
The effects of chronic exposure to stress or anxiety are less understood but may be be
related to the development of visceral hypersensitivity through increased sensitization of visceral
afferents and altered activity of brain regions that process pain perception or regulate stress
responses (Larauche et al., 2012). These effects have been suggested to stem primarily from
increased activity of CRH and the HPA axis, as well as increased sympathetic activity and
concomitant dampening of vagal tone (Greenwood-Van Meerveld & Johnson, 2018; Labanski et
al., 2020; Moloney et al., 2016).
Little of this aforementioned research has been conducted in sporting contexts, despite
the fact that athletes are exposed to a variety of psychological stressors that could affect the GI
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system both acutely (e.g. competition anxiety) and chronically through allostatic load. For
example, in addition to daily life stressors, athletes must balance rigorous training demands, the
stress of competition or injury recovery, and the expectations placed on them by others or
themselves (Rice et al., 2019). These sources of stress and anxiety increase their risk of GI
symptoms both during exercise and at rest. Thus, the following section reviews the research on
the associations between psychological factors and GI symptoms in athletic or physically active
populations.

Research in Active or Athletic Populations
Despite the voluminous literature on the gut-brain axis, and research suggesting a role of stress
and anxiety in clinical demonstration of GI symptoms, only a few studies have examined the
impact of stress and anxiety on GI symptoms in active or athlete populations. An early study by
Worobetz and Gerrard (1985) asked 70 endurance athletes to complete a questionnaire about GI
symptoms they experience during exercise. Over half (51.4%) reported GI symptoms
immediately before competition, when there tends to be competition stress or anxiety. Another
study had 110 triathletes complete a survey about GI symptoms during training and competition
(Sullivan, 1987). About a quarter (24%) of the athletes who experienced symptoms such as
urgent bowel movements, fecal incontinence, and abdominal cramps believed they were more
likely when anxious about competition performance. Additionally, while the exact numbers were
not clearly reported, the triathletes believed nausea or vomiting and bowel dysfunction to be the
GI symptoms most affected by anxiety in terms of incidence and severity. This was followed up
by a survey-based study of 109 distance runners, which found that 43% reported “nervous
diarrhea” before competition (Sullivan & Wong, 1992). While these early studies identified a
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potential relationship between psychological factors and GI symptoms during exercise, they were
primarily descriptive designs which included no statistical analysis of associations between the
factors or whether psychological factors differed between symptomatic and asymptomatic
athletes.
Not much additional research on the topic was conducted until 2013, when Li et al.
(2013) assessed the effects of intense combat training on GI symptoms and function. In this
study, 39 male soldiers completed a six-week medical response force combat-training course,
which included physically and psychologically demanding tasks such as combat simulations and
medical evacuations in restrictive gear and hot temperatures. The course was also a stark
transition from a period of low stress classroom instruction. They reported GI symptoms and
completed several questionnaires, including the Hospital Anxiety and Depression scale and the
Perceived Stress Scale (PSS)-10. Blood and urine samples were also collected to assess
biomarkers of GI function, stress response (e.g. cortisol and CRH), and inflammation. None of
the soldiers reported GI symptoms before training, but 70% reported significant symptoms
during training, including abnormal bowel habits (e.g. constipation, diarrhea) and abdominal
pain or discomfort. Notably, intestinal permeability, inflammatory markers, stress, anxiety, and
depressive symptoms all increased during training as well, and the severity of symptoms was
correlated with stress (r = 0.41) and depressive symptoms (r = 0.41). While this study provides
evidence of an association between psychological factors and GI symptoms in healthy, active
populations, it is challenging to determine what portion of the changes in GI symptoms and
permeability were due to the physical versus psychological aspects of the combat-training.
Three recent studies have evaluated associations between GI symptoms with
psychological factors in endurance athletes over the course of 30 days of training (Wilson, 2018)
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and during competitive endurance races (Wilson, 2020a; Wilson et al., 2021). Wilson (2018)
recruited 150 distance runners to prospectively record the severity of six GI symptoms from each
of their runs for a 30-day period on a 0-10 scale. The symptoms were categorized as upper GI
(nausea, regurgitation/reflux, stomach fullness) or lower GI (abdominal cramps, flatulence, urge
to defecate) symptoms. Considering some GI symptoms are very mild and unlikely to impact
performance (Jeukendrup et al., 2000), symptoms were considered meaningful if they were rated
as at least a 3 out of 10. At the end of the 30-day period, the runners completed the PSS-14 and
the Beck Anxiety Inventory, and the sum scores were correlated with the percentage of runs that
included a meaningful upper and lower GI symptom. Perceived stress and anxiety scores had
modest, but significant, positive correlations with both upper and lower GI symptoms
(Spearman’s rho = 0.18 to 0.36), which remained similar after adjusting for potential
confounders.
Given that formal competition is associated with additional psychological stressors,
Wilson et al. (2021) completed a subsequent study to evaluate whether GI symptoms
experienced during endurance racing were associated with stress and anxiety levels. Three
electronic surveys were sent to endurance athletes before and after one of their races. The first
was sent during the week before the race to obtain information about the athlete (e.g.
demographics, anthropometrics) and details about the race. They were also asked to complete
valid measures of perceived life stress (PSS-14) and anxiety (Anxiety Sensitivity Index [ASI]-3
and STICSA-Trait) (Cohen et al., 1983; Taylor et al., 2007; Ree et al., 2008). A subset of 125
athletes also completed the state version of the STICSA inventory (STICSA-State) on the
morning of their race to evaluate anxiety in the moment. Finally, a questionnaire was sent after
their race which asked about GI symptoms. Six different symptoms were evaluated on a 0-10
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scale: nausea, reflux/regurgitation, stomach fullness, abdominal cramps, gas/flatulence, and urge
to defecate. Logistic regressions were used to evaluate the association between high anxiety and
stress (operationally defined as being in the top tertile) and GI discomfort (severity >3 for a
given symptom). There were several statistically significant associations that remained
significant after adjusting for age, gender, body mass index, the type and duration of the race,
and experience. Specifically, individuals with high PSS-14 scores had increased odds of
experiencing nausea (odds ratio [OR] = 2.21; 95% confidence interval; [95CI] = 1.02, 4.78),
while high STICSA-Trait scores were associated with nausea (OR = 3.43; 95CI = 1.57, 7.50) and
regurgitation/reflux (OR = 3.31; 95CI = 1.26, 8.73). Of the 125 athletes who completed the
STICSA-State inventory, high anxiety was associated with increased odds of nausea,
regurgitation/reflux, fullness, and cramping (ORs = 2.98-5.57). Interestingly, high ASI-3 scores
were not associated with GI discomfort. Similarly, a third study by Wilson (2020a) asked
participants to complete a retrospective survey after endurance races and found that scores on the
STICSA-Trait and Sport Competition Anxiety Test were significantly correlated with in-race GI
discomfort (rho = 0.22 – 0.33; p < 0.05). Thus, higher levels of stress or anxiety appear to be
associated with in-race GI symptoms in endurance athletes, particularly anxiety during the
morning leading up to competitive races.

Gaps and Limitations in the Literature
The current literature strongly supports the idea that stress and anxiety can influence GI function.
These effects likely stem from activation of stress systems that overlap with neuroendocrine and
immunological pathways of the brain-gut axis (both acutely and chronically), which can elicit
damage to epithelial tissues, intestinal inflammation, and sensitization of the visceral afferent
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nerves and brain regions that process visceral sensations such as pain and discomfort (Larauche
et al., 2012; Moloney et al., 2015). Considering that the vagus nerve mediates many of these
responses, increased sympathetic drive and dampened vagal tone from acute or chronic
psychological stressors may contribute to the exacerbated stress response and GI symptoms.
Altered autonomic outflow in response to stress or anxiety may also influence blood flow
redistribution, which could exacerbate splanchnic hypoperfusion that occurs during prolonged or
intense endurance exercise (van Wijck et al., 2012a; Wilson, 2020b). While there is surprisingly
little data available in athletic populations, initial research seemingly confirms that stress and
anxiety are associated with GI symptoms during exercise, particularly when there are high levels
of anxiety on the morning of a race (Wilson, 2018; Wilson et al., 2021). However, there is
clearly a need for further research on psychological factors and GI discomfort in athletes.
First, considering that many factors contribute to GI symptoms during endurance
exercise, it will be important to identify how various factors interact with one another. One
specific example that warrants investigation is whether the effects of acute stress or anxiety
interact with the stimulatory effects of caffeine supplementation. As mentioned previously,
relatively high doses of caffeine can improve physical performance (Grgic et al., 2019) but also
increase catecholamine secretion and elicit GI symptoms, such as nausea, during exercise in
some individuals (Kaplan et al., 1997; Robertson et al., 1978). Many sport and exercise nutrition
studies do not evaluate or report caffeine-induced side effects (e.g. GI symptoms), and those that
do are typically performed in laboratory settings rather than competition environments. Thus,
little is currently known about whether the combination of stress or anxiety with caffeine results
in greater incidence and severity of GI symptoms in endurance athletes. It is possible that
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exercise, caffeine, and stress or anxiety could all interact to result in large concentrations of
circulating catecholamines and ultimately increase the risk of severe symptoms.
Of particular interest is the role of genetic modifiers of anxiety and caffeine side effects.
Caffeine-induced anxiety is moderated by genotype variation for ADORA2A, a gene that
encodes for adenosine A2A receptors that caffeine acts upon (Alsene et al., 2003). Specifically,
individuals with the T/T genotype variation for ADORA2A consistently demonstrate greater
degrees of caffeine-induced anxiety than other individuals (Yang et al., 2010). Interestingly,
individuals with this genotype variation are often more prone to anxiety from other stimulants
(Hohoff et al., 2005) and panic disorders (Deckert et al., 1998; Hamilton et al., 2004). As such,
ADORA2A has been suggested to moderate anxiety on a more general level, not just in response
to caffeine (Yang et al., 2010). It would be interesting to evaluate whether T/T carriers for
ADORA2A are more prone to GI symptoms during exercise, particularly after ingestion of
caffeine. Regardless, it is possible that athletes who are already prone to chronic or acute anxiety
(e.g. competition anxiety) could further increase their anxiety levels if they consume caffeine
prior to a race, which could subsequently exacerbate GI incidence and severity.
Another area worthy of attention is related to how various psychological (acute and
chronic stress or anxiety, GI-specific anxiety), perceptual (visceral sensitivity, body vigilance)
and nutritional factors interact and contribute to GI symptoms. For example, a highly anxious
runner with visceral hypersensitivity may be particularly prone to GI symptoms when consuming
large intakes of energy, carbohydrate, and other nutrients before or during exercise. If so, it is
also possible that such athletes modify their nutritional intake to minimize their risk of GI
symptoms during training or competition. Thus, not only should studies evaluate whether these
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factors interact to contribute to GI discomfort during exercise, but also whether athletes modify
their nutritional intake based on psychological or perceptual factors.
There is also a need to explore the nature of the relationship between psychological
factors and GI discomfort during exercise. It is possible that some athletes experience anxiety or
stress because they are prone to GI symptoms, rather than the anxiety or stress causing the
symptoms. Or the association could be bi-directional. Experimental studies that induce mild-tomoderate degrees of stress or anxiety followed by bouts of endurance exercise could help to
provide clarification. Stressors that have been used in non-exercise studies, such as the Trier
Social Stress Test or mental arithmetic (Holtmann & Enck, 1991; Kirschbaum et al., 1993),
could be administered, followed by the evaluation of GI symptoms and function during exercise
bouts. Additionally, these lab-based studies should be accompanied by field-based data
collection, where athletes are assessed for competition anxiety and measures of GI function or
symptomology immediately before and after a race. This would provide an indication of whether
competition anxiety influences GI symptoms in a more realistic setting, since it can be difficult
to replicate the physical and psychological stressors of competition in controlled laboratory
settings (Wilson, 2020b). Another approach would be to evaluate the effects of interventions that
can reduce stress or anxiety. Not only would these types of studies help determine the role of
psychological stress on GI symptoms during exercise, they would also aid in identifying
effective and feasible interventions that athletes could use to reduce their risk of GI discomfort
during training or competition. Two examples that may be effective and feasible for athletes
include slow deep breathing and mindful breath counting (Gorman & Green, 2016; Russo et al.,
2017).
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Deep breathing has a variety of effects on cardiopulmonary function, particularly when
respiratory rate is decreased to about six breaths per minute with concomitant increases in tidal
volume (Russo et al., 2017). Deep breathing can increase ventilation efficiency through
enhanced alveolar recruitment and distension, resulting in reduced physiological dead space
(Bernardi et al., 1998; Bilo et al., 2012). It also appears to influence cardiovascular
hemodynamics, as some data suggests that deep, diaphragmatic breathing enhances venous
return and synchronizes blood flow to the beat of the heart (Bordoni & Zanier, 2013; Dick et al.,
2014; Hsieh et al., 2003).
Perhaps most relevant to psychological factors and GI symptoms are the effects of slow
deep breathing on HRV and autonomic activity. HRV refers to the beat-by-beat variation in heart
rate or the duration of time between the R-R intervals in the cardiac cycle (Billman et al., 2011).
HRV is a product of both parasympathetic and sympathetic input and is commonly used as an
index of sympathovagal balance (Billman et al., 2011; Bootsma et al., 1994). A reduced HRV is
reflective of more sympathetic dominance and has been implicated in many disease states and
disorders, while a high HRV is often reflective of health and wellbeing (Billman et al., 2011; De
Jong & Randall, 2005; Thayer et al., 2010). Both branches of the autonomic nervous system are
regulated by the central respiratory centers, and slow deep breathing can dampen sympathetic
activity, promote vagal outflow, and ultimately increase HRV (Badra et al., 2001; Bernardi et al.,
2001; Chang et al., 2013; Paprika et al., 2014; Tharion et al., 2012). Considering that vagal nerve
activity is a primary mediator of pathways within the brain-gut axis and the stress axes that
overlap with them, increasing parasympathetic tone via slow deep breathing could be beneficial
for highly anxious and GI-prone endurance athletes (Boeckxstaens et al., 2016; Vanner et al.,
2016). Indeed, several studies have suggested that slow deep breathing interventions can
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attenuate motion-sickness symptoms, such as nausea (Jokerst et al., 1999), and enhance feeding
tolerance in those with functional dyspepsia (Hjelland et al., 2007).
Interventions that promote mindfulness may also be useful independently or in
conjunction with slow deep breathing may also be useful. Mindfulness is a difficult concept to
operationally define, though recent articles have referred to it as openly attending to and being
aware of the present moment (Creswell, 2017) or the concept of “bringing back” a wandering
mind (Levinson et al., 2014). Regardless, interventions that promote mindfulness have gained
popularity in research and practice due to findings of benefits to health, pain, attention, and other
outcomes (Brefczynski-Lewis et al., 2007; Hölzel et al., 2011; Ludwig & Kabat-Zinn, 2008;
Zeidan et al., 2011). A meta-analysis also found that mindfulness interventions tend to reduce
anxiety in individuals with anxiety disorders (Strauss et al., 2014), and one study even reported
improved symptom severity in women with IBS (Gaylord et al., 2011). The precise mechanisms
are not entirely clear and likely involve a multitude of psychological and neurobiological factors
(Creswell, 2017). However, one hypothesis is that mindfulness interventions can buffer stress
through enhanced activity of the prefrontal cortex that is responsible for top-down regulation of
stress responses, while simultaneously decreasing activity of brain regions involved in the stress
axis (e.g. amygdala) (Creswell & Lindsay, 2014; Creswell, 2017). Considering that the amygdala
and stress response systems are thought to contribute to stress-induced GI symptoms and
dysfunction (Greenwood-Van Meerveld & Johnson, 2018), interventions that promote
mindfulness may be effective in alleviating symptoms in athletes with high levels of stress or
anxiety. Mindful breath counting in particular may be a viable strategy as it has recently been
demonstrated to have positive effects on stress-induced alcohol-seeking behavior (Shuai et al.,
2020) and attentional effects associated with media multi-tasking (Gorman & Green, 2016). It
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also has the advantage of being simple to perform and brief in duration (Levinson et al., 2014).
Thus, if it is demonstrated to reduce GI discomfort in athletes, mindful breath counting could be
a feasible intervention for an athlete to incorporate into their daily routine.
Interventions such as slow deep breathing and mindful breath counting could also have
benefits to high anxiety athletes besides GI discomfort. For example, interventions that
successfully reduce stress or anxiety may also enhance aspects such as sleep and reduce the risk
of burnout (Cremades & Wiggins, 2008; Horváth et al., 2016; Uhde et al., 2009). Thus, research
should determine not only if these interventions reduce GI discomfort, but also evaluate
secondary outcomes that could be beneficial to athletes such as improved sleep quantity and
quality or subjective measures of recovery.

Overall Summary of the Literature Review
The GI system is a critical component of health, performance, and recovery for endurance
athletes. Compromised GI function can lead to symptoms ranging from mild inconveniences to
severe health concerns (de Oliveira et al., 2014; van Wijck et al., 2012a). Considering that an
untimely episode of GI discomfort can negatively affect performance or even cause an athlete to
drop out of a race (O’Brien et al., 2011; Stuempfle & Hoffman, 2015), a considerable amount of
research has sought to identify the underlying pathophysiology of GI dysfunction and the factors
that correlate with symptom incidence and severity. The precise pathophysiology of GI
symptoms during exercise still requires further elucidation, but current research suggests that a
complex interaction of circulatory, neuroendocrine, and immunological factors is involved
(Costa et al., 2017b). Specifically, blood flow redistribution during exercise can cause splanchnic
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hypoperfusion and subsequent damage to cells that form, support, and regulate the intestinal
epithelial barrier (van Wijck et al., 2012a). Increased sympathetic drive and the mechanical stress
of exercise can also contribute to altered GI function and potentially provoke symptoms (Costa et
al., 2017b; de Oliveira et al., 2014). Additionally, numerous other factors such as hypohydration
or heat stress, various nutritional factors (e.g. highly concentrated carbohydrate beverages, fiber,
proteins, FODMAPs), dietary supplements, and NSAIDs can all contribute to or exacerbate GI
symptoms during exercise (de Oliveira et al., 2014; Wilson, 2019). Other factors may affect the
incidence and severity of GI symptoms, including the genetics, age, gender, and training
experience of the athlete. Taken together, many individual factors are likely involved in exerciseinduced GI discomfort, and an unfavorable combination of factors may expose an athlete to a
higher risk of issues.
One potentially impactful area that is relatively understudied is the role of psychological
factors on GI discomfort during exercise. The central nervous system and GI system
communicate through an intricate bi-directional communication network known as the brain-gut
axis (Mayer et al., 2015). Many of the neuroendocrine pathways that form the brain-gut axis also
overlap with central and peripheral stress systems, which suggests that stress or anxiety could
influence GI function (Boeckxstaens et al., 2016; Vanner et al., 2016). Indeed, chronic stress and
anxiety are considered important factors in the development of functional GI disorders such as
IBS and inflammatory bowel diseases (Bonaz & Bernstein, 2013; Labanski et al., 2020) and have
been correlated with GI symptomology in the general population as well (Haug et al., 2002).
Numerous animal and human studies have also demonstrated that acute and chronic stress can
influence GI motility, barrier integrity, and visceral sensitivity (Elsenbruch & Enck, 2017; Taché
& Bonaz, 2007; Wilson, 2020b). Taken together, there is a strong psychobiological basis for how
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acute or chronic psychological factors could influence GI symptoms, most likely through altered
autonomic outflow and increased CRH secretion (Wilson, 2020b).
Recent studies have suggested that elevated stress and anxiety is associated with GI
symptoms during training and competition in endurance athletes (Wilson, 2018; Wilson, 2020a;
Wilson et al., 2021). However, many areas require further exploration. Future studies should
seek to evaluate how various factors interact to contribute to symptoms. Experimental studies
should be conducted to determine the precise relationship between psychological factors and GI
discomfort during exercise. This could be accomplished by inducing small-to-moderate amounts
of acute stress prior to exercise to determine if GI symptoms are elicited or aggravated. Another
option is implanting stress- or anxiety-reducing interventions such as slow deep breathing and
mindful breath counting (Gorman & Green, 2016; Russo et al., 2017). Such studies would not
only help identify the role of stress and anxiety on GI symptoms but also help identify effective
and feasible interventions that athletes could use to prevent or alleviate GI symptoms during
training or competition.
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CHAPTER III
METHODS
The overall purpose of this dissertation was to evaluate the role of several psychological factors
in the development and management of GI symptoms during running. Trained runners were
recruited for two studies. The first was a survey-based study with three primary aims: 1) to
evaluate whether measures of chronic stress, anxiety, GI-specific anxiety, and body vigilance
correlate with GI symptoms during runs, 2) to assess the associations between these
psychological factors and nutrition intake before and during runs, and 3) to analyze whether any
resulting associations between these psychological factors and nutrition intake are mediated by
GI symptomology. The second study was a randomized controlled trial with the aim of
determining the effects of four-week slow deep breathing and mindful breath counting
interventions on psychological and perceptual measures, HRV, and GI symptoms in runners who
have elevated levels of anxiety and who were prone to GI symptoms.

Study 1 Methods
Participants
A total of 82 trained runners were recruited to track details about their training runs for one
week, at the end of which they completed an electronic survey to evaluate several psychological
measures. To be eligible for inclusion, runners were required to be at least 18 years of age and
currently running >20 miles per week, with at least one run that was 60 minutes or longer in the
past week. This running volume threshold was used to increase the likelihood that recruited
participants were accumulating enough volume to be at risk for GI symptoms during runs, and
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that they were performing enough training to consider consuming foods and fluids during runs.
After initial contact with a prospective participant, they were sent a Qualtrics hyperlink to an
online consent form. The consent form provided details about the study’s purpose, inclusion and
exclusion criteria, the data collection procedures, potential risks and discomforts from
participation, time commitments, and measures taken to keep data confidential. Prospective
participants were encouraged to ask questions after reading through the consent form. No data
was collected until the informed consent process was completed and consent document was
signed.

Data Collection Materials and Procedures
The runners were first sent a prospective journal adapted from Wilson (2017). The journal was
used to collect information related to each training run for one week. This included the date/time
and average rating of perceived exertion (RPE; Borg, 1982) of each run. They were asked to rate
the severity of several GI symptoms during runs on a 0-10 scale. The symptoms and their
standardized definitions are included below:
•

Nausea: A feeling of sickness in the stomach marked by an urge to vomit.

•

Regurgitation/Reflux: A sensation of food or fluid returning from the stomach to
the esophagus or mouth.

•

Stomach Fullness: A sensation of fullness or abdominal pressure in the upper
abdomen.

•

Bloating: A feeling of distension from a buildup of gas in the gut.

•

Abdominal Cramps: Pain or cramping sensation, often experienced in the mid- or
lower portion of the abdomen.

•

Gas/Flatulence: Gas or flatus expelled through the anus.

•

Urge to Defecate: Sensation of needing to pass a bowel movement.
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Participants were also be asked to provide information about their nutritional intake
before (within 4 hours) and during each run. Detailed instructions prompted the participants to
specify the specific brands, flavors, and amounts of foods and fluids. After tracking run
information, GI symptoms, and nutrition intake for one week, participants were sent an
electronic survey to evaluate several psychological constructs.
The retrospective electronic survey asked about the participants’ demographics (age,
gender, race/ethnicity), running history (years running, number of miles per week), history of GI
conditions, and typical resting GI symptoms. It also contained a series of psychological
questionnaires, including the PSS, STICSA-Trait, body vigilance scale (BVS), and visceral
sensitivity index (VSI).
The 14-item PSS (Cohen et al., 1983) was designed to evaluate how stressful an
individual has perceived life to be over the preceding month. Participants are presented with a
series of questions and asked to rate how often they have felt or thought that way in the past
month using the following scale: 0 = never, 1 = almost never, 2 = sometimes, 3 = fairly often,
and 4 = very often. The positive items are reversed, and then all ratings are summed to obtain a
total score ranging from 0 to 56. The original validation study demonstrated adequate coefficient
alpha reliability in two samples of college students and one sample of community members of a
smoking-cessation program (alpha = 0.84 – 0.86; Cohen et al., 1983). PSS-14 scores were also
significantly correlated with outcomes such as life event scores, social anxiety, utilization of
health services, and depressive symptomology. Similarly, strong reliability and validity of the
PSS has been reported across multiple studies with various populations (e.g., Hewitt et al., 1992;
Pbert et al., 1992). Additionally, recent studies have demonstrated that PSS-14 scores are
correlated with GI symptoms during running (Wilson, 2018), and that endurance athletes with
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high PSS-14 scores were more likely to report nausea during competition (Wilson et al., 2021).
As such, the PSS-14 was used as a valid and reliable assessment of perceived stress in the
recruited runners.
The 21-item STICSA-Trait (Ree et al., 2008) was used to assess cognitive and somatic
aspects of anxiety at the trait level. The STICSA-Trait is considered a valid and reliable
questionnaire, with some data suggesting it is a purer measure of anxiety symptomology than
other common anxiety measures like the State-Trait Anxiety Inventory (Elwood et al., 2012;
Grös et al., 2007). Participants are asked to rate how often each statement generally applies to
them on the following scale: 1 = not at all, 2 = a little, 3 = moderately, and 4 = very much so.
The ratings are then summed to provide a score ranging from 21 to 84. Wilson et al. (2021)
recently found that endurance athletes with high STICSA-State scores had higher odds of
reporting nausea and regurgitation/reflux during competition than those with low-to-modest
STICSA-State scores. Thus, the STICSA-Trait served as a measure of trait anxiety for this study.
The BVS (Schmidt et al., 1997) is a 4-item questionnaire used to quantify the amount of
attentional focus that a person devotes towards internal sensations. Increased body vigilance is a
common observation in individuals with high anxiety and panic disorders, and some studies
suggest that BVS scores correlate with GI symptoms in IBS patients (e.g., Keough et al., 2011).
Further, the BVS has demonstrated high internal consistency (alpha coefficient: 0.82-0.84), and
adequate test-retest reliability over a 5-week period across several samples (mean r = 0.67 –
0.69; Schmidt et al., 1997). The first two items provide the following two statements: 1) “I am
the kind of person who pays close attention to internal sensations”, and 2) “I am very sensitive to
changes in my internal bodily sensations.” Participants are asked to rate how much each
statement applies to them in the past week using a Likert scales ranging from 0 (“Not at all like
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me”) to 10 (“Extremely like me”). The third item asks participants to rate the average amount of
time per day spent “scanning” their body for internal sensations on a scale from 0 (“No time”) to
100 (“All the time”). This rating is divided by ten to give an item score ranging from 0-10. The
final item asks the participant to rate the amount of focus they give to 15 individual sensations
such as heart palpitations, dizziness, and nausea on a scale from 0 (“none”) to 10 (“extreme”).
The individual sensation ratings are averaged to provide one item score of 0-10. These scores are
then summed across the four items to provide a total score ranging from 0-40. While there is
little-to-no data available in athletic populations, it is possible that runners with higher levels of
body vigilance are more likely to report GI symptoms during runs.
Finally, the VSI (Labus et al., 2004) is a 15-item questionnaire designed to evaluate GIspecific anxiety, which is thought to contribute to symptomology in functional GI disorders
(Jerndal et al., 2010). Specifically, the VSI addresses five dimensions of GI-related behaviors
and cognitions: worry, anxiety, avoidance, sensitivity, and vigilance. Participants are presented
with a series of statements about how some individuals respond to various symptoms or
uncomfortable sensations within their gut and abdomen. They are then asked to rate how much
they agree with each statement as it relates to their own responses using the following scale: 1 =
strongly agree, 2 = moderately agree, 3 = mildly agree, 4 = mildly disagree, 5 = moderately
disagree, and 6 = strongly disagree. The ratings are summed across the 15 statements to calculate
a total score ranging from 15-90. Labus et al. (2004) demonstrated that the VSI has strong
reliability and correlates with GI symptoms in both IBS and healthy participants (Labus et al.,
2004; Labus et al., 2007; Saigo et al., 2014), but there is limited data available in athletic
populations. Theoretically, athletes with high VSI scores could be more prone to GI discomfort,
either because of anxiety over past experiences or because of higher sensitivity to visceral
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sensations. Further, athletes that are more anxious about GI symptoms (i.e., have higher levels of
GI-specific anxiety) may be more likely to limit nutrition intake to avoid provoking GI
symptoms during their runs. However, there is currently limited data to support or refute these
hypotheses. Thus, this study sought to determine if VSI scores were correlated with GI
symptoms and nutritional intake in trained runners.

Data Processing
A score was calculated for each psychological questionnaire using the specific scoring
instructions for each measure. GI discomfort was quantified as the percentage of runs that a
runner reported at least one symptom >3 out of 10. This was calculated for all symptoms, upper
GI symptoms, and lower GI symptoms separately. Nausea, reflux/regurgitation, bloating, and
stomach fullness were categorized as upper GI symptoms, while abdominal cramps,
gas/flatulence, and urge to defecate were considered lower GI symptoms.
A runner’s mean intake of total energy (kcal), carbohydrates (g), protein (g), fat (g), fiber
(g), fluid from beverages (mL), and caffeine (mg) before and during runs was calculated
separately. These values were estimated from food/product information provided by participants
in the running journal. When specific brands or product names were provided by the participant,
the websites of the product were searched for nutrition information. For all other food/product
information, intake was estimated using Cronometer (https://cronometer.com/). Participants were
excluded from analyses involving the nutrition variables if they did not provide precise enough
information to estimate their intake.
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Statistical Analysis
The normality of data for each variable was first assessed with Shapiro-Wilks analysis and
inspection of the histograms. Because most variables were non-normally distributed, nonparametric analyses were used throughout this study. Continuous demographic and training
information were displayed as medians and interquartile range (IQR). Frequency and percentages
were provided for categorical variables (e.g., race/ethnicity, history of GI conditions). This
information was reported for the total sample and for men and women separately.
To address specific aim #1, Spearman’s rho correlation coefficients were calculated to
evaluate the association between psychological scores (PSS-14, STICSA, BVS, VSI) and
measures of GI discomfort during runs (% of runs with a symptom >3 for total GI, upper GI, and
lower GI symptoms). Partial correlations were also calculated to evaluate the associations after
adjusting for covariates (age, sex, running experience, resting GI symptoms, and mean running
RPE).
Specific aim #2 was addressed by calculating the correlations between the psychological
measures and mean nutrition intakes (total energy, carbohydrates, fats, proteins, fiber, total fluid,
caffeine) before and during runs. Correlations were carried out separately for pre-run and duringrun intakes. Because of the highly skewed data distribution and the lack of significant negative
associations between psychological data and nutritional intake as hypothesized, the mediation
analyses for specific aim #3 were not conducted.
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Study 2 Methods
Participants
For this study, 122 runners were screened for eligibility, 68 met the eligibility criteria, and 63
consented to participate. To be eligible for inclusion, participants were required to be at least 18
years of age and running at least 15 miles per week. Further, to maximize the likelihood that the
interventions would have meaningful effects on the dependent variables, only participants that
had at least mild levels of anxiety and who at least occasionally experienced GI symptoms
during runs were eligible. During the initial screening and informational call, participants
completed the General Anxiety Disorder-7 (GAD-7) questionnaire (Williams, 2014) and were
asked to report how often they had experienced GI symptoms during runs over the previous
month on a five-point Likert scale ranging from “never” to “almost always.” The GAD-7 is a
seven-item questionnaire that is commonly used to screen individuals for anxiety, which has
been validated in both clinical (Ruiz et al., 2011) and general (Lowe & Decker, 2008)
populations. Participants are asked to rate how often they have been bothered by seven different
problems related to anxiety on a scale from 0 (“Not at all”) to 3 (“Nearly every day”). The
ratings are summed, resulting in a sum score ranging from 0-21. A cut-off score of 5 has been
recommended as a cut-off for mild anxiety (Williams, 2014). Thus, participants were eligible if
they scored >5 on the GAD-7 and if they reported to occasionally, often, or almost always
experience GI symptoms during runs in the previous month.
Additional inclusion criteria included the following: 1) access to the internet and 2)
having a Smartphone that runs on an operating system (iOS or Android) that is compatible with
an app (Elite HRV) for collecting physiological data for the study. Finally, participants that were
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prescribed psychotropic drugs (e.g., SSRIs) needed to be on a stable dose for at least three
months prior to enrollment into the study.

Design Overview
A randomized controlled trial was used to evaluate the effects of manipulating breathing rate and
using breath counting on several psychological measures, HRV, and GI symptoms in runners
who are prone to elevations in anxiety and GI discomfort. Enrolled participants were randomly
assigned to one of three conditions: 1) slow deep breathing plus breath counting (SLOWBC), 2)
breath counting with breathing at a normal pace and depth (NORMALBC), or 3) control group.
The SLOWBC and NORMALBC groups were asked to perform a daily breathing intervention
for four weeks using a video imbedded with an adjustable breathing app (eXHALeR v. 2.0.6;
https://xhalr.com/). The videos were nearly identical except for several key differences. The
SLOWBC’s video prompted participants to take deep breaths and the breathing app was set to a
pace of 6 breaths per minute. The NORMALBC’s video prompted them to breathe at a normal
depth, and the breathing app was adjusted to a pace of 15 breaths per minute. Both groups were
asked to count their breaths over the course of five minutes. The control group did not perform a
daily breathing intervention and were asked to not engage in any sort of breathing intervention
during their involvement in the study.
Several dependent variables were assessed across multiple time points (pre, mid, post).
Electronic questionnaires containing five psychological questionnaires were sent during the preintervention period, mid-way through the intervention period, and after the completion of the
intervention. These were used to evaluate psychological and perceptual constructs such as
perceived stress, anxiety, body vigilance, GI-specific anxiety, and mindfulness throughout the

80

data collection period. A resting HRV measure was taken before and after the intervention period
with a portable HRV monitor to provide an objective physiological measure of the interventions’
effects (Billman et al., 2011; Bootsma et al., 1994). HRV measures are particularly relevant
given that slow deep breathing can promote vagal stimulation and increase HRV (Chang et al.,
2013; Tharion et al., 2012), and this could attenuate GI symptoms due to the large degree of
overlap between the pathways of the brain-gut axis and the stress response systems
(Boeckxstaens et al., 2016; Vanner et al., 2016). Further, participants were sent
a journal to track their run information (date/time, duration, RPE) and GI symptoms during runs
for one week before the intervention and during the final week of the intervention period. This
information was used to compare GI symptomology before and after the intervention period.
More detailed information about the intervention and data collection procedures are provided
below. Further, specifics about the data collection procedures are provided in Table 1 and
Figure 1.
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Table 1. Study 2 Data Collection Overview and Timing
Measures
HRV: Ln RMSSD, LF, HF, LF/HF ratio

Proposed Timing of Data Collection
Pre-Test: Collected during the week before starting the
intervention.
Post-Test: Collected the day after the intervention is completed.

Psychological surveys: PSS-14, GAD-7,
BVS, VSI, FFMQ

Pre-Test: Completed during the week before starting the
intervention.
Mid-Point: Completed halfway through intervention (end of
week 2).
Post-Test: Completed during final day of intervention.

GI symptoms during runs

Pre-Test: Tracked for one-week before starting the intervention.
Post-Test*: Tracked for one-week during final week of the
intervention (Week 4).
Note: * = Analyzed as a post-test measure but collected during final week of the intervention period. HRV,
heart rate variability; Ln RMSSD, log transformed root of the mean sum of the squared differences; HF,
high frequency; LF, low frequency; PSS-14, perceived stress scale-14; STICSA-Trait, State-Trait Inventory
for Cognitive and Somatic Anxiety-Trait; BVS, body vigilance scale; VSI, visceral sensitivity index; FFMQ,
five-faceted mindfulness questionnaire
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Figure 1. Overview of the data collection procedures for study 2.

Procedures
After screening potential participants based on their self-report anxiety and typical GI symptoms,
participants were sent an electronic informed consent document approved by the ODU
Institutional Review Board, and the study procedures, risks, etc. were reviewed with them. If
they agreed to participate, participants were contacted to begin the pre-intervention data
collection procedures.
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To provide an objective measure of the intervention’s effects, a resting HRV
measurement was evaluated using a portable CorSense HRV monitor (EliteHRV, Asheville, NC,
USA). The CorSense monitor estimates a variety of HRV measures using pulse detection via a
500 hertz multiwave sensor array. The data was then automatically uploaded to a smartphone
application. The participants were asked to send a screenshot of the results page to the
investigators through email or text. Time-domain measures evaluate beat-to-beat changes in
HRV and can be used as a simple marker of PNS input or stress reactivity (Kim et al., 2018;
Kleiger et al., 1992). A common time-domain HRV measure is the root mean square of
successive differences (RMSSD), which can be impacted by stress and anxiety (Uusitalo et al.,
2011; Vrijkotte et al., 2000). In contrast, frequency-domain measures evaluate the distribution of
power across different frequency bands (e.g., high frequency [HF], low frequency [LF]; Kim et
al., 2018). Notably, the HF band is a measure of PNS activity, while the LF band is a measure of
SNS activity (Kim et al., 2018; Malliani et al., 1991). As such, by assessing each of these and the
ratio between them (LF/HF ratio), it is possible to evaluate changes in ANS activity and
sympathovagal balance, though the validity of this method is debated. Further, these measures
are affected by psychological stress (Delaney & Brodie, 2000; Kaegi et al., 1999) and can be
improved with breathing interventions (Pal et al., 2014; Tharion et al., 2013).
Upon enrollment into the study, CorSense monitors were shipped to participants with
written instructions on how to measure HRV. They were asked to perform a resting HRV
assessment during the baseline week of GI-symptom recording that preceded the intervention,
and again immediately after completing the intervention. Participants were asked to download a
free app (Elite HRV), which syncs with the CorSense sensors via Bluetooth. While the goldstandard for HRV measurement is electrocardiogram, portable devices can provide a valid
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estimate (Dobbs et al., 2019). The Ln RMSSD measure derived using the EliteHRV application
software has been found to be similar to when using traditional computer program methods
(Perrotta et al., 2017) and was used as the primary HRV measurement. Additionally, HF, LF, and
LF/HF ratio were included as frequency-domain measures to evaluate the effects of the
interventions. Given the remote nature of the data collection in response to the COVID-19
pandemic, the user-friendly nature of the CorSense HRV monitor, and the relative accuracy of
portable devices, this method provided useful objective data to evaluate the effects of the
breathing interventions.
During the first week, participants were also sent an electronic survey to complete. The
survey asked participants about demographic information (age, gender, height, weight, running
experience, history of GI conditions, history of engaging in breathing interventions, etc.) and a
series of five psychological questionnaires. Perceived stress, anxiety, body vigilance, and GIspecific anxiety were assessed with the PSS-14, GAD-7, BVS, and VSI, respectively.
Additionally, five dimensions of mindfulness were quantified with the 15-item version of the
FFMQ (Gu et al., 2016). The psychological measures were sent pre-intervention, at the mid-way
point of the intervention period, and during the final day of the intervention. Participants were
also provided a journal to track run information (date/time, RPE, and duration for each run) and
GI symptoms over the course of one week. This journal was similar to that used for study #1 but
with the nutritional intake component removed to reduce participant burden.
After completion of the pre-intervention measures, participants were randomly assigned
into one of three groups: 1) SLOWBC, 2) NORMALBC, or 3) control group. The randomization
process was done using blocks of 3 and 6. Gender-specific randomization lists were generated
using the following website (https://www.sealedenvelope.com/simple-randomiser/v1/lists). A
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person not involved in the data collection was asked to generate the lists and then fill
sequentially labelled envelopes with the results. Once randomized, participants in the SLOWBC
and NORMALBC groups were asked to complete a daily 5-minute breathing intervention for
four weeks. While a longer duration intervention may maximize the potential benefit of
breathing interventions, there is evidence that deep breathing and other mindfulness techniques
can confer benefits in as few as four weeks and with sessions as brief as 5-10 minutes each
(Chung et al., 2010; Hjelland et al., 2007; Mackenzie et al., 2006). As such, four weeks was used
to reduce burden on the participants, increase adherence, and to allow for recruitment of a larger
sample size.
The SLOWBC intervention involved five minutes of deep breathing at six breaths per
minute each day. Changes in breathing frequency and depth can modify cardiorespiratory
responses (Pitzalis et al., 1998; Russo et al., 2017), with deep breathing at about six breaths per
minute having greater influence on factors such baroreflex sensitivity, blood pressure, and HRV
than faster breathing rates (Bernardi et al., 2001; Sin et al., 2010; Tharion et al., 2012). Deep
breathing routines at six breaths per minute can also increase vagal activity and HRV (Chang et
al., 2013; Tharion et al., 2012) and reduce reporting of pain intensity in response to heat stimuli
(Jafari et al., 2020). There is also some initial evidence that it can attenuate GI symptoms in
some circumstances, such as feeding tolerance in individuals with functional dyspepsia (Hjelland
et al., 2007).
However, breath counting at a relatively normal breathing rate could also confer benefits
on stress, anxiety, and GI symptoms by promoting mindfulness (Cresswell, 2017; Levinson et
al., 2014; Stauss et al., 2014). Indeed, one study found that mindfulness training attenuated GI
symptoms in IBS patients (Gaylord et al., 2011), and there is evidence that mindful breath
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counting can positively affect outcomes such as stress-induced alcohol-seeking behavior (Shuai
et al., 2020). Mindfulness has been suggested to buffer stress by affecting brain regions involved
with top-down processing of stress (e.g., prefrontal cortex) while decreasing activity in the
amygdala, which contributes to the stress axis (Creswell & Lindsay, 2014; Creswell et al., 2017).
As such, the NORMALBC intervention was included to evaluate the effects of mindful breath
counting independent of slow deep breathing. This was accomplished by setting the breathing
cadence to 15 breaths per minute with a normal depth while asking participants to count their
breaths.
Participants in the two breathing groups were sent a reusable link to a video containing
imagery from a breathing app (eXHALeR V. 2.0.6; https://xhalr.com/) that guided them through
their assigned breathing intervention. Upon clicking the link, a recorded voice message prompted
the participant to find a comfortable seated or laying position, remove any distractions, and then
proceeded to provide instructions for their assigned intervention. Participants in the SLOWBC
were instructed to breathe deeply in sync with the video and to count their breaths. The
NORMALBC group was asked to sync their breathing with visual cues in the video and count
their breaths, but to otherwise breathe at a normal depth. Both groups were prompted to count
their breaths until they reached 10, and then restart from 1 and continue as such until the session
was complete. After five minutes of regulated breathing, a voice message informed the
participant that the breathing session was completed and prompted them to record the time, date,
and a rating of their engagement in the task and how pleasant they found the session on a scale
from 1-10 in a provided breathing journal.
The breathing app provided a visual cue to help participants sync their breath to a
prescribed frequency. A white circle expanded and constricted within a larger circle. The white
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circle displayed the word “inhale” as it expanded, “hold” for a brief period at full expansion, and
“exhale” as the circle constricted back to the starting position. The timing of each phase was
manually adjusted. For SLOWBC, the timing was set to a 4-second inhalation, a 2-second hold,
and a 4-second exhalation so that participants breathe at a frequency of 6 breaths per minute. The
NORMALBC’s video was set to a 2-second inhale, no hold, and a 2-second exhale so that
breathing frequency was approximately normal at 15 breaths per minute. While there is some
variability in resting breathing rates between people (Flenady et al., 2017), standardization of the
breathing frequency allowed for the two interventions to be as similar as possible except for the
breathing frequency and depth. The control group did not perform a breathing intervention and
were asked to avoid performing breathing exercises during the intervention period.
Several steps were taken to maximize the standardization of the interventions. First, the
participants were asked to schedule a time to perform the interventions within 1-2 hours prior to
training runs. On days they did not run, they were asked to perform the intervention at a similar
time of day. A journal was provided to them to log information about each intervention session
(date/time, number of breaths taken). Finally, weekly email communication, phone calls, or
video chats were conducted with each participant to check adherence and answer any questions
they had about the intervention.

Statistical Analysis
Normality was first evaluated using the Shapiro-Wilks test with inspection of histograms and QQ plots. Both intention-to-treat (ITT) and per-protocol analyses were conducted to deal with
imperfect compliance to procedures and missing data (Gupta, 2011; Ranganathan et al., 2016;
Schulz et al., 2010). All participants that were randomized to a group were included in ITT
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analyses, regardless of their compliance (Gupta, 2011). Missing midpoint and post-intervention
data were inputted using “Last Observation Carried Forward” method, where the most recent
observation is retained for analysis (Streiner & Geddes, 2001). For the per-protocol analyses,
participants in the SLOWBC and NORMALBC groups were excluded if 1) they never
completed or sent a treatment journal, 2) there was >42 days between the first and last completed
breathing sessions (which equates to >2 additional weeks beyond the prescribed four week
treatment), 3) they completed <50% of sessions between the first and last sessions, and 4) postintervention measurements were completed >10 days after the final breathing session. Control
group participants were excluded if there was more than sixty days between pre- and postintervention measurements, as this equates to three weeks more than the prescribed study
timeframe (one week for pre-intervention measurements, four weeks for the intervention and
post-intervention data collection).
Independent t tests were used to compare measures of intervention compliance and
engagement between SLOWBC and NORMALBC groups. Mixed methods ANOVA was used to
evaluate normally distributed outcome data, with group allocation as the between-subjects factor
and time as the within-subjects factor. Mauchly’s test of sphericity was evaluated, and the
Hyunh-Feldt correction reported when the assumption of sphericity was violated. Simple main
effects were reported in the case of statistically significant time x group interactions. Nonnormally distributed data were compared across groups at each timepoint using the Kruskal
Wallis test. Bonferroni post hoc tests were used when the ANOVAs or Kruskal Wallis tests
detected a statistically significant effect. Partial eta squared (ηp2) and ranked epsilon squared (ε2)
were calculated as measures of effect size for the mixed ANOVAs and Kruskal Wallis tests
respectively (Tomczak & Tomczak, 2014). Exploratory a posteriori analyses were conducted to
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evaluate whether ratings of engagement in the interventions was associated with changes in
primary outcomes across both treatment groups (SLOWBC and NORMALBC).
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CHAPTER IV
ASSOCIATIONS BETWEEN PSYCHOLOGICAL FACTORS, NUTRITION INTAKE,
AND GASTROINTESTINAL SYMPTOMS IN RUNNERS
Introduction
The causes and implications of gastrointestinal (GI) dysfunction in endurance sport have been a
heavily studied topic in recent decades (de Oliveira et al., 2014; Costa et al., 2017b). GI
dysfunction can manifest as numerous symptoms affecting both upper (regurgitation/reflux,
nausea) and lower (abdominal cramping, gas, loose stools) aspects of the GI system during
exercise (de Oliveira et al., 2014). Symptoms are often relatively mild, but many endurance
athletes experience moderate-severe symptoms at some point across several weeks of training
(Wilson, 2017), particularly if they engage in ultra-marathons or other long duration endurance
events (Costa et al., 2017b; Jeukendrup et al., 2000; Stuempfle & Hoffman, 2015). Notably,
some symptoms can negatively affect endurance exercise performance and are often reported as
a barrier to optimal performance and as reasons for dropping out of a race by endurance athletes
(O’Brien et al., 2011; Stuempfle & Hoffman, 2015). At the very least, experiencing GI
symptoms may reduce the enjoyment of engaging in recreational or competitive running.
Substantial research has sought to identify causes and risk factors for GI symptoms
during exercise, with most focusing on physiological (splanchnic hypoperfusion, altered
neuroendocrine activity), mechanical (repetitive stress from running), and nutritional factors
(ingestion of highly concentrated beverages, and high intake of fats, proteins, fiber, etc.) (Costa
et al., 2017b; de Oliveira et al., 2014; van Wijck et al., 2012). However, despite a strong
psychobiological rationale (Wilson, 2020b), and anecdotal reports of stress/anxiety influencing
GI function during exercise or sporting events, the potential role of psychological factors has
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only been addressed in a few studies (Wilson, 2018; Wilson, 2020a; Wilson et al., 2021). In one
study, runners prospectively tracked GI symptoms during training runs for 30 days and
completed a retrospective survey (Wilson, 2018). Measures of GI symptoms were significantly
associated with levels of perceived stress (rho = 0.23 – 0.29; p <0.001) and anxiety (rho = 0.18 –
0.36; p < 0.02). More recently, Wilson et al. (2021) asked endurance athletes to complete a series
of surveys before and after a race to evaluate the associations between psychological factors and
GI symptoms. Those who scored in the top tertile for measures of perceived stress, trait anxiety,
and particularly pre-race state anxiety, had higher odds of reporting moderate-severe (>5 out of
10) symptoms such as nausea and regurgitation/reflux during a race. Finally, Wilson (2020a)
asked participants to complete a retrospective survey after completing an endurance race. There
were significant correlations between ratings of GI symptoms during the race and scores on the
STICSA-Trait (rho = 0.23 – 0.33; p < 0.05) and Sport Competition Anxiety Test (rho = 0.22 –
0.28; p < 0.05). Beyond these few recent studies, there has been limited attempts to evaluate the
contribution of psychological factors on GI symptoms during exercise.
The dearth of research is particularly surprising given the large number of studies on how
psychological factors influence GI function and health in other contexts. There is a wellestablished bi-directional communication network between the central nervous system and the
GI system which overlaps with central and peripheral stress systems (Boeckxstaens et al., 2016;
Mayer et al., 2015; Vanner et al., 2016). Alterations to this “brain-gut axis” are thought to
explain why abdominal pain conditions such as irritable bowel syndrome (IBS) are strongly
influenced by psychological factors (Labanski et al., 2020; Mayer & Tillisch, 2011). For
example, experimental studies have demonstrated that psychological stressors can influence GI
function (Bhatia & Tandon, 2005; Elsenbruch & Enck, 2017). Additionally, IBS and other
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functional GI disorders are associated with high rates of psychological comorbidity (Lee et al.,
2017; Wu. 2012), and numerous psychological factors correlate with IBS symptom severity
(Jerndal et al., 2010; McKinnon et al., 2015; Midenfjord et al., 2021). Further, psychological
treatments such as cognitive behavioral therapy and hypnotherapy have generally been effective
for improving IBS outcomes (Ballou & Keefer, 2017; Kinsinger, 2017).
Given the current paucity of data in exercise contexts, many areas require further
exploration. Additional studies should attempt to replicate the findings of recent studies that
found significant associations between GI symptoms and levels of perceived stress and anxiety
(Wilson, 2018; Wilson, 2020a; Wilson et al., 2021). Additional psychological factors should also
be considered. For example, hypervigilance to pain or GI sensations has been observed in IBS
patients (Posserud et al., 2009) and measures of body or pain vigilance have previously
correlated with GI symptom severity (Keough et al., 2011; McKinnon et al., 2015). Additionally,
GI-specific anxiety refers to anxiety and cognitions that are specific to the GI system, which
some believe to be highly relevant to GI symptomology (Jerndal et al., 2010; Labus et al., 2004).
Measures of GI-specific anxiety have correlated with symptom severity in both IBS and non-IBS
samples (Jerndal et al., 2010; Labus et al., 2004; Labus et al., 2007; Saigo et al., 2017), and there
is some evidence that the effects of psychological treatments on IBS symptomology are mediated
by changes in GI-specific anxiety and/or other GI-specific cognitions (Hesser et al., 2018;
Windgassen et al., 2017; Wolitzky-Taylor et al., 2012).
Finally, it is possible that psychological factors interact with well-established risk factors
to contribute to GI dysfunction during exercise. Runners often consume exogenous nutrients,
fluid, or other substances such as caffeine before and during runs to sustain peak performance.
But overconsumption of these substances is a well-established risk factor for GI symptoms (de
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Oliveira et al., 2014), and many endurance runners reportedly limit certain foods before exercise
to mitigate GI symptoms (Parnell et al., 2020). It is possible that certain psychological factors
influence the nutritional choices that runners make before and during runs. For example, runners
who have greater levels of GI-specific anxiety or body vigilance may limit nutrition intake in
fear of provoking GI symptoms, though this has not yet been evaluated.
This study recruited trained runners to address the gaps in the literature through three
specific aims: 1) to evaluate the associations between running-related GI symptoms and several
psychological factors (stress, anxiety, GI-specific anxiety, body vigilance), 2) to assess the
associations between these psychological factors and nutrition intake before and during runs, and
3) to determine if significant associations (if any) in specific aim #2 were mediated by GI
symptoms during runs. It was hypothesized that the psychological factors would have significant
positive correlations with GI symptoms, that the psychological factors would be negatively
associated with nutrition intake (i.e., higher levels of stress/anxiety are associated with lower
nutrition intake before and during runs), and that GI symptoms would mediate such an
association.

Methods
Participants and Informed Consent
Runners were recruited for the study by emailing and calling race organizers and contact persons
at running clubs/teams. The contact persons were asked to distribute a recruitment flyer that
contained information about the study and the contact information for the investigators. To be
eligible for inclusion, runners were required to: 1) be at least 18 years of age, 2) run at least 20
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miles during a typical week of training, and 3) had run at least one run of at least 60 minutes in
duration or longer in the last two weeks. These criteria were selected to increase the likelihood
that the participants were engaging in enough training to be at high risk of significant GI
symptoms and to consider consuming exogenous nutrients or fluids before/during runs.
Interested runners were asked to confirm that they met the inclusion criteria and were then sent
an electronic informed consent document. They were encouraged to carefully read through the
document and to contact the investigators with questions about the study. No data were collected
from the participants until they had this opportunity to seek clarification about the study
procedures, risks, etc., and had electronically signed the consent document.

Procedures
This study used an observational design involving a combination of prospective and
retrospective measurements. After providing consent, participants were first sent a running
journal that was used to prospectively track information about their running for seven days. For
each run completed during that period, they were asked to report 1) the time, date, and duration
of the run, 2) an overall rating of perceived exertion (RPE) on the 6-20 Borg scale (Borg; 1982),
3) a rating of overall discomfort for seven different GI symptoms during the run, and 4) a list of
all foods and beverages consumed in the four hours leading up to each run and during the run
separately. The GI symptoms were rated on a 0-10 scale, with descriptors at 0 (“no discomfort”),
5 (“moderate discomfort”) and 10 (“unbearable discomfort”). The following standardized
definitions were provided:
•

Nausea: A feeling of sickness in the stomach marked by an urge to vomit.
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•

Regurgitation / Reflux: Sensation of food or fluid returning from the stomach to the
esophagus or mouth.

•

Stomach Fullness: A sensation of fullness or abdominal pressure in the upper abdomen.

•

Bloating: A feeling of distension from a buildup of gas in the gut.

•

Abdominal Cramps: Pain or cramping sensation, often experienced in the mid- or lowerportion of the abdomen.

•

Gas: Gas or flatus expelled through the anus.

•

Urge to defecate: Sensation of needing to pass a bowel movement.

Participants were asked to return the journal seven days after their first run. At that time,
they were sent a link to an electronic retrospective survey through Qualtrics. The survey first
asked participants about their age, sex, race/ethnicity, height, weight, years of running
experience, and whether they had a medical disorder that provokes GI symptoms. They were also
asked to rate the overall level of discomfort experienced for each of the seven GI symptoms at
rest over the past month using the same scale as the running journal. This was followed by a
series of questionnaires used to quantify the psychological factors of interest.
The 14-item Perceived Stress Scale (PSS-14) was used to quantify life stress. This scale
has been shown to be a reliable and valid means of quantifying life stress (Cohen et al., 1983)
and has previously been demonstrated to correlate with GI symptoms during running (Wilson,
2018; Wilson et al., 2021). Participants were presented with a series of thoughts and feelings and
were asked to report how often they experienced them with the following scale: 0 (“never”), 1
(“almost never”), 2 (“sometimes”), 3 (“fairly often”), and 4 (“very often”). Scores across the 14
items were summed, with the sum scores ranging from 0-56.
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The State-Trait Inventory for Cognitive and Somatic Anxiety-Trait subscale was used to
assess perceived anxiety (STICSA-Trait; Ree et al., 2008). The STICSA-Trait consists of 21
items about somatic and cognitive manifestations of anxiety and is considered a valid and
reliable measure of anxiety symptomology (Elwood et al., 2012; Grös et al., 2007). Participants
are asked to rate how often each statement is generally true for them on a scale ranging from 1
(“almost never”) to 4 (“almost always”). Ratings are summed, providing a score that ranges from
21 to 84.
The 4-item Body Vigilance Scale (BVS) was administered to evaluate the participants’
body vigilance, or the degree to which they consciously attend to internal cues or perceptions
(Schmidt et al., 1997). The first two items provided the following statements: 1) “I am the type
of person who pays close attention to internal body sensations” and 2) “I am very sensitive to
changes in my internal body sensations.” Participants were asked to rate their level of agreement
with each statement based on the past week on a scale ranging from 0 (“Not at all like me”) to 10
(“Extremely like me”). Item 3 asked the participant to rate how much time they spend
“scanning” their body for sensations such as sweating, heart palpitations, and dizziness. The
response options ranged from 0 (“No time”) to 100 (“All of the time”) in increments of 10, with
50 described as “half the time.” This rating was divided by 10 to provide a score ranging from 010. Item 4 consisted of a series of 15 specific internal sensations (heart palpitations, chest
pain/discomfort, tingling, etc.), and the participant were asked to rate how much attention they
pay to each sensation on a scale ranging from 0 (“None”) to 10 (“Extreme”). The ratings across
the 15 sensations were averaged to provide a single score ranging from 0-10. The scores were
then summed across the four items to provide a BVS sum score ranging from 0-40. The original
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validation paper found that the BVS had adequate test-retest reliability and high internal
consistency across a five-week sampling period (Schmidt et al., 1997).
The 15-item Visceral Sensitivity Index (VSI) was designed to quantify GI-specific
anxiety (Labus et al., 2004). Each item presented the participant with a statement that describes
how some people respond to discomfort or symptoms within the GI tract (i.e., pain, diarrhea,
sense of urgency, etc.). They were then asked to answer how strongly they agree or disagree with
each of the statements on the following Likert scale: “strongly agree”, “moderately agree”,
“mildly agree”, “moderately disagree”, “strongly disagree”. The ratings were scored from 0
(“strongly disagree”) to 5 (“strongly agree”), and then summed to provide a total VSI score. The
VSI has demonstrated good internal consistency (Cronbach’s α = .93), as well as convergent,
discriminant, content, and predictive validity (Labus et al., 2004, Labus et al., 2007).

Data Processing
Average run duration and RPE were calculated for each participant. In the case of missing data
for an individual run, the mean from the other runs was calculated and inputted. Running-related
GI problems were quantified as the percentage of runs that a participant reported at least one
symptom > 3 out of 10, which was then converted to a value ranging from 0.0 to 100.0 for
analysis. This was done separately for all GI symptoms, upper GI symptoms, and lower GI
symptoms. Nausea, reflux/regurgitation, bloating, and stomach fullness were categorized as
upper GI symptoms, while abdominal cramps, gas/flatulence, and urge to defecate were
categorized as lower GI symptoms. Nutrition intake information provided by the runners was
used to estimate their total energy (total Kcal), carbohydrates (g), fiber (g), fat (g), protein (g),
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fluid from beverages (mL), and caffeine (mg) both before each run (within 4 hours) and during
each run. Intake was estimated using Cronometer (https://cronometer.com/) and when applicable,
by looking up nutrition intake for specific products on official company websites. These values
were then averaged across all runs for each participant. Participants were excluded from analyses
involving nutrition or beverage intake if they did not provide specific enough information to
allow for accurate estimation of intake. The sum scores for each of the psychological and
perceptual variables were calculated using the instructions for each questionnaire.

Statistical Analysis
Data was first checked for normality using the Shapiro-Wilk analysis and inspection of
histograms. Because most variables were non-normally distributed, non-parametric analyses
were used for the analyses.
First, Spearman’s rho correlation coefficients were calculated to evaluate the association
between the psychological and perceptual scores (PSS-14, STICSA-Trait, BVS, VSI) and the
percentage of runs with a GI symptom > 3 (for all, upper, and lower symptoms separately).
Partial correlation coefficients were then calculated after controlling for the following potential
confounders: age, sex, years of running experience, a sum score calculated from the seven
resting GI symptom ratings, and mean RPE across runs. These control variables were selected
because they have previously been demonstrated to be independent predictors of GI symptoms
during exercise and as such, are commonly controlled for in other similar studies (Wilson, 2016;
Wilson, 2018; Wilson et al., 2021). Second, Spearman’s rho correlation coefficients were
calculated to quantify the association between the psychological and perceptual scores and the
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mean values for the nutrition and beverage intake both before and during runs. Mediation
analyses were not conducted due to the lack of significant associations that warranted follow-up
analysis based on a priori hypotheses.

Results
A total of 104 runners provided consent, with 22 lost to follow-up or that did not complete the
necessary data collection. Of the 82 participants (43 men, 39 women) who completed data
collection, 11 provided nutrition intake data that was incomplete or too vague to estimate the
outcomes of interest. These participants were excluded from analyses involving the nutrition data
but were included for analyses on other outcomes (GI symptoms, psychological factors, etc.).
The characteristics of the participants are included in Table 2.
The participants reported at least one GI symptom >3 out of 10 during 50% of their runs.
When symptoms were categorized by location (upper or lower GI), the runners reported at least
one symptom >3 out of 10 during 16.7% and 36.7% of their runs for upper and lower GI
symptoms, respectively. The sum of resting GI symptoms was significantly correlated with all,
upper, and lower GI symptoms during runs (rho = 0.35 – 0.42; p < 0.001), and mean RPE was
associated with upper GI discomfort during runs (rho = 0.24; p = 0.035). The remainder of the
demographic, anthropometric, and training variables were not significantly correlated with GI
symptoms (Table 3).
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Table 2. Characteristics of the Participants in Study 1
All Participants
(n = 82)
47.0 (19.0)

Men
(n = 43)
48.0 (20.0)

Women
(n = 39)
46.0 (19.0)

BMI (kg/m2)†

21.7 (3.4)

22.7 (3.1)

20.5 (3.2)

Running Experience (years)

12.0 (16.0)

12.0 (19.0)

10.0 (15.0)

PSS-14 (0-56)

18.5 (8.0)

18.0 (5.0)

20.0 (10.0)

STICSA-Trait (21-84)

31.0 (8.0)

30.0 (8.0)

32.0 (10.0)

BVS (0-100)

17.0 (10.3)

15.6 (13.4)

17.5 (8.8)

VSI (0-75)

8.0 (11.0)

5.0 (10.0)

8.0 (14.0)

Total GI at Rest (0-70)

8.0 (12.0)

8.0 (10.0)

8.0 (14.0)

Mean RPE† (6-20)

12.7 (1.7)

12.6 (1.4)

12.8 (2.6)

Mean Duration (min)

64.0 (21.2)

62.3 (19.1)

65.0 (24.1)

All GI (% of runs)

50.0 (60.2)

50.0 (50.0)

57.1 (80.0)

Upper GI (% of runs)

16.7 (51.8)

14.3 (42.9)

25.0 (60.0)

Lower GI (% of runs)

36.7 (60.6)

40.0 (60.0)

33.3 (66.7)

Age (years)

Note: All variables displayed as median (IQR). †N=81

Table 3. Correlations of Demographics and Training Data with Running GI Symptoms
All GI (% of runs)

Upper GI (% of runs)

Lower GI (% of runs)

Age (y)

0.08 (.470)

-0.01 (.935)

0.13 (.240)

BMI (kg/m2)†

0.06 (.618)

-0.04 (.716)

0.09 (.443)

Running Exp. (y)

0.00 (.990)

0.02 (.889)

-0.01 (.930)

Resting GI Total

0.42 (.000)*

0.40 (.000)*

0.35 (.001)*

Mean Duration (min)

-0.05 (.658)

0.04 (.756)

0.02 (.839)

Mean RPE†

0.15 (.191)

0.24 (.035)*

0.12 (.291)

Note: All correlations are Spearman’s rho correlation coefficients. Values in parentheses are p values. * =
p < 0.05. †N=81
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The associations between the psychological scores and GI symptoms during runs are
displayed in Table 4. Scores on the VSI were significantly correlated all, upper, and lower GI
symptoms during runs (rho = 0.32 – 0.38; p < 0.003). The associations remained significant after
controlling for potential confounders (age, sex, running experience, sum of resting GI symptoms,
and mean RPE) (partial rho = 0.23 – 0.25; p < 0.043). The presence of GI symptoms during runs
was not significantly associated with scores from the PSS-14, STICSA-Trait, or BVS.

Table 4. Associations Between Psychological Factors and Running GI Symptoms
Standard Correlations (Unadjusted)
All GI %

Upper GI %

Lower GI %

PSS-14

0.10 (.364)

0.12 (.267)

0.08 (.490)

STICSA-Trait

0.08 (.488)

0.01 (.935)

0.16 (.147)

BVS

0.14 (.196)

0.20 (.076)

-0.05 (.687)

VSI

0.36 (.001)*

0.38 (.000)*

0.32 (.003)*

Partial Correlation (controlling for age, sex, running experience, resting GI, and mean RPE)
All GI %

Upper GI %

Lower GI %

PSS-14

0.04 (.747)

0.06 (.636)

0.04 (.735)

STICSA-Trait

-0.06 (.635)

-0.15 (.193)

0.09 (.437)

BVS

0.07 (.558)

0.10 (.388)

-0.11 (.328)

VSI

0.23 (.043)*

0.23 (.043)*

0.25 (.029)*

Note: N=81 for the partial correlations due to a missing RPE value. Bold font and * are used to
indicate statistically significant associations at P < 0.05.
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Information about the pre- and during-run nutrition intake is shown in Table 5. The
associations between nutrition intake variables and the psychological scores among the 71
participants with complete dietary data are displayed in Table 6. Scores on the PSS-14 were
significantly positively associated with pre-run intake of fat (rho = 0.31; p =0.009) and protein
intake (rho = 0.27; p = 0.022). Scores on the VSI were significantly positively correlated with
pre-run intake of energy (rho = 0.25; p = 0.037) and fat (rho = 0.25; p = 0.033). There were no
other significant associations between psychological scores and nutrition intake.

Table 5. Overview of Nutrition Intake Data
All Participants
(n = 71)
220.9 (276.7)

Men
(n = 32)
251.2 (299.4)

Women
(n = 39)
199.8 (263.5)

Pre-Run CHO (g)

33.2 (35.7)

34.1 (33.9)

30.2 (38.8)

Pre-Run Fiber (g)

3.6 (4.4)

3.6 (4.9)

3.8 (3.9)

Pre-Run Fat (g)

7.4 (15.0)

7.8 (16.4)

6.3 (12.8)

Pre-Run Protein (g)

6.4 (12.3)

7.3 (11.6)

6.2 (12.3)

Pre-Run Fluids (mL)

354.9 (318.5)

334.2 (526.9)

361.6 (263.4)

41.5 (84.9)

41.3 (70.6)

41.5 (75.7)

During-Run Energy (kcal)

0 (8.6)

0 (0.5)

0 (11.0)

During-Run CHO (g)

0 (2.0)

0 (0.2)

0 (2.8)

During-Run Fiber (g)

0 (0)

0 (0)

0 (0)

During-Run Fat (g)

0 (0)

0 (0)

0 (0)

During-Run Protein (g)

0 (0)

0 (0)

0 (0)

During-Run Fluids (mL)

0 (71.0)

0 (27.1)

0 (78.3)

0 (0)

0 (0)

0 (0)

Pre-Run Energy (kcal)

Pre-Run Caffeine (mg)

During-Run Caffeine (mg)

Note: All variables displayed as median (IQR)
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Table 6. Associations Between Nutrition Intake and Psychological Factors (n=71)
Pre-Run Nutrition
PSS-14

STICSA-Trait

BVS

VSI

Pre-Run Energy

0.23 (.056)

0.10 (.416)

0.02 (.856)

0.25 (.037)*

Pre-Run CHO

0.15 (.226)

0.02 (.844)

-0.04 (.726)

0.19 (.111)

Pre-Run Fiber

0.18 (.134)

0.12 (.335)

0.11 (.359)

0.22 (.064)

Pre-Run Fat

0.31 (.009)*

0.19 (.110)

0.09 (.480)

0.25 (.033)*

Pre-Run Protein

0.27 (.022)*

0.15 (.210)

0.04 (.755)

0.15 (.213)

Pre-Run Fluids

0.13 (.295)

-0.02 (.883)

0.08 (.485)

0.15 (.204)

Pre-Run Caffeine

0.04 (.762)

-0.09 (.444)

-0.02 (.881)

-0.15 (.201)

During Run Nutrition
PSS-14

STICSA-Trait

BVS

VSI

During Run Energy

-0.04 (.751)

-0.07 (.591)

0.11 (.349)

0.03 (.833)

During Run CHO

-0.04 (.732)

-0.08 (.507)

0.11 (.366)

0.02 (.873)

During Run Fiber

0.01 (.942)

-0.12 (.321)

0.06 (.649)

0.04 (.742)

During Run Fat

0.03 (.786)

0.06 (.630)

0.06 (.625)

0.15 (.198)

During Run Protein

-0.09 (.466)

0.08 (.507)

0.10 (.389)

0.01 (.943)

During Run Fluids

0.10 (.401)

0.05 (.663)

0.02 (.896)

-0.01 (.932)

During Run Caffeine

-0.09 (.464)

0.11 (.365)

0.02 (.897)

-0.09 (.453)

Note: Bold font and * are used to indicate statistically significant associations at P < 0.05.

Discussion
Several recent studies found that measures of perceived stress and anxiety were associated with
GI symptoms during endurance exercise (Wilson, 2018; Wilson, 2020a; Wilson et al., 2021).
However, the contribution of psychological factors in the etiology of exercise-induced GI
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problems remains relatively unexplored. Many psychological factors have been linked to GI
function and symptomology in clinical settings (e.g., hypervigilance, GI-specific anxiety, etc.)
but have been understudied in the context of exercise. Further, some endurance athletes limit
intake of certain foods before races to reduce their risk of GI symptoms (Parnell et al., 2020), but
there has been no attempt to determine if nutritional choices are associated with psychological
characteristics of the athlete. As such, the present study sought to determine if GI symptoms
were associated with several psychological factors, and whether these psychological factors were
associated with peri-run nutrition intake across a week of running.
The present study found no significant associations between running-related GI
symptoms and scores on the PSS-14, STICSA-Trait, or BVS, which does not support our
hypotheses based on findings from previous research. Wilson (2018) found PSS-14 scores had
modest correlations with the occurrence of substantial running-related GI symptoms across a
month of training (rho = 0.23 – 0.29). Notably, the runners had similar characteristics to those in
the present study in terms of age, running experience, PSS-14 scores, and percentages of runs
with GI symptoms that were > 3 out of 10. While the study methodologies and analyses differed,
the present findings are also not in-line with Wilson et al. (2021), who found that endurance
athletes scoring in the top tertile for PSS-14 and STICSA-Trait were at significantly higher odds
for reporting certain GI symptoms of >5 on a 0-to-10 scale during races. A third investigation by
Wilson (2020a) found that scores on the STICSA-Trait and Sport Competition Anxiety Test had
significant correlations with GI symptom ratings during endurance races (rho = 0.22 – 0.33; p <
0.05). While the methodologies differed across these studies, they each found significant
associations between measures of stress/anxiety and GI symptoms during running or endurance
exercise, which was not the case in the present study.
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There are several potential explanations for the disparate findings between the present
study and previous investigations. First, the 7-day training period in the present study may not
have been long enough to accurately depict runners’ tendencies to experience GI symptoms
compared to the 30 days used by Wilson (2018). Though it is difficult to ascertain whether this
influenced the results since the percentages of runs with a symptom > 3 were similar between the
two studies. Second, it is possible that differences are partially due to how GI problems were
defined. Wilson et al. (2021) evaluated GI symptoms individually rather than categorizing them
by all, upper, or lower GI problems. Using this methodology, they found that only certain GI
symptoms (nausea, reflux/regurgitation) had higher odds of being reported by athletes in the top
tertile for PSS-14 and STICSA-Trait.
Perhaps the most likely explanation for the disparate results to date is that Wilson et al.
(2021) and Wilson (2020a) evaluated psychological factors and GI symptoms in relation to
competition. Theoretically, a competitive setting is when competitive anxiety would be at its
highest, athletes are pushing themselves the hardest, and when the associations between
psychological factors and GI problems should be most pronounced. Indeed, the largest
statistically significant odds ratios in Wilson et al. (2021) were reported for those in the top
tertile for state anxiety during the morning of the race (odds ratios = 2.99 – 5.57; p < 0.05). The
present study suggests that there is minimal association of perceived stress and trait anxiety with
GI symptoms during a typical week of training, but results may differ if a study was conducted
during the week of a competition, or if a longer timeframe of tracking was employed.
It was also hypothesized that there would be a significant positive association between
BVS scores and GI problems. This was the first study to evaluate such an association in exercise
contexts, but the BVS and other measures of vigilance have been used in non-exercise contexts.
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For example, a study with IBS patients found that BVS scores were associated with GI
symptomology (Keough et al., 2011), and hypervigilance to pain or GI symptoms is commonly
reported in functional GI disorders (Posserud et al., 2009). However, the present results do not
support our hypothesis. Future research could consider evaluating runners’ vigilance to painful
stimuli specifically, using questionnaires such as the pain vigilance and awareness scale
(McCracken, 1997).
There were, however, statistically significant associations between GI-symptom burden
and VSI scores, which remained significant after controlling for potential confounders such as
age, sex, running experience, resting GI symptoms, and mean running RPE (Table 4). Notably,
the magnitude of these associations is comparable to those that have been reported for other GIsymptom risk factors such as perceived stress/anxiety, age, and running intensity (Wilson, 2018),
as well as pre-race energy, carbohydrate, and caffeine intakes (Wilson, 2016). The VSI was
designed to evaluate anxiety that is specific to the GI-system (Labus et al., 2004). While this is,
to our knowledge, the first study to evaluate associations between VSI and GI symptoms in an
exercise context, this scale has been used extensively in relation to GI symptomology in irritable
bowel syndrome (IBS). The findings from these studies may provide some context for the
present findings and potential avenues for future research.
Recent evidence has suggested that psychological factors that are specific to the GI
system, such as GI-specific anxiety and GI-specific cognitions, may be highly relevant to GI
symptomology and outcomes (Hesser et al., 2018; Jerndal et al., 2010; Labus et al., 2007;
Windgassen et al., 2017). For example, VSI scores tend to be significantly associated with GI
symptomology in individuals with and without IBS (Jerndal et al., 2010; Labus et al., 2007;
Saigo et al., 2018), and in some cases, associations between general psychological factors and GI
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symptomology have been mediated by VSI scores (Labus et al., 2004; Labus et al., 2007).
Further, recent studies have suggested that the effects of psychological treatments on IBS
outcomes may be mediated by reductions in VSI scores (Garland et al., 2012; Ljótsson et al.,
2013; Windgassen et al., 2017). As such, several authors have suggested that GI-specific
constructs such as GI-specific anxiety and maladaptive GI-related cognitions or behaviors should
be primary targets for interventions that seek to improve IBS outcomes (Garland et al., 2012;
Jerndal et al., 2010; Windgassen et al., 2017). Though it is important to note that others have
argued that the primary treatment target should be context-specific, as some patients may
respond best to reductions in general psychological comorbidities, while others may need a
larger focus on anxiety or maladaptive behaviors/cognitions that are GI-specific (Spiegel et al.,
2011). Taken together, there is some evidence that GI-specific anxiety is an important
consideration for those with functional GI disorders, though it is currently unknown how well
these findings generalize to athletic or physically active populations.
Additional studies should expand on the findings from the present study to determine to
what extent GI-specific anxiety or other GI-specific psychological constructs contribute to
symptoms in the context of exercise. Studies should include the VSI as a measure of GI-specific
anxiety, particularly in competitive settings as done by Wilson et al. (2021) and Wilson (2020a).
There are also other factors that may be useful to evaluate, such as the GI-Specific Cognitions
Questionnaire, which aims to quantify an individual’s GI-specific catastrophic cognitions (Hunt
et al., 2014). Further, it may be useful to conduct path analyses with large samples to see how
various psychological factors interact and contribute to GI symptoms. For example, a recent
study with IBS patients evaluated a comprehensive battery of psychological factors and found
evidence of a pathway through which personality factors (higher levels of neuroticism)
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contributed to greater amounts of negative appraisal, which is turn led to greater pain
catastrophizing and vigilance. The byproduct of these factors was greater levels of GI-specific
anxiety, and ultimately worsened symptom ratings (McKinnon et al., 2015). Given the relative
paucity of data available in exercise settings currently, such studies may help clarify the role of
various psychological factors (if any) on GI symptoms during exercise. Finally, experimental
studies could compare the effects of highly GI-specific psychological treatments to those that
target general stress or anxiety reduction. The addition of follow-up mediation analyses may help
clarify which psychological factors (if any) mediate treatment effects within and across
conditions.
A second aim of this study was to evaluate the associations between psychological
factors and nutrition intake before and during runs. Surprisingly, there were relatively weak
associations between psychological factors and nutrition intake before and during runs (Table 6).
The few significant associations were positive in direction, which runs in contrast to our
hypothesis that those with higher levels of stress or anxiety would consume less food and
beverages prior to running to avoid GI symptoms. It is difficult to determine why this result
occurred, although it is possible that the few significant positive associations represent
confounding by some other unmeasured factor(s). Also, as previously discussed, the associations
might differ in a competitive setting. The present study evaluated outcomes during a typical
week of running, which may have resulted in lower levels of stress/anxiety and nutrition intake
in comparison to competition weeks. Further, it is possible that a 7-day period is not long enough
to get an accurate depiction of their typical pre- and during-run fueling strategies, and the remote
nature of this study meant that data collection relied on self-report journaling of nutrition intake
which could introduce error (Schoeller, 1995). Taken together, future studies should consider
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evaluating the associations between psychological factors and nutrition intake immediately
before and during a competitive race rather than during a training week and when possible,
observe nutrition intake directly or use additional methods to limit self-report error (i.e., have
athletes send pictures of their pre-run meals).
There are several limitations to this study. First, the observational design does not allow
for evaluation of the causal nature of the observed associations. Indeed, reverse causality or even
bi-directional associations are possible. For example, higher scores on the VSI may predispose a
runner to report GI symptoms due to a causal relationship between GI-specific anxiety and GI
symptomology. However, it is also possible that the GI-specific anxiety/higher VSI scores
resulted from runners’ previous experiences with GI symptoms. Longitudinal studies are
required to parse out the nature of the association between VSI scores and GI symptoms. Second,
the use of self-report dietary journals may have resulted in inaccurate nutrition intake estimates.
While this is a difficult limitation to circumvent, future studies may consider directly observing
food and beverage intake or take steps to improve the accuracy of portion size estimates (e.g., by
requiring pictures of food and beverages). Finally, previous studies that have identified
psychological correlates have either asked participants to track runs for 30 days (Wilson, 2018)
or asked about symptoms during a competitive race (Wilson, 2020a; Wilson et al., 2021). It is
possible that the seven days used in this study was not enough to accurately quantify typical GI
symptoms and nutrition intake. Further, the associations between psychological factors, nutrition
intake, and GI problems could be more prominent during competitive races, when competition
anxiety is higher, and runners are more likely to consume larger quantities of foods and
beverages to fuel optimal performance. This type of design was not possible for the present
study, given the restrictions on races that were imposed due to the COVID-19 pandemic.
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CHAPTER V
EFFECTS OF DAILY BREATHING INTERVENTIONS ON GI SYMPTOMS, HEART
RATE VARIABILITY AND PSYCHOLOGICAL FACTORS IN RUNNERS
Introduction
The GI system and central nervous system communicate through numerous
neuroendocrine and immunological pathways collectively known as the “brain-gut axis” (Mayer
et al., 2015). There is considerable overlap between pathways of the brain-gut axis and stress
response systems in the body (Boeckxstaens et al., 2016; Vanner et al., 2016), and alterations to
such pathways are thought to explain why conditions involving abdominal pain (e.g., IBS) have
a strong psychological component (Labanski et al., 2020; Mayer & Tillisch, 2011). For example,
experimental models have demonstrated that various acute and chronic psychological stressors
have various effects on GI functions such as altered motility (Almy et al., 1949; Holtman &
Enck, 1991), delayed gastric emptying (Bhatia & Tandon, 2005; Enck & Holtmann, 1992),
damage to the intestinal epithelial barrier (Hyland et al., 2014; Söderholm et al., 2002), and
development of visceral hypersensitivity (Larauche et al., 2012). Additionally, psychological
factors like stress, anxiety, and depression are risk factors for IBS (Bennett et al., 1998; Labanski
et al., 2020; Moloney et al., 2016) and correlate with GI symptomology in the general population
(Haug et al., 2002; Stanghellini, 1999). Further, psychological treatments such as cognitive
behavioral therapy and hypnotherapy have generally been effective for improving IBS outcomes
(Ballou & Keefer, 2017; Kinsinger, 2017). Taken together, current evidence suggests that
psychological factors are relevant to GI function and symptomology.
Surprisingly, little research has evaluated the role of psychological factors in the context
of exercise-induced GI dysfunction and symptoms. Early descriptive studies found that many
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endurance athletes reportedly experience symptoms (including “nervous diarrhea”) before
competition (Sullivan & Wong, 1992; Worobetz & Gerrard, 1985) and that some athletes believe
GI symptoms are more likely when anxious about competing (Sullivan, 1987). More recently,
three studies found that measures of perceived stress and anxiety were associated with GI
symptoms during 30-days of running (Wilson, 2018) and during competitive endurance races
(Wilson, 2020a; Wilson et al., 2021). These findings appear to demonstrate that psychological
factors are associated with exercise-induced GI symptomology, though more research is clearly
needed, particularly from experimental designs. For example, some athletes may have higher
levels of stress or anxiety because they tend to experience GI symptoms during runs, not because
the stress or anxiety caused the symptoms. Or the association could be bi-directional.
Randomized trials utilizing psychological treatments may help clarify the causative relationship
between psychological factors and exercise-related GI symptoms while also potentially
identifying efficacious treatments. Two interventions that could be effective and feasible for
endurance athletes are slow deep breathing and mindful breath counting (Gorman & Green,
2016; Russo et al., 2017).
Slow deep breathing at about six breaths per minute has numerous physiological effects,
including enhanced HRV by promoting increased vagal outflow and dampened sympathetic
activity (Badra et al., 2001; Bernardi et al., 2001; Chang et al., 2013; Paprika et al., 2014;
Tharion et al., 2012). This is potentially relevant to GI dysfunction since the vagus nerve is a key
mediator of pathways within the brain-gut axis and the stress response systems that overlap with
it (Boeckxstaens et al., 2016; Vanner et al., 2016). There is also some evidence that slow deep
breathing interventions can impact GI function in some circumstances, such as improving
feeding tolerance in functional dyspepsia (Hjelland et al., 2007) and nausea in motion sickness
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scenarios (Jokerst et al., 1999). Mindfulness interventions may also be beneficial, due to their
positive effects on various health outcomes including anxiety and pain (Strauss et al., 2014;
Zeidan et al., 2011). This seems to include benefits to GI function, as one study reported
improved IBS symptom severity after a mindfulness intervention (Gaylord et al., 2011). The
precise underlying mechanisms are not clear, but mindfulness interventions could buffer stress
through effects on brain regions that regulate top-down responses to stress and those involved
with stress axes (Creswell & Lindsay, 2014; Creswell, 2017). There is also the possibility that
they could promote nonreactivity to gut sensations and reduce GI-specific anxiety or catastrophic
thoughts about visceral sensations (Gaylord et al., 2011). There are many different mindfulness
interventions, but simple breath counting has the advantage of being simple to perform, timeefficient (Levinson et al., 2014), and has been shown positively affect outcomes such as stressinduced alcohol seeking behavior (Shuai et al., 2020).
Given that recent studies have identified psychological factors as potential risk factors for
GI symptoms during exercise (Wilson, 2018; Wilson, 2020a; Wilson et al., 2021), experimental
studies that evaluate the effects of stress or anxiety reducing interventions on GI symptoms
would be useful. As such, the purpose of this randomized controlled trial was to evaluate the
effects of simple daily breathing interventions on GI symptoms, psychological factors (stress,
anxiety, GI-specific anxiety, body vigilance, mindfulness), and HRV in endurance runners.
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Methods
Participants and Screening
Runners were recruited by contacting race organizers and contact persons at running clubs. The
contact persons were sent a recruitment flyer that outlined the study and included the
investigators’ contact information. A phone or video information call was scheduled with each
runner that contacted the investigators. During the call, prospective participants were first
screened to ensure they were eligible to participate. To be eligible for inclusion, participants
were required to meet the following criteria:
•

At least 18 years of age.

•

Currently running at least 15 miles during a typical training week.

•

Currently residing in the contiguous United States.

•

Access to the internet and a smartphone or tablet that was compatible with the iOS or
Android versions of the Elite HRV smartphone application.

•

If prescribed a psychotropic drug (e.g., SSRIs), the dose had to have been stable for 3+
months prior to enrollment.

•

At least sometimes experience GI symptoms during runs. This was assessed by asking
them to report how often they had experienced GI symptoms during runs in the past
month. The criterium was fulfilled if they answered either “sometimes”, “often” or
“always” on a five-point Likert scale.

•

Have at least mild anxiety at the time of enrollment. To quantify anxiety levels,
participants completed the GAD-7 questionnaire. A score of 5 or higher was used as a
cut-off score for mild anxiety based on previous recommendations (Williams, 2014).
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Those who met the criteria were sent an electronic informed consent document and provided an
overview of the study procedures, risks, etc. They were encouraged to carefully read through the
informed consent document and ask questions before indicating their agreement to participate on
the consent form.

Design Overview
A parallel-group, unblinded randomized controlled trial was used to evaluate the effects of two
breathing interventions on GI symptoms, psychological factors, and HRV. All procedures were
completed remotely due to restrictions during the COVID-19 pandemic. After enrollment,
participants were provided materials and instructions to complete three pre-intervention
measurements: 1) a running journal used to track information about their runs and GI symptoms
for seven days, 2) a portable HRV monitor to take a resting HRV measurement, and 3) a preintervention survey to collect information about their demographics, training information, and to
quantify baseline levels of the psychological factors of interest for this study (stress, anxiety, GIspecific anxiety, body vigilance, mindfulness). Participants were then randomly allocated to one
of three groups for four weeks: SLOWBC, NORMALBC, or control (the specifics of each are
described later on in the ‘Interventions’ section). The randomization process was done using
blocks of 3 and 6. Gender-specific randomization lists were generated using the following
website (https://www.sealedenvelope.com/simple-randomiser/v1/lists). A person not involved in
the data collection was asked to generate the lists and then fill sequentially labelled envelopes
with the results.
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Participants were sent a midpoint electronic survey two weeks into their assigned
intervention period to assess resting GI symptoms and the psychological factors. At the end of
week three, they were sent a second running journal and portable HRV monitor to replicate the
pre-intervention measurements. A final electronic survey was sent on the final day of the
intervention.

Measurements
Running Journal
The running journal was adapted from study 1 and was used to record the following information
about each run participants performed during a 7-day period: 1) the time, date, and duration (in
minutes) of the run, 2) an overall 6-20 RPE for the run, and 3) 0-10 ratings for the same seven GI
symptoms as used in Study 1. The symptoms and scale were identical to those used for study 1
(See Chapter III for more information). Participants were asked to send the journal back seven
days after their first completed run. A journal was sent upon enrollment (pre-intervention
running journal) and after the third week of the intervention period (post-intervention running
journal). The timing of the post-intervention measurement was done to maximize the chances of
detecting any transient effects of the breathing sessions by evaluating GI symptoms during the
final days of the intervention. The variables assessed from each running journal were the number
of runs completed, average run duration (min), average run RPE (6-20), the percentage of runs
with at least one symptom > 3 out of 10 across all, upper, and lower GI symptoms
independently. Average running GI burden was also calculated by summing GI symptom scores
during each run and then averaging the sum scores across runs.
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HRV Measurement
A portable CorSense HRV monitor was shipped to participants with instructions to complete a
resting measurement. Portable HRV devices are generally considered a valid alternative to goldstandard methods (e.g., electrocardiogram; Dobbs et al., 2019), and user-friendly methods for
collecting data remotely were necessary for this study due to the COVID-19 pandemic.
Participants were provided step-by-step instructions for downloading the Elite HRV smartphone
application and using the HRV monitor. The participant was told to lay comfortably in the supine
position, place the monitor on a fingertip, and initiate a measurement through the smartphone
application. After a short sampling period, the monitor collected information for five minutes
and results were uploaded to the smartphone application. Participants were asked to take a
screenshot of the results page and send it to the investigators through email or text message. A
monitor was sent upon enrollment (pre-intervention) and after week 3 of the intervention period
(post-intervention). The primary variable assessed and analyzed was Ln (RMSSD) in ms, as this
variable has been recently validated using the Elite HRV smartphone application (Perrotta et al.,
2017).

Electronic Surveys
Qualtrics-based electronic surveys were sent to each participant upon enrollment (preintervention), after week two of the intervention (midpoint), and on the final day of the
intervention (post-intervention) through email. The pre-intervention survey first asked
participants about demographic information such as age, sex, race/ethnicity, running experience,
GI conditions, use of medications to manage GI symptoms during running, history of performing
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breathing interventions, employment status, and job stress. Participants were then asked to rate
the typical severity of the seven GI symptoms at rest and to complete a series of psychological
questionnaires. Perceived stress, anxiety, body vigilance, GI-specific anxiety, and mindfulness
were quantified using the PSS-14, GAD-7, BVS, VSI, and FFMQ questionnaires respectively
(See Chapter III for more thorough descriptions of each scale). The midpoint and postintervention surveys excluded the questions about participant demographics but were otherwise
identical to the pre-intervention survey. Aside from demographic information (age, sex, running
experience, etc.), the variables assessed from each survey were the sum of the resting GI
symptom scores and the scores for each of the psychological questionnaires.

Interventions
Individuals in the SLOWBC and NORMALBC groups were asked to complete a guided 5minute daily breathing sessions for four weeks. The interventions were similar other than the
breathing frequency (six breaths/minute for SLOWBC, 15 breaths/minute for NORMALBC) and
breathing depth (SLOWBC was asked to take deep breaths, NORMALBC was asked to take
normal breaths). They were sent a reusable link to a video embedded with audio instructions and
a breathing application (eXHALeR V. 2.0.6; https://xhalr.com/) to guide them through the
sessions. They were also sent a treatment journal to track their progress. After a short audio
message that provided instructions for the intervention, the video displayed a visual aid that
participants were asked to sync their breathing to. Each breathing cycle (inhalation, hold,
exhalation) was visually shown by a circle that expanded and constricted to simulate the
prescribed breathing pattern. The words “inhale”, “hold”, and “exhale” were displayed as the
circle constricted, at full expansion, and as the circle constricted respectively (Figure 2).
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Figure 2. Visual aid used in the SLOWBC and NORMALBC videos.

The SLOWBC video was set to a 4-second inhalation, 2-second hold, and 4-second exhalation so
that participants breathed at six breaths per minute. The NORMALBC video was set to 2-second
inhalations and exhalations with no hold to equate to 15 breaths per minute. Both groups were
asked to count their breaths until they reached 10, restart from 1, and continue that cycle
throughout the session. However, the SLOWBC group was prompted to take deep breaths while
the NORMALBC group was asked to take regular breaths.
At the end of the five minutes, an audio message prompted participants to record the
time/date and 1-10 ratings of how engaged they were in the task and how pleasant they found the
session in the treatment journal. Participants were asked to complete each session within two
hours of running when possible. On days they did not run, or a pre-run session was not possible,
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participants were asked to schedule a time to complete the session and try to be consistent with
timing each day. Participants were contacted weekly through phone and email correspondence to
check on their compliance to the intervention and answer questions about the intervention. The
control group did not perform a daily breathing intervention and were asked to not engage in any
sort of breathing intervention during their involvement in the study.

Data Processing
Scores for the psychological factors were calculated according to scoring instructions for each
questionnaire. Resting GI symptom burden was quantified by summing resting GI symptom
ratings in each survey. The primary method of quantifying GI symptom burden during runs was
as the percentage of runs with at least one symptom >3 out of 10. This was done for all
symptoms, upper GI symptoms (nausea, reflux/regurgitation, bloating, stomach fullness), and
lower GI symptoms (abdominal cramping, gas, urge to defecate) separately. This methodology
tends to result in more normality distributed data and also gives a sense of the burden of notable
symptoms over time. Additionally, average running GI-symptom burden was calculated by
summing the reported GI symptom scores during each run and averaging across the total number
of runs logged. Mean running RPE and duration were calculated for each participant. When data
for an individual run was not reported, the mean value across all other runs was inputted.
Due to the remote nature of this study, some participants did not strictly adhere to the
prescribed timing of measurements or intervention period. As such, the following information
was derived from the treatment journals: 1) the total number of days from the first completed
session to the final completed session, 2) the total number of breathing sessions completed
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within that timeframe, 3) the percentage of days where a breathing session was completed during
that timeframe, and 4) mean ratings of engagement and pleasantness across all breathing sessions
completed. Additionally, the dates of each completed measurement and for the first and last
breathing session completed were recorded to quantify the degree of compliance to the
procedures. The number of days between each of these dates were calculated and reported below
(Table 7).

Table 7. Overview of Measurement Timing
Number of Days

SLOWBC

NORMALBC

Control

Pre-Running Journal to 1st
Treatment Day

6.4 ± 4.9

6.6 ± 5.2

-

Pre-Survey to 1st Treatment Day

6.6 ± 5.7

8.2 ± 5.6

-

Pre-HRV to 1st Treatment Day

7.9 ± 5.2

5.3 ± 6.0

-

1st Treatment Day to PostRunning Journal

29.7 ± 6.1

28.8 ± 3.4

-

1st Treatment Day to post-survey

31.1 ± 6.8

30.7 ± 3.5

-

1st Treatment Day to post-HRV

31.5 ± 7.5

27.1 ± 2.5

-

Last treatment day to post-survey

1.3 ± 3.1

1.9 ± 2.8

-

-0.2 ± 1.8*

0.0 ± 1.2

-

Last treatment day to post-HRV

1.7 ± 3.9

-0.9 ± 3.8*

-

Pre-running journal to postrunning journal

36.1 ± 6.6

35.4 ± 7.1

34.6 ± 9.9

Pre-survey to post Survey

36.9 ± 6.8

39.2 ± 6.6

39.2 ± 9.6

Pre-HRV to Post-HRV

43.5 ± 11.7

34.2 ± 6.4

34.9 ± 4.9

Last treatment day to postrunning journal

Note: Data from all participants that completed the study. *Negative values indicate that the measurement
was completed before the last recorded treatment day. The final date where a run was logged was used as
the completion date for the running journals. The first and last treatment days were defined as the first and
last day that the participant logged a breathing session on the treatment journal.
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Statistical Analysis
Shapiro-Wilk tests with visual inspection of histograms and Q-Q plots were used to evaluate the
normality of the data. Imperfect compliance and missing outcomes were handled by conducting
both intention-to-treat (ITT) and per-protocol analyses (Gupta, 2011; Ranganathan et al., 2016;
Schulz et al., 2010). ITT analyses include all participants that were randomized into groups,
regardless of their compliance with the study procedures (Gupta, 2011). This is done to mitigate
bias that comes from excluding non-compliant participants, maintain the characteristics of the
groups that results from randomization, and reflects the reality of practical implementation of
treatments, where compliance is not always perfect (Fergusson et al., 2002; Wertz, 1995). In
contrast, per-protocol analyses exclude participants with poor compliance and missing outcomes
and allow for a more direct analysis of treatment effects amongst those who completed the study
procedures (Ranganathan et al., 2016; Schulz et al., 2010). For the ITT analyses, missing
midpoint and post-intervention data was inputted using the “Last Observation Carried Forward”
method, where a participant’s most recent observation prior to withdrawal from the study is
retained (Streiner & Geddes, 2001). The specific inclusion and exclusion criteria for the perprotocol analysis are listed below:
•

Participants in the SLOWBC or NORMALBC groups were excluded if they met one of
the following criteria: 1) a breathing treatment journal was never completed or sent to the
investigators, 2) poor treatment compliance, defined as completing <50% of sessions
between the first and last breathing session; 3) post-intervention measurements were
completed >10 days after the final breathing session; 4) poor treatment timing, defined as
>42 total days between the first and last breathing sessions. The 42-day cut-off was
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selected as this equated to two additional weeks beyond the prescribed four-week
intervention.
•

Participants in the control group were excluded from analyses for a given outcome if
there was >60 days between the pre- and post-intervention measurements. Sixty days was
selected because it equated to more than three weeks longer than the prescribed time
between the beginning of the pre-intervention measurements and the end of the
intervention period (1 week for baseline measurements, 4 weeks for the intervention).
Data related to the intervention compliance and engagement were compared between

SLOWBC and NORMALBC groups with independent t-tests. Normally distributed data were
analyzed using mixed methods ANOVA, with group allocation (SLOWBC, NORMALBC,
Control) as the between-subjects factor and time (pre-intervention, midpoint, post-intervention)
as the within-subject factor. Mauchly’s test of sphericity was checked, and in cases of p < 0.05,
the Huynh-Feldt correction was reported instead. When a significant group x time interaction
was detected, simple main effects were reported instead of main effects. Non-normally
distributed data was compared across groups with the Kruskal Wallis test at each time point.
Bonferroni post hoc tests were used when ANOVAs or Kruskal Wallis tests identified
statistically significant effects. Partial eta squared (ηp2) and ranked epsilon squared (ε2) were
calculated as measures of effect size for the mixed ANOVAs and Kruskal Wallis tests,
respectively (Tomczak & Tomczak, 2014).

123

Results
Participants
A total of 121 runners were screened for eligibility. Sixty-eight were eligible to participate based
on the inclusion criteria. Ultimately, 63 runners consented to participate and were enrolled in the
study. Of the 63 participants that enrolled in the study, seven did not complete the preintervention measurements and were not randomized. The remaining 56 participants were
randomly allocated to either the SLOWBC (n=20), NORMALBC (n=18), or control (n=18)
groups. An overview of the baseline characteristics of the participants is shown in Table 8.
Two participants from the SLOWBC group and three participants from the NORMALBC
group were lost to follow-up. The last observed datapoints were inputted for use in ITT analyses.
An additional four participants were excluded from the per-protocol analyses due to poor
compliance to the treatment (n=2) or because they never sent a completed treatment journal
(n=2). The ITT analyses and per-protocol analyses included data from 56 and 47 total
participants, respectively. Among the 47 participants available for the per-protocol analyses,
there were missing data points for some measurements due to compliance issues, resulting in
slightly different sample sizes depending on the outcome being analyzed. The flow of
participants through the study is displayed in Figure 3.
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Table 8. Characteristics of the Participants in Study 2

Age (years)

SLOWBC
(n = 20)
38.5 (22.0)

NORMALBC
(n = 18)
30.0 (13.0)

Control
(n = 18)
37.0 (14.0)

BMI (kg/m2)

22.0 (3.6)

21.7 (2.0)

21.6 (3.9)

Job Stress Rating (0-10)

7.0 (3.0)

7.0 (3.0)

6.0 (2.0)

Running Experience (years)

15.5 (17.0)

10.0 (7.0)

10.0 (9.0)

Resting GI burden (0-70)

14.0 ± 7.9

14.4 ± 10.1

17.9 ± 8.8

Pre-Intervention Run RPE (6-20)

11.8 ± 1.7

12.0 ± 1.2

12.6 ± 1.4

Post-Intervention Run RPE (6-20)

11.9 ± 1.9

12.0 ± 1.2

12.2 ± 1.4

Pre-Intervention Run Duration
(min)

48.2 ± 16.6

52.7 ± 17.6

75.3 ± 35.0

Post-Intervention Run Duration
(min)

47.8 ± 15.3

51.7 ± 18.6

69.0 ± 29.0

% Female

65.0

66.7

72.2

% Male

35.0

33.3

27.8

% Employed

90.0

88.9

83.3

% with Reported GI Condition

25.0

27.8

11.1

% with prior experience with
breathing exercises

60.0

44.4

38.9

% that use medications to mitigate
GI symptoms during runs

10.0

11.1

5.6

Note: Normally-distributed variables are displayed as means ± standard deviation. Non-normally
distributed variables are displayed as medians (Interquartile Range).
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Figure 3. Participant flow through the study.

Intervention Compliance and Comparison
An overview the two interventions is displayed in Table 9. Thirty-one participants submitted a
treatment journal for either the SLOWBC (n=17) or NORMALBC (n=14) intervention. The
SLOWBC participants completed an average of 23.9 ± 4.1 sessions across a timeframe of 30.9 ±
6.0 days, which equated to sessions being completed on 79.4 ± 16.7% of days. The
NORMALBC participants completed an average of 24.4 ± 6.9 sessions across a timeframe of
29.8 ± 3.8 days, which equated to sessions completed on 81.2 ± 17.4% of days. One participant
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from each of these groups was excluded from the per-protocol analyses due to poor compliance.
When excluding these participants, compliance values were similar. The SLOWBC group
completed 24.2 ± 4.1 sessions across 30.1 ± 4.9 days (81.7 ± 14.2% compliance), while the
NORMALBC group completed 25.5 ± 6.0 sessions across 30.0 ± 3.9 days (84.3 ± 13.4%
compliance). There were no significant differences between the two groups in terms of total
treatment days, the number of sessions completed, the percentage of treatment days where a
session was completed, mean rating of engagement in the task, or mean rating of how pleasant
each session was (p > 0.074 for all outcomes) for data included in either ITT or per-protocol
analyses.

Primary Outcomes
Intention-to-Treat Analysis
Table 10 provides a summary of the ITT results for normally distributed variables. There
were no statistically significant group effects or time x group interactions for all five
psychological factors, resting GI symptoms, or for Ln (RMSSD) (p > 0.093). However, FFMQ
scores tended to increase, and PSS-14 and GAD-7 scores tended to decrease over time as
evidenced by modest sized, but statistically significant time effects (Table 10).
A summary of results for analyses of non-normally distributed variables is displayed in
Table 11. There were no statistically significant differences between groups for any of the
measures of GI symptoms during runs at any time point (p > 0.468).
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Table 9. Overview and Comparison of the Interventions
Intention-to-Treat Analysis
SLOWBC (n = 17)

NORMALBC (n=14)

P value

Total Treatment Days (d)*

30.9 ± 6.0

29.8 ± 3.8

0.539

Cohen’s d
(95% CI)
0.22 (-0.49, 0.93)

# Sessions Completed (d)

23.9 ± 4.1

24.4 ± 6.9

0.788

-0.10 (-0.81, 0.61)

% of Treatment Days
Completed**

79.4 ± 16.7

81.2 ± 17.4

0.771

-0.11 (-0.81, 0.60)

Mean Engagement (1-10)

7.6 ± 1.0

7.2 ± 0.9

0.270

0.41 (-0.31, 1.12)

Mean Pleasantness Rating
(1-10)

7.6 ± 1.1

7.0 ± 1.2

0.206

0.47 (-0.26, 1.18)

SLOWBC (n = 16)

NORMALBC (n = 13)

P Value

Total Treatment Days*

30.1 ± 4.9

30.0 ± 3.9

0.971

Cohen’s d
(95% CI)
0.01 (-0.72, 0.75)

# Sessions Completed

24.2 ± 4.1

25.5 ± 6.0

0.503

-0.25 (-0.99, 0.48)

% of Treatment Days
Completed

81.7 ± 14.2

84.3 ± 13.4

0.620

-0.19 (-0.92, 0.55)

7.7 ± 1.0

7.1 ± 0.8

0.074

0.69 (-0.07, 1.44)

Per-Protocol Analysis

Mean Engagement (1-10)

Mean Pleasantness Rating
7.6 ± 1.1
6.9 ± 1.1
0.080
0.68 (-0.08, 1.43)
(1-10)
Note: *Total treatment days refers to the number of days from the first breathing session completed until the last
session completed. This varies from the prescribed four weeks for some participants due to issues with compliance
and communication given the remote nature of the study. **Calculated as: (# Sessions Completed/Total Treatment
Days)*100. The intention-to-treat analysis comparisons included data from all participants that were allocated and
that submitted a treatment journal. The per-protocol analysis comparison included data from participants that met
the criteria for the inclusion in the per-protocol analyses as outlined in the methods section. P values and Cohen’s d
values are from independent t tests used to compare between groups.
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Table 10. Mixed ANOVA Results for Normally Distributed Variables: Intention-to-Treat
Measure

SLOWBC
(n=20)

NORMALBC
(n=18)

Control
(n=18)

Time Effect
P value (ηp2)
.087 (.045)

Group Effect
p value (ηp2)
.491 (.026)

Time*Group
p value (ηp2)
.153 (.061)

Resting GI
(0-70)
Pre
13.8 ± 7.9
15.7 ± 10.5
17.4 ± 8.2
Mid
14.0 ± 9.4
13.9 ± 11.6
15.3 ± 7.0
Post
14.6 ± 9.9
9.3 ± 7.6
15.1 ± 8.9
PSS-14 (0-56)
.029* (.065)
.748 (.011)
.538 (.029)
Pre
23.2 ± 8.2
24.6 ± 5.9
24.4 ± 4.9
Mid
22.5 ± 9.4
23.3 ± 5.2
22.6 ± 4.6
Post
21.2 ± 8.3
22.8 ± 6.2
23.8 ± 4.8
GAD-7 (0-21)
.008* (.087)
.740 (.011)
.093 (.072)
Pre
8.2 ± 4.7
9.1 ± 4.7
7.5 ± 3.5
Mid
6.8 ± 4.7
7.0 ± 4.3
8.1 ± 3.5
Post
6.0 ± 3.3
7.6 ± 3.7
7.1 ± 3.6
BVS (0-40)
.776 (.005)
.773 (.010)
.573 (.027)
Pre
19.0 ± 8.5
17.9 ± 8.8
19.2 ± 7.5
Mid
19.9 ± 7.3
17.7 ± 7.0
19.8 ± 6.3
Post
19.9 ± 9.1
18.2 ± 7.3
18.1 ± 6.9
VSI (15-90)⁑
.674 (.006)
.525 (.024)
.394 (.037)
Pre
22.0 ± 19.7
19.7 ± 17.7
22.4 ± 14.9
Mid
23.7 ± 22.0
16.1 ± 16.1
21.8 ± 17.2
Post
20.3 ± 17.6
19.6 ± 18.3
25.8 ± 19.5
FFMQ (15.023* (.068)
.367 (.037)
.762 (.017)
75)
Pre
51.5 ± 7.8
49.8 ± 9.2
48.2 ± 7.1
Mid
52.6 ± 8.1
50.8 ± 7.8
49.5 ± 9.3
Post
54.0 ± 8.0
50.6 ± 7.2
50.1 ± 6.9
Ln RMSSD†
.738 (.002)
.857 (.007)
.690 (.016)
(ms2)
Pre
4.1 ± 0.6
4.2 ± 0.6
4.1 ± 0.7
Post
4.1 ± 0.6
4.2 ± 0.7
4.2 ± 0.5
Note: All descriptive data is presented as means ± standard deviations. Mixed ANOVAs with one between-subject
factor (group allocation) and one within-subject factor (time) were used to evaluate the effects of the treatments.
The p values and measures of effect size (ηp2) are presented for each measure. * signifies that the effect was
statistically significant at p < 0.05. ⁑VSI results were square root transformed for use in Mixed ANOVA models
but are presented here as means ± standard deviations for ease of interpretation.† Due to missing data, sample sizes
for Ln RMSSD are as follows: SLOWBC (n=19), NORMALBC (n=15), Control (n=15).
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Table 11. Kruskal Wallis Test Results for Non-normally Distributed Data
Measure
All GI %
Pre
Post
Upper GI %
Pre
Post
Lower GI %
Pre
Post
Run GI Burden
(0-70)
Pre
Post
Measure

SLOWBC
(n=20)

Intention-to-Treat
NORMALBC
Control
(n=18)
(n=18)

P value

Effect Size (ε2)

63.3 (62.5)
50.0 (73.7)

66.7 (63.8)
53.6 (51.3)

60.0 (37.9)
50.0 (89.3)

.737
.951

.011
.002

50.0 (64.5)
26.8 (76.7)

32.5 (68.8)
25.0 (59.5)

33.3 (66.7)
45.0 (76.3)

.729
.719

.011
.012

48.6 (72.9)
29.2 (57.5)

50.0 (50.0)
36.7 (52.7)

40.0 (43.5)
33.3 (58.9)

.468
.688

.028
.014

7.0 (6.2)
4.0 (9.9)

7.7 (5.9)
6.0 (6.1)

.809
.709

.008
.012

P value

Effect Size (ε2)

SLOWBC
(n=16)

6.2 (6.3)
6.6 (11.4)
Per-Protocol
NORMALBC
Control
(n=13)
(n=18)

All GI %
Pre
63.3 (62.5)
71.4 (50.0)
60.0 (37.9)
.562
.025
Post
46.4 (70.2)
57.1 (54.2)
50.0 (89.3)
.677
.017
Upper GI %
Pre
41.7 (67.7)
25.0 (63.7)
33.3 (66.7)
.968
.001
Post
12.5 (60.0)
25.0 (50.0)
45.0 (76.3)
.579
.024
Lower GI %
Pre
57.1 (69.3)
60.0 (46.4)
40.0 (43.5)
.135
.087
Post
36.7 (57.5)
42.9 (54.2)
33.3 (58.9)
.724
.014
Run GI Burden
(0-70)
Pre
6.2 (6.2)
8.4 (5.7)
6.2 (6.3)
.779
.011
Post
3.7 (11.3)
6.0 (5.9)
6.6 (11.4)
.598
.022
Note: All descriptive data are presented as median (IQR). All p values and effect sizes are based on results from
Kruskal H tests comparing groups at the pre-intervention and post-intervention time-points independently. Effect
sizes are rank epsilon squared (ε2) statistics that were calculated from Kruskal Wallis H test results.

Per-Protocol Analysis
Table 12 displays the results from per-protocol analyses of normally distributed variables. There
was a significant time effect, F(2,74) = 7.70, p < 0.001, and a significant time x group
interaction, F(4, 74) = 2.53, p = 0.047, for GAD-7 scores. Analyses of simple main effects
suggested that GAD-7 scores decreased in the SLOWBC group from pre-intervention to
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midpoint (mean difference = 2.5 [95% CI = 0.1, 4.8]; p = 0.041) and from pre-intervention to
post-intervention (mean difference = 2.9 [95% CI = 0.5, 5.3]; p = 0.013). GAD-7 scores in the
NORMALBC group significantly decreased from pre-intervention to midpoint (mean difference
= 2.6 [95% CI = 0.1, 5.2]; p = 0.045) but did not change between other timepoints. Scores did
not significantly change between timepoints in the control group. Analysis of FFMQ scores
revealed a significant time effect, F(2,74) = 3.58, p = 0.033, and a significant group effect,
F(2,37) = 4.12, p = 0.024. However, there was not a time x group interaction, F(4,74) = 0.22, p =
0.928. The remainder of the effects were not statistically significant. Like the ITT analysis, nonparametric analyses did not reveal statistically significant group differences for measures of GI
symptoms during runs (p > 0.135; Table 11).

A Posteriori Analyses
To evaluate if compliance or engagement with the interventions affected the results, simple a
posteriori analyses were conducted. Data was collapsed across both experimental groups
(SLOWBC and NORMALBC) and Pearson’s correlation coefficients were calculated between
changes in the primary outcomes (post-intervention value – pre-intervention value) and 1)
average ratings of engagement with the treatment sessions and 2) average ratings of how pleasant
the sessions were. Most associations were not statistically significant (p > 0.05), but there was a
significant negative association between average ratings of engagement and change in GAD-7
scores from pre-to-post (n = 31; r = -0.43, p = 0.012). There was also a significant negative
association between mean rating of engagement and Ln(RMSSD) (n = 31; r = -0.44; p = 0.022).
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Table 12. Mixed ANOVA Results for Normally Distributed Variables: Per-Protocol
Measure

SLOWBC
(n = 13)

NORMALBC
(n = 11)

Control
(n = 16)

Time Effect
P value (ηp2)
.115 (.057)

Group Effect
p value (ηp2)
.364 (.053)

Time*Group
p value (ηp2)
.075 (.107)

Resting GI (070)
Pre
12.2 ± 7.2
15.3 ± 8.9
16.1 ± 7.2
Mid
12.5 ± 8.5
14.6 ± 12.0
15.0 ± 7.3
Post
12.9 ± 9.1
7.0 ± 3.7
15.3 ± 9.4
PSS-14 (0-56)
.073 (.068)
.252 (.072)
.683 (.030)
Pre
21.0 ± 8.2
24.7 ± 6.6
24.4 ± 5.1
Mid
20.3 ± 10.7
23.4 ± 6.2
22.5 ± 4.6
Post
18.5 ± 8.4
23.1 ± 7.4
23.4 ± 4.0
GAD-7 (0-21)
.001* (.172)
.357 (.054)
.047* (.120)
Pre
8.4 ± 4.8
10.3 ± 4.0
7.4 ± 3.6
Mid
5.9 ± 4.6
7.6 ± 4.7
8.1 ± 3.5
Post
5.5 ± 3.3
8.1 ± 4.2
6.7 ± 3.0
BVS (0-40)
.396 (.025)
.939 (.003)
.767 (.024)
Pre
17.1 ± 8.8
18.3 ± 9.4
18.8 ± 6.8
Mid
18.5 ± 6.5
17.9 ± 6.4
19.5 ± 5.3
Post
17.7 ± 8.2
17.6 ± 7.9
17.4 ± 6.2
VSI (15-90)⁑
.457 (.021)
.428 (.045)
.208 (.075)
Pre
16.3 ± 12.0
18.5 ± 13.7
21.6 ± 12.8
Mid
20.8 ± 19.1
14.4 ± 13.4
20.4 ± 14.4
Post
18.8 ± 18.0
12.5 ± 11.6
23.8 ± 18.3
FFMQ (15-75)
.033* (.088)
.024* (.182)
.928 (.012)
Pre
54.2 ± 4.3
46.3 ± 8.5
48.1 ± 6.7
Mid
54.8 ± 7.0
48.3 ± 7.3
49.8 ± 9.3
Post
55.7 ± 6.2
48.1 ± 6.9
50.3 ± 6.7
Ln (RMSSD)†
.892 (.001)
.746 (.018)
.289 (.075)
(ms2)
Pre
4.2 ± 0.6
4.3 ± 0.6
4.1 ± 0.7
Post
4.0 ± 0.6
4.3 ± 0.8
4.2 ± 0.5
Note: All descriptive data is presented as means ± standard deviations. Mixed ANOVAs with one between-subject
factor (group allocation) and one within-subject factor (time) were used to evaluate the effects of the treatments.
The p values and measures of effect size (η2) are presented for each measure. * signifies that the effect was
statistically significant at p < 0.05. ⁑VSI results were square root transformed for use in Mixed ANOVA models
but are presented here as means ± standard deviations for ease of interpretation.† Due to missing data, sample sizes
for Ln(RMSSD) are as follows: SLOWBC (n=12), NORMALBC (n=8), Control (n=15).

Discussion
The purpose of this randomized controlled trial was to evaluate the effects of simple
breathing interventions on GI symptoms, psychological factors, and HRV in runners. The
SLOWBC and NORMALBC groups were assigned to complete five minutes of daily breathing
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sessions over the course of four weeks. The only evidence of a significant treatment effect was a
time x group interaction for GAD-7 scores in the per-protocol analysis. Specifically, GAD-7
scores tended to decrease over time in the SLOWBC and NORMALBC groups, but not the
control group. However, scores significantly declined from pre-intervention to post-intervention
in SLOWBC only, which suggests that this intervention had more persistent effects than
NORMALBC. However, there were no other statistically significant effects of either treatment
on the remaining outcomes. The generally null findings are somewhat surprising considering the
recently reported associations between psychological factors and GI symptoms during exercise
(Wilson, 2018; Wilson, 2020a; Wilson et al., 2021), the beneficial effects of psychological
treatments on GI symptomology in other contexts (Ballou & Keefer, 2017; Kinsinger, 2017), and
the previously reported effects from other simple breathing interventions (Chung et al., 2010;
Hjelland et al., 2007; Russo et al., 2017).
There are several potential explanations for the null findings. First, the interventions may
not have been intensive enough to produce meaningful changes in the outcomes. The short
duration (five minutes daily) and simplicity of the interventions were chosen because the remote
nature of the study required simple-to-perform interventions. Further, we were interested in
evaluating interventions that (if efficacious) would be simple and feasible for athletes to add to
their busy schedules. Previous studies have reported significant benefits from other simple and
short-duration interventions across similar timeframes (Chung et al., 2010; Hjelland et al., 2007;
Mackenzie et al., 2006). However, these previous studies had additional aspects that may have
facilitated larger effects. For example, Chung et al. (2010) also used a home-based breathing
intervention over the course of four weeks, but participants were first given a 30-minute training
session on proper breathing technique before the intervention. They also completed the breathing
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three times each day compared to once daily in the present study. Like the interventions used in
the present study, Hjelland et al. (2007) used a breathing intervention that was five minutes per
day for four weeks. But the intervention had an additional vagal biofeedback component that
could have enhanced the effects. Thus, it is possible that SLOWBC and NORMALBC did not
provide a strong enough stimulus to induce noticeable changes. Or the five minutes of breathing
per day could have caused short-lasting benefits on the psychological factors that did not persist
long enough to be detected in the post-intervention measurements.
Another possibility is that the effectiveness of the interventions and statistical power may
have been influenced by suboptimal compliance. Participants completed, on average, about 80%
of the breathing sessions, but this ranged from 40.7% to 100%. Given that the interventions were
just five minutes/day for four weeks, it is possible that greater compliance was needed to elicit a
detectable treatment effect. Additionally, several participants were excluded from the perprotocol analysis due to poor compliance (completing <50% of sessions) or because they were
lost to follow-up, which likely affected statistical power. While these participants were retained
in the ITT analysis, ITT analyses tend to be more conservative than per-protocol analyses since
they assume no change in outcomes for those that withdraw prematurely and retain data from
those with poor compliance to the treatment (Gupta, 2011).
In addition to compliance, the general nature of the interventions may have become
repetitive over time or affected how engaged participants felt during the sessions. A posteriori
analyses were conducted to evaluate whether engagement levels in the interventions could have
influenced the null findings. Higher average ratings of engagement in the interventions were
associated with larger reductions in GAD-7 scores (r = -0.43; p = 0.012). Notably, SLOWBC
tended to have higher mean ratings of engagement, though it did not reach statistical significance
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(Cohen’s d = 0.69; p =0.074; Table 9). The association between GAD-7 change scores and
ratings of engagement, and the group differences in engagement, may partially explain why
GAD-7 significantly declined from pre-intervention to post-intervention for SLOWBC, but not
NORMALBC in the per-protocol analysis. Regardless, levels of engagement should be
considered in future studies, though it is still not clear whether this explains the null findings
since engagement ratings were not significantly associated with change scores for the outcomes
besides GAD-7.
As seen in Table 7, there was also variability in terms of compliance to study procedures
in terms of timing of measurements. It is inevitable that compliance will vary in a remote study
of this nature, but it could theoretically influence the results. For example, any transient effects
of the breathing interventions may not be detected in participants that have a multiple-day delay
between the final treatment session and completion of post-intervention measurements.
Finally, the relatively small sample size combined with outcomes that had relatively large
amounts of variance could have affected the ability to statistically detect group differences. For
example, several of the measurements of GI symptoms during running had measures of variance
that were larger than the measures of central tendency (See Table 11). Given the large variance
in some outcomes, it is possible that detecting statistically significant changes would have
required a relatively large treatment effect and/or more statistical power.
There are several limitations to this study. First, all aspects of the study were done
remotely, which may have influenced the accuracy of the measurements, compliance to study
procedures, and potentially the effectiveness of the interventions. This decision was made due to
the restrictions placed on human subjects’ research at the time of study design and throughout
data collection due to the COVID-19 pandemic. To maximize the likelihood of success,
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participants were regularly contacted throughout the study through video calls, phone calls, and
email. Detailed instructions were provided for each measurement, and participants were
encouraged to contact the investigators if they had any difficulty with the procedures.
Regardless, it is possible that the remote nature of the study affected the results, particularly
since the investigators could not directly observe compliance to the measurement or intervention
procedures. Second, because of the remote nature of the study and to reduce burden on the
participants, there was no effort to account for some potential confounding factors such as
nutrition intake. Well-controlled studies in a laboratory setting may be useful to identify the
effects of psychological treatments on GI dysfunction during exercise, or at least to identify
interventions that are most likely to elicit positive results in future remote studies such as this
one. Finally, the sample of participants included in the analyses was relatively small after
accounting for those that withdrew or declined to participate. The decision was made to require
participants to report at least occasional GI discomfort during runs, and to score at least a 5 on
the GAD-7. This was done to maximize the likelihood of the intervention having a benefit, but it
may have also limited sample size. Further, recruitment was restricted to the contiguous United
States so that HRV monitors could be efficiently shipped to participants at the beginning and end
of the study.
In summary, the present findings suggest that five minutes of breathing exercises per day
for four weeks did not clearly influence psychological factors, GI symptoms (at rest or during
running), or HRV. Results of per-protocol and exploratory a posteriori analyses suggest that
runners who comply with breathing interventions and find them engaging may experience some
modest reductions in GAD-7 with little change in other outcomes. Future studies should evaluate
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the effects of more intensive psychological treatments in well-controlled studies to determine
whether reductions in stress or anxiety positively influences GI symptoms during exercise.
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CHAPTER VI
SUMMARY AND CONCLUSIONS
GI disturbances and symptoms are a common problem for many endurance athletes, particularly
those that compete in events such ultra-marathons and long-duration triathlons (de Oliveira et al.,
2014; Jeukendrup et al., 2000; Stuempfle & Hoffman, 2015). Considerable research has
attempted to identify the underlying pathophysiology of exercise-induced GI symptoms, which
appears to be due to a complex interaction of circulatory, neuroendocrine, and mechanical
factors (Costa et al., 2017b; de Oliveira et al., 2014; van Wijck et al., 2012). Further, there are
numerous well-established risk factors for experiencing symptoms during exercise such as
younger age, less training experience, higher intensity and longer duration exercise, hot and
humid environments, consumption of various nutritional components (protein, fats, fibers), and
use of certain dietary supplements (caffeine, sodium bicarbonate) and NSAIDs (de Oliveira et
al., 2014; Peters et al., 1999; Pfeiffer et al., 2012; Snipe et al., 2018; Wilson, 2018). The role of
psychological factors in causing GI symptoms during exercise remains underexplored, despite a
strong psychobiological plausibility (Wilson, 2020b) and considerable research on the how
psychological factors influence GI function in other contexts (Haug et al., 2002; Labanski et al.,
2020; Mayer & Tillisch, 2011). Recent studies found that measures of stress and anxiety were
associated with GI symptoms during 30 days of running (Wilson, 2018) and during endurance
races (Wilson, 2020a; Wilson et al., 2021), but much more research is needed.
The overall purpose of this dissertation was to evaluate the role of psychological factors
in the context of GI symptoms during running. This was addressed via two studies. Study 1 was
an observational survey-based study that sought to evaluate: 1) the associations between several
psychological factors (stress, anxiety, GI-specific anxiety, body vigilance) and GI symptoms
across seven days of running, 2) the associations between the psychological factors and nutrition
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intake before and during runs and 3) if any resulting associations between psychological factors
and nutrition intake were mediated by reported GI symptoms. It was hypothesized that runningrelated GI symptoms would be positively associated with scores on the psychological
questionnaires, that scores on the psychological questionnaires would be negatively associated
with the nutrition intake variables (i.e., higher levels of stress/anxiety would be associated with
lower intake before and during runs), and that the associations between the psychological scores
and nutrition intake would be mediated by the measures of GI symptoms. Study 2 was a
randomized controlled trial that evaluated the effects of two simple daily breathing interventions
(SLOWBC and NORMALBC) on measures of GI symptoms (resting and during runs),
psychological factors, and HRV. It was hypothesized that both the SLOWBC and NORMALBC
would mitigate GI symptoms and measures of stress and anxiety and increase mindfulness and
HRV compared to the control group, with SLOWBC having larger effects than NORMALBC.
For study 1, 82 runners (43 males, 39 females; age = 47.0 ± 19.0 years; running
experience = 12.0 ± 16.0 years) tracked information about their runs (duration, RPE, GI
symptoms, nutrition intake before and during) for seven days and completed an electronic survey
that contained questions about demographic information and four psychological questionnaires
(PSS-14, STICSA-Trait, BVS, VSI). All participants were at least 18 years of age, currently
running at least 20 miles per week, and had completed at least one run that was >60 minutes in
duration during the two weeks leading up to enrollment. Surprisingly, measures of GI symptoms
during runs were not significantly associated with scores on the PSS-14, STICSA-Trait, or BVS.
Further, there were not significant negative associations between psychological scores and
nutrition intake as hypothesized. This lack of negative associations meant that mediation
analyses were not performed to evaluate specific aim #3. However, scores on the VSI were
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significantly associated with the measures of GI discomfort (rho = 0.32 – 0.38; p < 0.003), and
the associations remained significant after controlling for potential confounders (partial rho =
0.23 – 0.25; p < 0.043).
The VSI questionnaire was designed to evaluate GI-specific anxiety, or fears and anxiety
related to sensations within the GI system specifically (Labus et al., 2004). GI-specific anxiety
and other GI-specific psychological constructs are thought to be important factors in the severity
of functional GI conditions such as IBS (Jerndal et al., 2017; Labus et al., 2004; Labus et al.,
2007), and there is some evidence that the benefits of psychotherapies on IBS outcomes are
mediated by reductions in VSI scores (Windgassen et al., 2017). VSI scores have also been
shown to correlate with GI symptom scores in healthy controls or non-IBS comparison samples
(Labus et al., 2007; Saigo et al., 2014). Thus, the finding of VSI scores being significantly
associated with GI symptoms in exercise contexts is interesting and requires further research.
Notably, studies should continue to evaluate whether GI-specific anxiety or other GI-specific
psychological constructs are associated with symptomology in exercise settings. Further,
experimental studies could attempt to target reductions in GI-specific anxiety and determine if
that reduces GI symptomology during exercise.
For study 2, 63 runners with at least mild anxiety and occasional GI symptoms during
runs were enrolled, with 56 being randomized into one of the three groups (18 males, 36 females;
age= 37.4 ± 12.4 years; running experience = 15.4 ± 10.4 years). Each participant was sent
materials and instructions for three pre-intervention measurements: 1) a running journal to track
information about their runs and GI symptoms for seven days, 2) a portable HRV monitor to take
a resting HRV measurement, and 3) an electronic survey that asked about demographic
information, resting GI symptoms, and contained five psychological questionnaires (PSS-14,
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GAD-7, BVS, VSI, FFMQ). After these measurements were completed, participants were
randomly allocated into one of the three groups. The SLOWBC and NORMALBC groups were
sent materials and instructions for video-guided 5-minute breathing interventions, which they
were asked to complete daily for four weeks. The interventions were similar except that the
SLOWBC group was asked to breathe deeply at six breaths/minute while the NORMALBC
group was asked to breathe normally at 15 breaths/minute. Both groups were asked to engage in
breath counting. The control group was asked to not engage in breathing exercises during their
time in the study. A second running journal and HRV monitor were sent to participants three
weeks into the intervention to complete post-intervention measurements during the final week.
Additional electronic surveys were sent after week two (midpoint) and on the last day of the
intervention (post-intervention).
Overall, there was no significant effects of either intervention on the primary outcomes
compared to the control group except for a time x group interaction for GAD-7 scores in the perprotocol analysis (Table 12). Simple main effects analyses suggested that GAD-7 scores
decreased from pre-intervention to midpoint in SLOWBC and NORMALBC groups, and from
pre-intervention to post-intervention in the SLOWBC group. There were no significant changes
over time in the control group. These findings suggest that the treatments may have had a modest
effect on anxiety, but that it was more persistent in the SLOWBC group. The persistent effect
may be related to higher mean ratings of engagement in the treatment. For example, exploratory
a posteriori analyses suggested that higher ratings of engagement in the treatment sessions was
associated with greater reductions in GAD-7 scores (r = -0.43; p = 0.012) and the SLOWBC
participants tended to report higher mean ratings of engagement in a per-protocol analysis,
though it did not reach statistical significance (Cohen’s d = 0.69; p = 0.074; Table 9).
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However, the remainder of the analyses did not suggest significant treatment effects for
any of the other outcomes. There are several potential explanations for the null findings. It is
possible that the interventions were not intensive enough to meaningfully affect the outcomes
during the midpoint and post-intervention periods. While other similar interventions have elicited
significant results, they have also tended to include additional components such as preintervention training sessions and sessions multiple times per day (Chung et al., 2010), or the
addition of vagal biofeedback to the five minutes of breathing (Hjelland et al., 2007). Additional
factors that could have affected the results are poor compliance to study procedures, a relatively
small sample size, and large amounts of variance in some of the primary outcomes.
Across the two studies, the findings did not support most of the a priori hypotheses. In
study 1, VSI score was the only measure of psychological factors that significantly correlated
with GI discomfort during seven days of running. The hypothesis of a negative association
between psychological scores and nutrition intake was also not supported. It is important to note
that these measurements were taken during a typical training week. Future studies should
evaluate these factors during the week of a competitive race when it is expected that anxiety
levels and nutrition intake would be higher. For example, Wilson et al. (2021) found that
individuals in the top tertile for state anxiety on the morning of a race had significantly higher
odds of experiencing GI symptoms such as nausea and regurgitation/reflux during the race.
However, the finding of a significant association between VSI scores and GI symptoms is
interesting and will hopefully spur additional research on the role of GI-specific anxiety or other
GI-specific psychological constructs in the context of exercise. The hypothesis that the
SLOWBC and NORMALBC interventions would positively influence the primary outcomes in
study 2 was also mostly not supported. As mentioned previously, this could be attributed to

142

several explanations. Regardless, the results suggest that if a runner wishes to reduce exerciserelated GI symptoms, then five minutes of daily breathing exercises is not a sufficient
intervention to achieve substantial improvements. Future research should evaluate more
intensive psychological treatments in well-controlled settings. If highly effective interventions
are identified in well-controlled settings, then follow-up studies should consider evaluating their
efficacy in less controlled settings.
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